Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ACTC1 "ACTC, CMD1R" ENSG00000159251 "Actin alpha cardiac muscle 1" P68032 15 34790230-34795549 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "heart muscle: 11410.0" "Cell type enriched" "Detected in some" 30 "Cardiomyocytes: 9746.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 20.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1131.8;LHCN-M2: 4544.5;RH-30: 2053.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB037330, HPA041264, HPA041271" Enhanced NA NA 2400000000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (8.18e-3)" "unprognostic (3.74e-2)" "unprognostic (4.82e-3)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (3.26e-1)" "unprognostic (2.05e-3)" "unprognostic (2.26e-1)" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (2.10e-3)" "unprognostic (5.68e-4)" "unprognostic (8.79e-2)" "unprognostic (1.65e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (9.32e-4)" 51.1 1.8 1.9 24.7 1.7 0.0 11.9 2.1 2.6 8.6 1.3 4.0 0.8 6.9 1.1 22.8 1.6 11.8 11410.0 1.9 2.8 1.5 0.6 3.9 2.6 2.7 2.8 3.2 12.9 1.0 2.2 8.9 3.0 73.0 3.6 31.6 11.5 538.1 135.2 4.6 0.6 8.8 1.4 1.3 9.3 0.5 4.0 11.3 2.4 195.0 0.2 439.6 16.1 1.5 0.0 0.2 0.1 0.0 0.2 3.3 0.2 2.2 0.7 5.2 1.3 0.0 0.0 0.0 1.3 1131.8 0.2 0.0 0.4 0.0 1.3 0.0 0.0 0.1 23.9 0.0 0.1 1.4 0.0 457.2 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 4544.5 0.0 0.0 0.0 3.8 0.0 0.0 0.0 2053.3 0.0 0.0 0.0 0.1 0.1 4.0 0.0 0.0 31.2 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.7 2.1 2.6 1.9 2.8 2.7 2.8 3.0 1.4 4.0 1.5 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 11.9 0.1 0.0 9746.1 0.0 0.0 0.0 20.9 0.1 0.0 0.0 1.9 0.0 5.0 0.0 0.1 69.2 0.0 0.0 0.2 0.2 4.3 315.2 0.0 0.0 0.0 0.1 0.4 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 63.4 86.5 1.0 0.7 0.0 0.4 0.3 0.1 0.1 0.0 0.0 ADAMTSL2 KIAA0605 ENSG00000197859 "ADAMTS like 2" Q86TH1 9 133532164-133575519 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 73.2;liver: 35.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;Endothelial cells: 5.7;Fibroblasts: 8.5;Microglial cells: 12.2;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 7.4;RPMI-8226: 10.1;SH-SY5Y: 30.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045634, HPA053812" Approved Approved Vesicles "Secreted in other tissues" NA NA 170000000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA045634: AB_2679399, HPA053812: AB_2682271" "unprognostic (5.10e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.35e-2)" "unprognostic (1.07e-1)" "unprognostic (5.50e-2)" "unprognostic (6.78e-3)" "unprognostic (1.31e-2)" "unprognostic (5.49e-2)" "unprognostic (1.35e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.17e-2)" "unprognostic (7.37e-2)" "unprognostic (1.56e-1)" "unprognostic (3.40e-1)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" 3.7 28.5 6.8 1.0 7.3 0.1 1.5 12.0 10.1 2.3 1.4 2.7 1.4 3.1 3.1 1.8 3.1 2.5 73.2 5.8 7.9 25.9 35.8 23.2 3.4 19.3 11.1 4.9 7.1 1.2 15.9 1.5 20.8 8.4 0.3 0.3 3.4 2.2 4.3 0.8 3.2 0.9 8.5 6.4 2.3 3.1 9.3 0.6 12.1 0.5 0.6 5.3 1.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.6 0.5 0.0 1.1 0.7 10.1 0.0 0.0 1.4 30.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 7.3 12.0 10.1 5.8 7.9 19.3 11.1 20.8 8.5 9.3 7.6 1.4 0.0 0.5 4.9 0.1 0.1 0.1 0.0 0.0 4.2 0.0 0.1 2.3 0.0 0.0 1.8 0.0 0.1 0.0 1.4 5.9 0.2 0.1 0.1 0.1 5.7 5.3 0.0 5.0 0.0 0.1 8.5 0.0 0.0 0.0 0.1 4.6 0.9 0.3 0.0 3.8 0.4 0.0 0.3 0.8 1.1 4.7 0.6 0.0 12.2 0.0 0.4 0.0 2.5 4.0 0.2 0.5 3.0 0.0 0.2 0.0 0.7 0.0 0.2 6.6 1.1 1.6 0.1 0.8 0.4 0.3 0.0 0.6 0.7 1.1 0.2 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449090 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;heart muscle: 105.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2" "Region enriched" "Detected in all" 5 "basal ganglia: 388.0" "Region enriched" "Detected in all" 6 "basal ganglia: 155.9" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 18.9 3.3 25.5 4.9 97.7 0.0 10.6 13.9 43.9 9.8 0.0 35.1 5.2 14.7 5.7 18.8 12.7 10.0 105.2 25.8 15.9 12.8 3.3 4.1 2.3 20.5 18.3 13.2 7.5 0.8 14.3 6.1 17.4 19.8 5.6 4.5 4.0 21.5 2.7 2.6 13.0 18.2 10.8 6.5 21.2 8.2 34.4 1.3 1.9 5.8 3.0 23.2 7.8 30.1 0.0 0.6 1.3 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.2 2.3 0.5 0.6 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 15.5 0.0 0.0 0.8 0.0 0.1 0.0 0.3 2.7 5.2 0.5 1.8 1.6 0.0 0.5 0.1 1.7 0.0 0.1 0.0 0.1 1.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 97.7 13.9 43.9 25.8 15.9 20.5 18.3 17.4 10.8 34.4 30.1 0.3 0.0 0.0 8.1 0.1 0.3 0.1 0.2 0.0 21.8 0.4 5.8 75.5 8.6 0.0 7.3 0.0 1.4 0.0 2.6 0.0 15.9 0.9 1.5 7.1 1.8 0.0 0.0 34.0 6.9 4.0 5.2 0.0 4.0 0.0 4.6 3.9 0.1 0.3 0.0 44.0 0.3 0.0 0.0 0.3 3.0 20.5 0.1 0.0 6.5 1.0 1.0 0.0 19.1 89.7 0.4 59.6 73.7 0.0 0.1 0.3 0.8 0.0 2.2 65.7 0.6 21.4 0.8 6.3 0.2 0.9 12.4 0.2 1.0 2.0 0.1 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551278-141655244 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.4;Inhibitory neurons: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 97.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: AB_2682164" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 10.1 14.7 9.4 8.5 10.9 5.6 11.9 8.3 12.8 11.5 10.2 11.8 5.9 11.7 14.5 12.2 12.2 7.8 30.4 11.1 10.8 15.7 14.1 11.6 12.1 8.0 8.8 11.3 10.1 21.5 13.7 10.0 9.0 12.8 13.1 12.7 13.7 11.4 8.6 9.6 12.0 15.4 8.2 16.6 12.2 6.6 10.0 14.0 12.7 10.0 14.7 10.8 11.5 9.0 23.7 25.6 26.7 21.8 21.2 29.4 16.2 23.5 29.3 44.5 50.9 24.7 18.3 26.3 24.0 26.8 40.5 18.7 41.6 32.8 51.0 33.8 32.7 26.1 10.7 18.7 34.1 15.6 12.5 29.9 26.9 36.3 33.1 19.8 34.1 32.3 36.3 36.9 25.3 24.6 47.3 9.1 25.6 19.9 32.4 29.2 4.2 80.1 33.1 20.8 23.3 29.6 24.6 29.7 27.1 26.1 16.3 20.2 19.5 18.9 14.1 23.8 38.1 29.5 31.9 14.4 30.7 9.1 50.4 0.4 7.1 1.2 22.1 13.9 15.3 10.8 17.3 26.0 16.2 6.5 12.8 23.5 1.2 97.3 8.2 6.3 18.9 15.7 9.4 10.9 8.3 12.8 11.1 10.8 8.0 8.8 9.0 8.2 10.0 9.0 8.4 0.0 6.0 22.5 11.4 3.1 5.6 7.9 5.2 11.8 5.5 5.1 18.1 2.8 6.6 12.9 8.4 15.7 15.8 3.0 9.8 6.6 9.9 7.4 9.0 7.5 0.0 11.8 43.4 6.9 8.2 7.7 10.7 6.6 8.2 9.9 4.2 4.1 7.0 15.2 43.0 3.9 12.2 5.1 4.9 12.0 6.8 5.6 7.2 26.2 12.4 11.2 27.8 38.7 37.9 6.1 2.1 10.5 22.1 2.9 2.4 8.2 7.6 17.4 0.0 6.2 8.0 6.2 4.9 11.3 2.7 9.2 15.0 14.2 5.6 3.8 ANKRD1 "ALRP, C-193, CARP, CVARP, MCARP" ENSG00000148677 "Ankyrin repeat domain 1" Q15327 10 90912096-90921087 "Metabolic proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "heart muscle: 6540.8" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 13820.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 474.5;EFO-21: 1248.9;hTERT-RPE1: 679.8;LHCN-M2: 1573.6;SuSa: 469.1;TIME: 2206.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA038736 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoli fibrillar center" Nucleoplasm "HPA038736: AB_2676184" "unprognostic (2.45e-1)" "unprognostic (6.14e-3)" "unprognostic (2.24e-1)" "unprognostic (4.39e-1)" "unprognostic (9.14e-3)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.28e-2)" "unprognostic (6.63e-3)" "unprognostic (2.19e-1)" "unprognostic (3.27e-1)" "unprognostic (4.51e-2)" "unprognostic (3.40e-1)" "unprognostic (2.72e-5)" "unprognostic (3.40e-2)" "unprognostic (2.79e-1)" "unprognostic (7.22e-2)" "unprognostic (3.16e-3)" 0.9 0.7 0.0 0.4 0.0 0.0 1.8 0.2 0.3 0.6 0.6 0.7 0.0 0.4 0.0 0.6 0.1 1.3 6540.8 0.0 0.2 0.7 1.6 48.6 2.5 0.0 0.2 0.7 4.8 0.2 1.1 4.2 0.0 6.8 0.0 0.0 8.7 0.1 571.0 2.3 0.6 2.1 0.0 0.5 1.0 0.9 0.8 1.5 1.7 20.5 0.0 1.2 0.5 0.1 37.2 10.8 6.6 0.3 5.8 6.7 0.5 21.5 2.2 6.0 10.8 474.5 17.9 0.3 1248.9 1.8 48.5 13.3 2.3 3.1 15.7 1.4 1.2 0.2 2.9 148.5 27.7 0.0 0.0 44.2 0.1 9.5 21.6 679.8 437.8 0.0 0.3 0.0 1573.6 0.4 0.0 0.0 1.3 2.7 0.3 0.0 104.3 0.0 3.9 0.5 0.1 0.0 0.3 0.4 1.2 469.1 0.3 1.9 2206.7 4.1 163.9 3.2 175.0 0.0 1.2 3.0 0.9 0.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.0 913.5 42.0 0.0 0.0 0.0 3.5 18.5 0.0 0.0 0.0 0.0 13820.4 7.2 6.6 0.0 0.0 0.6 0.0 0.0 0.0 66.3 5.7 9.4 0.2 83.6 0.0 0.0 0.0 0.2 0.2 243.5 0.0 4.6 3.8 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.0 0.1 1.0 0.0 0.0 74.5 100.9 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.1 AP2M1 "AP50, CLAPM1, mu2" ENSG00000161203 "Adaptor related protein complex 2 subunit mu 1" Q96CW1 3 184174689-184184091 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036849, HPA069870" Uncertain Supported "Plasma membrane" NA NA 7500 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane" "HPA036849: AB_10672101, HPA069870: AB_2686217" "unprognostic (1.16e-1)" "unprognostic (1.35e-2)" "unprognostic (5.28e-3)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (9.12e-4)" "unprognostic (3.80e-3)" "unprognostic (2.09e-1)" "unprognostic (5.53e-2)" "unprognostic (4.11e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (7.45e-6)" "unprognostic (2.61e-2)" "unprognostic (4.09e-2)" "unprognostic (1.60e-2)" "unprognostic (1.28e-1)" 191.8 364.2 233.5 164.7 250.3 231.3 164.6 211.3 257.3 222.8 196.3 232.4 167.5 216.4 104.2 218.1 178.6 166.5 366.2 261.1 249.0 196.0 140.9 180.0 148.2 234.8 211.1 198.6 106.4 224.8 224.9 243.3 248.9 183.2 141.1 230.4 167.2 231.8 181.2 157.2 156.2 243.7 200.9 162.5 156.3 106.4 235.4 158.4 148.0 194.0 157.6 223.7 192.4 225.6 436.3 327.5 275.7 311.8 432.1 450.8 284.3 714.3 412.5 788.5 550.5 355.1 309.9 198.2 851.3 1076.1 516.1 480.0 376.3 482.9 647.1 409.8 470.4 512.2 365.8 317.9 508.9 254.8 311.5 577.0 269.4 501.1 318.5 711.0 595.3 258.3 250.0 377.1 750.1 993.6 330.1 151.2 674.1 388.1 484.7 302.7 351.5 393.7 489.7 389.3 292.0 212.6 561.3 696.4 335.1 427.5 934.4 305.7 645.0 497.1 400.1 492.4 960.2 336.9 318.7 441.6 937.1 369.9 331.7 194.4 294.8 244.9 137.5 238.8 136.2 114.3 127.6 134.0 268.7 112.7 107.7 111.8 127.7 170.2 206.8 134.1 185.4 441.0 233.5 250.3 211.3 257.3 261.1 249.0 234.8 211.1 248.9 200.9 235.4 225.6 146.8 54.5 50.7 41.4 84.8 124.9 177.2 275.1 97.9 174.2 108.0 98.2 195.9 112.9 133.5 114.0 70.9 400.9 117.3 155.9 375.6 243.7 326.6 69.3 131.2 172.2 140.8 277.8 62.0 161.3 327.1 161.5 71.4 78.5 149.1 173.6 182.4 78.0 576.9 277.6 63.4 119.0 201.4 137.1 162.9 347.8 164.7 185.1 199.3 34.7 369.4 199.4 130.7 26.2 46.1 232.1 153.1 214.8 100.2 138.8 253.8 290.7 58.3 125.9 197.2 106.9 278.0 83.3 101.7 128.5 126.6 513.6 102.6 278.1 154.1 185.1 ASAH1 "AC, ACDase, ASAH, FLJ21558, PHP32" ENSG00000104763 "N-acylsphingosine amidohydrolase 1" Q13510 8 18055992-18084998 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 573.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 777.0;Hofbauer cells: 921.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 392.8;SK-MEL-30: 590.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005468 Supported "Intracellular and membrane" NA NA 400000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" "HPA005468: AB_1845062" "unprognostic (1.99e-1)" "unprognostic (1.86e-1)" "unprognostic (4.15e-3)" "unprognostic (9.23e-2)" "unprognostic (4.69e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-2)" "unprognostic (4.29e-3)" "unprognostic (2.44e-1)" "unprognostic (4.85e-2)" "unprognostic (1.89e-1)" "unprognostic (3.03e-2)" "prognostic favorable (3.08e-8)" "unprognostic (1.95e-1)" "unprognostic (3.91e-2)" "unprognostic (6.54e-3)" "unprognostic (7.36e-3)" 214.3 71.9 50.1 51.6 51.5 107.7 95.8 62.1 50.8 98.5 62.6 84.3 54.7 55.8 131.5 73.2 70.4 99.1 573.9 49.9 66.2 204.0 60.9 190.3 65.9 66.0 59.4 50.1 49.6 117.8 83.6 121.5 69.0 84.3 87.0 79.5 66.6 77.9 66.0 52.6 56.8 61.7 66.3 85.4 61.2 18.2 59.1 26.0 325.5 70.7 57.7 112.8 54.8 102.2 48.1 66.4 25.9 63.3 392.8 46.0 39.2 48.2 67.3 23.0 41.0 35.4 66.1 30.2 60.3 54.5 159.1 62.6 15.0 25.3 28.4 22.9 38.9 134.4 46.7 96.7 107.5 27.7 140.7 100.2 86.5 33.6 22.9 53.2 6.2 50.6 24.3 61.7 67.9 46.0 15.5 48.3 30.3 105.2 40.5 19.4 25.5 41.4 112.0 273.0 40.4 55.0 43.8 145.2 590.5 35.6 47.9 31.3 43.6 30.3 43.1 55.8 23.7 75.5 184.3 22.0 89.5 61.3 24.6 285.2 455.4 318.7 47.6 676.4 43.1 83.9 35.5 36.1 175.1 65.9 40.8 37.9 627.6 60.5 731.4 33.0 43.7 407.2 50.1 51.5 62.1 50.8 49.9 66.2 66.0 59.4 69.0 66.3 59.1 102.2 98.5 317.3 405.0 36.9 92.8 58.6 83.3 103.7 35.3 97.5 105.6 87.8 777.0 100.1 280.9 450.6 45.9 177.4 67.6 83.4 60.7 150.6 2.8 85.7 51.5 79.7 98.1 106.3 49.8 104.1 65.2 122.0 43.3 133.8 257.0 49.3 134.6 50.6 921.2 77.4 53.2 99.3 201.4 564.3 89.9 6.0 88.6 524.6 318.4 56.2 259.2 532.6 53.5 49.8 49.0 64.7 125.5 105.7 87.4 87.8 77.6 304.2 147.3 88.0 177.5 74.5 157.0 14.0 63.6 84.9 64.2 148.2 61.3 53.4 89.7 139.9 B3GALNT1 "B3GALT3, beta3Gal-T3, galT3, GLOB, P1" ENSG00000169255 "Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)" O75752 3 161083883-161105411 "Blood group antigen proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 53.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 56.3;Cardiomyocytes: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 8.8;NK-cell: 22.1" "Group enriched" "Detected in many" 7 "granulocytes: 8.8;NK-cells: 22.1" "Cell line enhanced" "Detected in many" "RT4: 128.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041204 Approved Vesicles NA NA 400000 "Cluster 48: NK-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA041204: AB_10795585" "unprognostic (3.85e-2)" "unprognostic (5.11e-3)" "unprognostic (3.02e-1)" "unprognostic (1.06e-2)" "unprognostic (7.83e-2)" "unprognostic (4.07e-2)" "unprognostic (9.26e-5)" "unprognostic (1.49e-2)" "unprognostic (1.12e-2)" "unprognostic (1.88e-2)" "unprognostic (3.44e-2)" "unprognostic (3.24e-1)" "unprognostic (2.09e-3)" "unprognostic (1.32e-1)" "unprognostic (4.90e-2)" "unprognostic (3.66e-2)" "unprognostic (3.19e-3)" 5.3 7.2 20.7 3.9 21.5 4.8 9.8 14.7 19.6 20.1 8.0 2.7 1.9 9.9 8.5 6.8 14.2 9.9 53.3 21.7 26.7 19.4 1.2 14.6 4.9 12.8 21.7 18.8 11.1 8.6 9.8 13.9 18.0 11.6 2.4 26.6 22.3 8.5 1.4 2.5 2.4 9.9 14.1 6.2 10.7 8.4 25.7 2.8 27.0 3.2 5.4 12.3 5.4 13.0 17.3 0.3 7.5 0.1 1.0 2.8 0.1 9.3 8.7 22.3 7.3 11.3 13.2 0.0 35.7 8.0 12.7 3.9 0.0 16.9 7.5 0.0 0.0 9.0 5.7 0.0 11.2 0.2 0.0 23.3 5.4 6.1 1.4 15.6 31.6 0.0 0.0 0.0 8.3 29.4 0.1 0.0 17.4 0.2 38.9 0.1 0.0 0.2 9.3 128.3 15.1 0.1 23.7 8.8 6.3 3.0 35.6 13.3 0.0 0.2 15.5 0.5 0.2 3.6 0.1 0.2 14.7 0.0 0.0 8.8 0.2 0.0 0.4 0.2 0.4 2.3 0.2 0.4 1.7 0.2 0.4 0.9 0.4 22.1 0.1 1.1 0.0 0.7 20.7 21.5 14.7 19.6 21.7 26.7 12.8 21.7 18.0 14.1 25.7 13.0 5.0 19.2 2.2 10.1 2.1 5.0 5.2 5.7 6.2 56.3 7.5 6.2 56.9 0.0 8.0 14.7 12.5 21.2 1.2 0.1 11.7 3.5 0.7 4.9 5.8 7.7 1.8 17.0 22.3 8.5 13.0 13.3 4.6 8.7 10.2 13.0 6.1 0.2 9.8 6.7 27.5 0.1 6.1 2.1 6.8 2.2 7.2 3.4 10.6 9.4 4.3 12.6 1.0 14.6 3.2 9.8 0.1 5.3 0.2 6.2 0.1 15.8 3.1 8.4 0.0 5.3 13.2 6.5 20.7 8.4 2.6 5.1 1.2 4.6 0.7 4.5 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193178730-193186613 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.2;gallbladder: 15.0;heart muscle: 21.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 46.6;Cardiomyocytes: 34.4;Excitatory neurons: 27.6;Inhibitory neurons: 28.3;Leydig cells: 31.7;Peritubular cells: 21.1" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "MAIT T-cell: 8.4" "Lineage enriched" "Detected in single" 53 "T-cells: 8.4" "Group enriched" "Detected in some" 4 "AF22: 18.3;ASC TERT1: 8.1;LHCN-M2: 12.6;WM-115: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 17: WM-115 - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" "HPA078659: AB_2686887" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.3 1.2 13.4 0.7 15.3 0.2 0.3 4.9 17.1 0.2 2.3 1.0 0.9 0.1 1.0 0.6 0.2 15.0 21.0 17.2 7.1 0.9 0.2 1.8 0.2 5.8 7.4 10.4 0.2 0.0 0.5 0.3 5.8 4.7 1.2 6.6 0.1 5.1 0.1 0.2 3.0 0.1 7.0 0.8 1.3 0.7 8.5 0.0 1.0 0.3 0.9 1.4 0.3 15.9 0.0 0.0 18.3 0.0 0.5 8.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.6 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.2 0.0 8.4 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.2 13.4 15.3 4.9 17.1 17.2 7.1 5.8 7.4 5.8 7.0 8.5 15.9 0.6 0.0 0.5 1.6 0.9 0.3 0.1 0.0 0.6 46.6 0.0 0.1 34.4 11.5 0.0 1.8 4.2 0.0 0.2 0.1 0.0 0.1 0.0 0.3 1.3 1.1 3.0 0.8 27.6 0.0 0.0 2.0 0.0 0.9 2.5 0.4 0.7 0.1 0.3 8.4 28.3 0.7 0.0 0.6 0.3 0.7 31.7 0.7 0.0 4.7 0.0 2.4 0.0 12.1 9.3 0.5 0.1 21.1 0.4 0.1 3.4 0.1 2.2 6.2 0.0 0.3 1.2 0.0 0.0 0.3 0.3 0.0 4.9 0.3 0.5 0.0 BMP10 ENSG00000163217 "Bone morphogenetic protein 10" O95393 2 68860909-68871397 "Predicted secreted proteins" "Cell adhesion" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "heart muscle: 447.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 230000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 447.8 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BSG "CD147, EMMPRIN, EMPRIN, OK" ENSG00000172270 "Basigin (Ok blood group)" P35613 19 571277-583494 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1535.0" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 1408.0;Syncytiotrophoblasts: 1654.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002427, HPA036048, HPA074870" Enhanced Approved Vesicles NA NA 340000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719" "unprognostic (1.88e-1)" "unprognostic (4.85e-2)" "unprognostic (9.53e-3)" "prognostic favorable (2.59e-4)" "unprognostic (3.34e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.54e-3)" "unprognostic (1.55e-1)" "unprognostic (9.46e-2)" "unprognostic (4.48e-3)" "unprognostic (2.61e-2)" "prognostic favorable (1.95e-6)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (7.30e-2)" "unprognostic (3.22e-1)" 378.6 518.8 652.6 154.5 615.4 431.3 313.8 575.6 847.5 320.6 975.8 543.5 231.3 413.3 259.5 245.1 323.1 176.2 1535.0 629.0 606.0 469.7 186.0 253.6 101.9 578.5 611.2 300.7 301.6 255.3 331.2 320.2 599.8 228.8 155.9 189.6 274.8 194.4 472.3 226.6 239.7 164.1 551.0 200.0 455.8 486.0 724.3 92.8 302.1 292.2 74.2 366.9 233.0 581.2 622.6 739.3 339.5 852.3 975.0 426.0 800.4 499.2 507.6 506.1 437.9 607.1 569.4 208.4 564.3 383.5 148.7 967.8 341.0 575.0 129.6 468.1 840.3 150.0 545.5 812.3 683.6 361.6 679.0 455.5 578.5 302.4 304.5 613.1 383.3 198.3 722.9 992.5 298.6 1015.8 261.6 706.6 901.9 353.7 408.3 522.8 301.2 745.2 655.9 412.1 561.0 539.1 984.4 408.1 769.7 257.9 432.3 1118.9 478.7 557.5 353.4 940.1 751.5 639.7 701.8 201.1 1066.9 510.2 712.8 189.0 324.7 348.9 226.4 245.9 200.5 115.0 150.7 218.4 209.6 93.2 114.0 144.7 474.8 173.5 284.2 235.2 192.0 434.0 652.6 615.4 575.6 847.5 629.0 606.0 578.5 611.2 599.8 551.0 724.3 581.2 313.5 22.4 31.5 75.1 101.5 208.6 176.8 668.0 91.0 157.7 202.8 187.6 80.6 128.7 253.4 286.9 204.3 1408.0 156.5 1140.1 146.8 580.9 261.6 156.6 296.6 246.7 255.1 1091.4 35.4 371.4 1095.5 279.8 192.1 190.1 116.2 181.1 132.1 96.9 416.7 139.7 31.4 337.2 510.6 137.8 179.6 600.2 300.4 139.8 506.9 122.7 264.5 495.5 221.4 20.6 30.7 458.0 929.1 336.7 192.4 172.8 450.7 306.7 178.8 269.2 203.8 74.3 235.6 347.9 604.4 127.7 156.7 1654.9 130.9 223.5 478.2 181.4 C14orf180 "C14orf77, NRAC" ENSG00000184601 "Chromosome 14 open reading frame 180" Q8N912 14 104579764-104590515 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.8;breast: 26.7;heart muscle: 109.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.7;Cardiomyocytes: 7.6;Fibroblasts: 2.0;Hepatic stellate cells: 3.3;Horizontal cells: 3.3;Smooth muscle cells: 1.4" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "ASC diff: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "unprognostic (2.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (3.19e-3)" "unprognostic (1.89e-1)" "unprognostic (3.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.32e-1)" "unprognostic (9.80e-2)" 40.8 3.1 0.0 0.1 0.2 0.0 26.7 0.2 0.2 0.9 13.5 0.9 0.3 1.1 0.0 0.0 1.8 0.2 109.5 1.5 0.0 1.8 4.1 0.4 0.0 0.5 0.8 0.8 0.8 0.0 1.8 0.8 0.5 0.6 0.0 0.1 0.9 0.4 5.7 0.6 1.4 0.0 0.0 0.5 2.2 0.1 0.4 0.0 0.9 0.7 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 1.5 0.0 0.5 0.8 0.5 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 2.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 CDH19 CDH7 ENSG00000071991 "Cadherin 19" Q9H159 18 66501083-66604138 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4;heart muscle: 37.1;intestine: 19.4" "Cell type enhanced" "Detected in some" "Fibroblasts: 60.1;Melanocytes: 44.4;Oligodendrocyte precursor cells: 57.8;Oligodendrocytes: 192.6" "Cancer enriched" "Detected in some" 21 "melanoma: 16.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "SK-MEL-30: 35.9;WM-115: 63.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056332 Uncertain NA NA 320000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 17: WM-115 - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA056332: AB_2683102" "unprognostic (1.63e-2)" "unprognostic (2.63e-2)" "unprognostic (4.26e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (3.14e-2)" "unprognostic (1.93e-1)" "unprognostic (3.79e-1)" "unprognostic (1.02e-1)" "unprognostic (4.39e-2)" "unprognostic (9.33e-2)" "unprognostic (2.25e-2)" "unprognostic (4.58e-3)" "unprognostic (8.16e-3)" "unprognostic (8.21e-2)" "unprognostic (1.56e-5)" 2.3 4.2 3.3 3.1 11.4 0.1 1.3 4.4 7.2 6.7 0.0 19.4 2.2 0.9 1.6 3.0 1.9 2.6 37.1 4.7 5.3 0.4 4.1 1.2 0.1 8.8 7.4 1.1 1.2 0.1 0.4 2.9 7.5 4.2 2.8 0.1 3.4 4.1 4.2 1.9 5.4 1.7 2.7 2.2 4.9 0.7 7.7 0.1 1.0 1.2 0.0 5.2 5.9 18.4 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 35.9 0.1 1.5 0.0 0.0 0.1 0.3 0.2 0.1 4.0 0.2 0.0 0.1 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 11.4 4.4 7.2 4.7 5.3 8.8 7.4 7.5 2.7 7.7 18.4 0.0 0.0 0.0 1.0 0.0 1.1 0.3 0.2 2.8 0.0 1.1 0.3 9.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 2.8 0.0 0.0 60.1 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.0 0.5 0.0 2.0 0.6 1.0 0.2 5.3 0.1 44.4 0.0 0.0 0.0 0.0 57.8 192.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 3.6 2.7 0.9 0.3 0.3 0.0 0.1 0.0 0.0 0.4 CDH2 "CD325, CDHN, NCAD" ENSG00000170558 "Cadherin 2" P19022 18 27932879-28177946 "CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 196.0" "Cell type enhanced" "Detected in many" "Astrocytes: 217.7;Cardiomyocytes: 368.8;Excitatory neurons: 311.2;Granulosa cells: 312.5;Inhibitory neurons: 198.2;Muller glia cells: 157.9;Oligodendrocyte precursor cells: 267.9" "Cancer enhanced" "Detected in all" "glioma: 39.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.7;neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "AF22: 278.2;BJ: 230.7;fHDF/TERT166: 459.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000141, CAB018580, HPA058574, CAB078686" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 160000000 "Cluster 10: Basophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Cell Junctions" "CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760" "unprognostic (9.42e-2)" "unprognostic (2.69e-3)" "unprognostic (9.07e-3)" "unprognostic (5.45e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" "unprognostic (3.97e-2)" "unprognostic (2.53e-3)" "unprognostic (6.70e-3)" "unprognostic (1.00e-2)" "unprognostic (7.53e-2)" "unprognostic (3.51e-2)" "unprognostic (3.02e-2)" "unprognostic (1.93e-3)" "unprognostic (6.69e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-3)" 0.6 66.5 27.4 2.6 29.0 0.2 0.3 20.6 31.6 6.6 7.9 4.8 0.8 6.2 1.1 0.4 10.5 3.1 196.0 30.0 31.6 18.1 57.2 1.0 1.9 21.7 26.3 6.7 0.9 29.8 8.1 0.4 20.1 2.4 1.1 60.3 0.4 10.8 0.4 0.3 1.4 6.8 24.1 13.5 5.9 44.4 33.3 3.8 6.2 2.2 1.6 1.1 2.7 22.7 0.3 25.8 278.2 0.3 48.1 7.8 0.2 230.7 72.0 94.9 80.8 0.1 0.4 0.0 128.3 459.1 46.0 36.7 50.0 0.2 130.4 0.4 35.8 0.0 66.8 86.7 48.0 0.0 0.1 4.6 0.4 198.6 37.4 212.9 84.0 15.4 0.0 0.1 77.8 0.0 59.4 0.1 43.8 0.1 30.5 0.2 37.1 45.6 0.1 9.9 83.4 144.4 0.1 0.2 26.8 116.8 0.3 0.5 11.6 206.6 63.6 2.9 181.6 0.2 0.3 0.3 40.6 0.2 163.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 27.4 29.0 20.6 31.6 30.0 31.6 21.7 26.3 20.1 24.1 33.3 22.7 0.8 0.0 0.6 217.7 1.2 0.3 0.0 3.4 0.0 38.7 1.6 0.4 368.8 67.2 1.2 11.0 150.1 0.1 0.0 0.0 0.0 12.9 53.2 1.4 15.2 9.8 0.0 6.1 311.2 0.4 0.0 16.7 0.0 2.6 0.0 312.5 12.5 125.3 0.3 3.3 198.2 0.0 2.0 2.2 0.4 17.7 2.1 1.2 3.6 106.8 0.1 157.9 0.0 267.9 138.6 19.2 0.0 12.8 0.0 0.1 0.0 47.5 1.7 99.9 6.6 0.4 45.8 4.8 24.1 0.0 0.0 0.3 0.6 1.6 0.0 0.1 CDS2 ENSG00000101290 "CDP-diacylglycerol synthase 2" O95674 20 5126879-5197887 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 160.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019698 Approved Approved "Endoplasmic reticulum" No No "Cluster 38: Basophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 16: U-266 - Nucleosome" "Cluster 48: Smooth muscle cells - ECM organization" "Endoplasmic reticulum" "HPA019698: AB_1846464" "unprognostic (4.59e-2)" "unprognostic (1.98e-1)" "unprognostic (2.39e-1)" "unprognostic (3.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.48e-1)" "unprognostic (3.35e-3)" "unprognostic (1.65e-1)" "prognostic favorable (3.53e-9)" "unprognostic (8.89e-2)" "unprognostic (3.53e-1)" "unprognostic (1.38e-1)" "unprognostic (2.44e-1)" 14.3 13.8 30.0 9.1 32.4 13.0 10.6 22.9 28.6 10.5 2.1 13.0 5.2 11.5 8.2 9.2 10.7 8.9 24.8 30.3 34.6 14.6 12.8 13.4 8.8 27.2 36.1 9.3 6.5 17.3 14.4 9.9 37.4 13.4 10.7 31.5 7.6 16.7 9.7 5.9 10.1 18.0 18.8 9.4 10.6 11.7 42.5 13.3 12.5 12.7 12.6 10.8 7.7 21.7 25.4 27.4 28.1 13.7 16.4 14.9 11.7 13.9 28.5 22.7 32.2 17.8 23.8 19.8 6.8 26.4 41.1 36.5 23.1 29.5 23.9 18.4 6.8 23.5 7.9 27.0 15.3 13.9 8.1 12.8 16.1 29.8 11.5 20.3 30.7 26.5 11.6 23.9 21.4 4.6 30.1 5.7 12.1 12.4 7.6 25.0 22.5 9.4 14.5 25.0 11.4 15.5 15.3 26.2 34.6 33.8 16.4 6.7 25.4 15.6 11.6 14.1 14.0 20.8 160.2 15.9 7.4 11.7 8.1 55.3 17.3 21.2 15.2 14.7 16.6 12.1 15.6 17.3 13.8 11.4 12.0 11.8 49.7 12.0 13.4 10.9 19.5 23.7 30.0 32.4 22.9 28.6 30.3 34.6 27.2 36.1 37.4 18.8 42.5 21.7 43.3 19.2 15.7 36.9 36.2 17.6 30.3 33.0 14.2 60.1 17.7 14.4 55.2 18.6 19.6 33.1 95.9 22.2 29.6 15.3 5.9 33.1 71.6 20.1 14.0 42.3 10.7 14.9 39.3 22.7 40.0 17.9 15.3 21.5 21.0 20.5 27.8 21.7 60.8 43.7 52.0 12.4 12.2 36.6 26.1 33.3 16.1 31.5 32.0 21.5 38.7 21.9 28.8 28.6 56.1 31.7 20.3 24.8 48.9 23.1 15.7 13.2 23.5 65.5 19.7 19.7 52.1 26.8 34.7 14.8 15.3 16.3 36.7 13.0 13.1 29.1 CERK "dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4" ENSG00000100422 "Ceramide kinase" Q8TCT0 22 46684410-46738252 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064699 Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" Vesicles "HPA064699: AB_2685327" "unprognostic (2.93e-2)" "unprognostic (1.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (2.67e-2)" "unprognostic (1.49e-3)" "unprognostic (8.55e-2)" "unprognostic (3.60e-2)" "unprognostic (3.87e-1)" "unprognostic (1.35e-2)" "prognostic favorable (2.35e-4)" "unprognostic (2.26e-1)" "unprognostic (1.50e-3)" "unprognostic (1.27e-1)" "unprognostic (4.78e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.58e-4)" 15.7 23.7 17.5 22.2 18.1 21.1 12.7 33.2 22.5 17.8 16.4 17.9 31.6 17.5 6.0 14.8 18.2 17.4 39.0 18.3 37.4 19.5 18.9 16.6 26.1 32.1 34.5 26.6 30.2 11.5 49.0 10.0 33.2 11.7 14.9 21.1 17.5 13.4 20.8 16.3 31.2 15.2 20.8 19.4 21.9 6.0 26.2 38.7 21.0 19.2 25.2 13.7 12.4 18.4 25.6 15.1 71.6 22.6 40.3 30.2 6.7 43.7 33.8 24.5 17.2 22.3 8.4 35.3 19.9 46.9 15.1 16.3 30.4 19.8 24.9 12.6 33.0 15.8 36.9 29.0 27.9 49.9 4.0 25.3 25.0 26.7 9.1 39.2 73.5 37.1 12.1 44.5 45.4 1.9 34.0 24.8 32.4 10.3 16.3 62.8 81.2 40.4 14.7 0.5 66.4 60.6 21.5 10.3 47.1 16.5 11.3 37.6 67.4 50.2 26.8 37.5 64.4 45.7 59.5 22.3 53.5 28.0 41.7 0.7 3.0 3.7 10.3 7.0 17.9 2.0 10.7 10.0 5.4 2.1 6.3 5.8 4.2 2.6 8.7 5.7 10.4 4.4 17.5 18.1 33.2 22.5 18.3 37.4 32.1 34.5 33.2 20.8 26.2 18.4 28.6 9.6 16.6 16.0 17.0 3.4 6.3 6.1 18.2 24.4 6.1 9.8 44.2 10.0 11.0 1.8 6.2 2.4 25.4 23.4 15.6 12.8 7.8 10.3 19.8 27.4 14.4 8.0 11.7 11.8 1.4 14.1 9.2 19.8 10.1 10.2 25.4 22.1 10.8 26.9 21.9 6.6 8.2 24.8 16.9 16.0 9.6 22.1 3.6 15.9 18.6 25.6 22.6 9.5 4.2 10.9 15.2 15.1 43.3 2.1 50.0 16.8 0.7 9.7 0.0 8.3 13.2 4.7 1.7 11.0 4.4 1.8 37.6 5.3 20.0 1.7 CHRM2 ENSG00000181072 "Cholinergic receptor muscarinic 2" P08172 7 136868652-137020255 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 36.1;intestine: 21.2" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 59.9;Excitatory neurons: 49.4;Inhibitory neurons: 119.2" "Cancer enhanced" "Detected in single" "stomach cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 86.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022338, HPA029795" Approved NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB022338: , HPA029795: AB_10601357" "unprognostic (3.51e-2)" "unprognostic (3.73e-4)" "unprognostic (5.77e-2)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.00e-1)" "unprognostic (2.69e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" 0.1 0.2 2.8 1.3 2.0 0.1 0.0 0.1 2.3 0.3 0.0 21.2 0.7 0.4 0.0 0.3 0.3 10.7 36.1 0.1 2.5 0.0 1.1 0.8 0.0 9.3 5.4 0.2 0.1 0.0 0.0 1.4 9.1 0.2 3.5 0.8 0.0 0.0 0.0 0.1 4.4 9.7 1.8 0.0 5.9 0.6 6.8 0.1 0.0 0.0 0.0 8.9 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 17.6 0.2 0.0 0.0 0.0 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.0 0.1 2.3 0.1 2.5 9.3 5.4 9.1 1.8 6.8 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 59.9 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.2 0.2 0.0 0.0 49.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 119.2 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CHRNE ACHRE ENSG00000108556 "Cholinergic receptor nicotinic epsilon subunit" Q04844 17 4897771-4934438 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 55.3;pituitary gland: 27.6" "Cell type enriched" "Detected in many" 5 "Late spermatids: 161.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "HEL: 5.0;HMC-1: 11.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 14 "basal ganglia: 6.3" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.00e-3)" "unprognostic (1.56e-1)" "unprognostic (3.94e-2)" "unprognostic (4.35e-3)" "unprognostic (6.55e-2)" "unprognostic (2.27e-3)" "unprognostic (7.80e-4)" "unprognostic (7.75e-2)" "unprognostic (3.24e-1)" "unprognostic (1.34e-1)" "unprognostic (3.69e-2)" "unprognostic (6.58e-2)" "unprognostic (8.42e-4)" "unprognostic (1.39e-3)" "unprognostic (1.26e-1)" "unprognostic (5.83e-2)" "unprognostic (5.70e-2)" 0.7 0.4 0.1 0.4 0.1 0.7 0.7 0.6 0.4 0.7 0.0 0.3 0.3 0.4 1.3 0.4 0.6 1.0 55.3 0.2 0.1 1.0 3.5 0.8 0.5 0.3 0.0 0.8 1.7 0.2 27.6 0.6 0.1 0.6 0.0 5.1 0.8 0.2 1.8 2.2 0.8 0.2 0.0 1.8 0.5 0.7 0.1 0.1 0.4 2.1 0.2 0.3 0.5 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 5.0 0.0 0.8 0.4 0.0 11.5 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 1.3 2.5 0.4 0.0 0.0 0.1 0.8 0.2 0.4 0.1 0.7 1.1 0.8 0.6 0.1 0.0 0.7 0.1 0.1 0.6 0.4 0.2 0.1 0.3 0.0 0.1 0.0 0.1 0.2 4.9 0.0 0.0 0.3 4.2 1.7 1.4 0.8 1.2 5.0 1.6 2.0 6.5 1.5 0.6 1.8 4.2 0.6 10.2 0.0 1.9 0.3 27.8 0.6 1.1 3.3 0.0 0.0 0.5 0.9 7.3 2.3 1.1 0.8 8.2 1.4 2.9 7.4 3.4 3.3 0.4 0.1 2.0 1.3 13.0 161.5 0.9 9.9 0.0 2.8 5.3 1.1 8.2 0.5 0.7 0.7 0.0 0.4 3.5 1.1 0.0 2.9 0.6 10.0 0.0 0.9 1.1 5.6 8.4 0.2 1.1 11.1 3.5 6.2 0.2 0.7 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593999-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "heart muscle: 56.9" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 69.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 44.0" "Region enhanced" "Detected in some" "basal ganglia: 2.6" "Low region specificity" "Detected in some" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" Yes No "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: AB_2686324" "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.4 0.1 0.1 0.1 0.1 0.0 1.0 0.1 0.2 2.1 0.6 0.3 0.1 4.5 0.6 0.9 1.4 4.5 56.9 0.0 0.3 1.0 0.1 1.9 0.0 0.7 0.6 0.5 0.2 1.1 1.9 0.4 0.1 2.3 0.0 0.3 0.4 6.1 0.1 7.5 0.3 0.7 0.1 1.1 0.5 2.5 0.3 0.1 0.1 0.1 0.1 1.2 3.9 0.1 0.0 0.0 0.1 0.3 10.3 44.0 0.0 2.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 2.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.4 0.0 0.3 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.3 0.7 0.6 0.1 0.1 0.3 0.1 0.3 0.0 7.5 1.0 0.0 3.8 0.3 0.0 0.0 1.0 8.3 0.3 69.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 1.3 1.0 0.0 0.0 6.5 0.0 0.0 9.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 10.8 0.0 0.0 0.6 5.5 2.0 4.7 0.1 5.4 1.0 0.0 0.7 0.0 2.0 3.9 0.0 0.0 2.6 0.0 0.6 0.0 0.2 0.0 0.3 0.0 0.3 2.3 4.6 4.4 0.1 2.7 0.0 0.6 0.1 0.0 0.3 CPNE5 "COPN5, CPN5, KIAA1599" ENSG00000124772 "Copine 5" Q9HCH3 6 36740775-36839444 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.4;heart muscle: 92.7" "Cell type enhanced" "Detected in many" "B-cells: 50.6;Cardiomyocytes: 30.0;Excitatory neurons: 35.1;Oligodendrocyte precursor cells: 36.7;Plasma cells: 89.6" "Cancer enhanced" "Detected in all" "glioma: 11.3" "Region enhanced" "Detected in many" "basal ganglia: 62.4" "Group enriched" "Detected in some" 80 "memory B-cell: 51.6;naive B-cell: 26.8" "Lineage enriched" "Detected in single" 105 "B-cells: 51.6" "Group enriched" "Detected in some" 5 "Daudi: 59.4;HUVEC TERT2: 25.7;U-266/70: 19.7;U-266/84: 17.1;U-698: 28.1" "Region enhanced" "Detected in many" "basal ganglia: 103.3" "Region enhanced" "Detected in many" "basal ganglia: 135.5" HPA031369 Enhanced Approved Cytosol NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA031369: AB_10601801" "unprognostic (5.71e-3)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.73e-2)" "unprognostic (1.04e-1)" "prognostic favorable (2.87e-5)" "unprognostic (1.07e-1)" "unprognostic (3.07e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-3)" "unprognostic (2.45e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.68e-2)" "unprognostic (3.80e-1)" "unprognostic (2.00e-1)" "unprognostic (3.57e-1)" 6.4 0.9 16.6 10.7 62.4 1.4 2.3 0.0 29.5 3.9 0.0 6.2 5.6 5.8 1.0 2.4 19.9 2.0 92.7 23.0 2.7 4.5 0.8 2.6 23.6 0.0 4.6 6.6 1.0 0.4 11.0 1.4 0.0 5.8 5.0 2.8 3.5 2.5 0.5 1.8 8.6 4.7 1.1 20.0 5.1 25.3 0.8 2.3 3.3 0.2 28.1 4.9 5.7 13.3 0.9 0.0 0.5 0.1 0.1 0.0 0.3 0.2 0.2 0.3 0.5 0.0 0.2 59.4 0.5 0.8 2.7 0.4 0.1 0.4 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.7 0.0 4.1 25.7 0.2 0.2 1.7 0.5 0.0 0.0 0.4 0.1 0.8 0.0 0.3 0.5 0.0 0.0 0.1 0.5 0.1 0.0 0.0 5.3 0.3 0.0 0.8 5.9 0.4 0.7 0.0 2.1 19.7 17.1 28.1 0.3 6.5 0.1 0.0 0.1 0.0 0.0 0.2 0.2 51.6 0.2 0.0 0.1 26.8 0.0 0.0 0.4 0.0 0.2 0.3 0.0 4.5 16.6 62.4 0.0 29.5 23.0 2.7 0.0 4.6 0.0 1.1 0.8 13.3 2.8 0.0 3.6 1.3 50.6 0.6 0.2 0.2 0.0 13.4 0.3 0.5 30.0 0.0 0.0 0.0 0.0 0.0 1.5 15.1 1.9 0.0 3.3 0.4 0.8 7.4 4.2 0.0 35.1 0.2 0.0 2.8 1.5 1.4 12.6 0.3 5.0 1.0 0.4 0.0 8.6 1.8 0.0 1.9 0.6 4.8 0.0 6.2 3.6 2.8 0.2 1.3 2.1 36.7 0.8 0.5 12.5 0.4 89.6 0.2 2.3 0.1 0.0 1.6 0.0 2.3 1.0 0.8 1.5 1.1 0.1 0.0 2.0 0.2 1.7 0.4 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 1113.7" "Cell type enhanced" "Detected in many" "Adipocytes: 459.4;Cardiomyocytes: 863.3;Endothelial cells: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 52.1;memory CD4 T-cell: 80.4;naive B-cell: 109.9;T-reg: 115.6" "Group enriched" "Detected in all" 30 "B-cells: 109.9;T-cells: 115.6" "Cell line enhanced" "Detected in many" "EFO-21: 321.9;MCF7: 306.5;SK-BR-3: 303.7;T-47d: 266.4;TIME: 259.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 160000 "Cluster 26: Non-specific - Mitochondria" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 177.6 44.7 160.4 31.3 172.0 1.5 162.5 137.7 259.5 101.6 124.2 101.9 27.0 138.1 36.4 127.3 130.0 47.9 1113.7 172.7 186.4 205.1 52.7 185.7 30.0 157.3 158.7 51.2 46.1 19.2 175.0 49.6 158.6 89.0 8.3 4.1 100.0 72.9 52.5 128.9 82.8 32.0 145.0 104.1 66.1 92.8 191.9 10.4 155.6 42.7 16.5 121.4 100.4 140.8 2.5 201.2 37.9 98.3 4.3 19.9 10.0 17.5 1.9 2.8 1.0 7.1 44.2 0.2 321.9 73.8 4.5 166.8 3.6 50.8 0.1 2.3 1.9 0.2 132.5 73.8 24.3 0.0 25.5 10.5 4.4 5.2 26.2 38.4 192.7 0.2 0.5 1.4 26.8 306.5 0.5 0.6 10.0 45.7 143.4 0.4 7.7 9.9 140.1 0.6 61.6 175.3 30.0 303.7 1.9 4.9 266.4 0.1 259.3 82.7 38.8 2.3 50.5 0.7 0.6 0.9 24.3 0.3 179.3 0.2 1.9 0.0 7.5 0.9 6.8 52.1 80.4 17.2 3.6 109.9 17.8 4.5 1.0 3.7 0.5 0.5 115.6 10.4 160.4 172.0 137.7 259.5 172.7 186.4 157.3 158.7 158.6 145.0 191.9 140.8 459.4 157.0 33.7 17.9 15.0 153.2 96.7 206.4 29.0 2.7 110.0 140.7 863.3 107.2 127.1 189.4 4.2 2.6 8.2 0.9 154.6 106.8 37.9 125.1 28.8 510.4 25.2 9.7 16.4 87.6 30.5 132.9 32.1 126.6 7.6 0.4 346.3 30.4 3.0 94.2 3.0 0.3 81.4 11.8 92.6 84.0 28.0 9.3 156.5 27.2 2.5 57.2 1.0 4.5 3.1 48.9 0.1 14.7 7.0 37.4 0.2 17.0 155.7 4.0 276.1 108.1 339.5 27.8 46.1 20.1 196.8 32.0 32.5 5.9 0.2 103.2 CRLF1 "CISS, CISS1, CLF, CLF-1" ENSG00000006016 "Cytokine receptor like factor 1" O75462 19 18572220-18607741 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 88.5" "Cell type enhanced" "Detected in some" "Astrocytes: 15.3;Basal keratinocytes: 9.7;Fibroblasts: 16.0;Respiratory ciliated cells: 11.9;Skeletal myocytes: 19.9;Smooth muscle cells: 10.5" "Group enriched" "Detected in all" 4 "lung cancer: 27.4;thyroid cancer: 36.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "ASC diff: 1048.7;Hep G2: 458.8" "Region enriched" "Detected in many" 7 "hippocampal formation: 21.1" "Group enriched" "Detected in some" 6 "cerebellum: 2.3;spinal cord: 8.6" "HPA041493, HPA041793" Approved "Secreted in other tissues" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA041493: AB_10795637, HPA041793: AB_10804117" "unprognostic (1.97e-1)" "unprognostic (2.29e-1)" "unprognostic (2.34e-3)" "unprognostic (9.31e-3)" "unprognostic (1.58e-2)" "unprognostic (1.71e-2)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (4.69e-2)" "unprognostic (3.34e-3)" "unprognostic (4.95e-2)" "unprognostic (7.92e-2)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.86e-2)" "unprognostic (5.27e-3)" 40.1 14.5 18.7 0.9 24.6 0.0 18.7 22.4 51.7 25.7 11.2 8.9 0.5 12.8 0.9 17.4 11.3 1.4 88.5 22.0 13.5 7.7 1.5 16.0 0.4 24.3 28.0 4.5 8.9 0.5 8.9 11.3 17.8 8.9 0.4 0.1 14.9 6.2 21.4 27.3 5.0 1.5 18.7 2.4 7.5 1.3 13.4 0.3 50.3 0.9 0.2 9.3 15.5 25.5 0.0 0.0 0.0 10.7 1048.7 15.3 5.2 5.4 0.0 0.0 0.0 0.1 0.0 0.0 66.5 33.2 1.9 0.4 10.8 0.2 0.0 0.0 1.4 0.0 18.1 458.8 7.5 0.1 0.5 12.0 1.0 0.2 0.3 1.6 0.3 0.0 0.1 0.2 0.3 16.6 0.0 0.0 1.2 0.1 0.3 0.0 9.1 0.1 0.0 0.5 0.0 0.1 14.2 0.0 0.0 2.0 13.0 0.6 1.3 0.1 11.1 0.8 0.4 0.1 0.0 0.5 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 24.6 22.4 51.7 22.0 13.5 24.3 28.0 17.8 18.7 13.4 25.5 0.4 0.0 0.0 15.3 0.3 9.7 0.6 6.8 0.0 0.2 0.7 4.2 2.5 0.0 2.6 0.0 0.0 0.1 0.3 0.1 5.9 0.3 6.9 2.6 1.9 0.5 0.0 0.0 7.8 0.2 1.3 16.0 0.5 0.5 0.0 0.2 0.4 0.1 0.3 0.0 1.0 0.0 2.0 0.0 1.0 0.4 0.0 0.4 0.0 0.0 0.1 0.9 1.0 0.5 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.3 11.9 1.3 0.0 19.9 10.5 0.2 2.2 0.6 4.5 0.3 0.6 0.2 0.1 0.3 CRYM DFNA40 ENSG00000103316 "Crystallin mu" Q14894 16 21238874-21303083 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.7;heart muscle: 175.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1" "Cancer enhanced" "Detected in many" "prostate cancer: 14.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 21 "plasmacytoid DC: 82.0" "Lineage enriched" "Detected in many" 21 "dendritic cells: 82.0" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 100.3" "Group enriched" "Detected in all" 11 "amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4" "Low region specificity" "Detected in all" "HPA019086, HPA030619" Enhanced Supported Cytosol NA NA 150000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 5: Muller glia cells - Visual perception" Cytosol "HPA019086: AB_1847260, HPA030619: AB_2673551" "unprognostic (1.32e-1)" "unprognostic (2.93e-3)" "unprognostic (8.96e-2)" "unprognostic (1.44e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.88e-1)" "unprognostic (5.75e-3)" "unprognostic (2.81e-1)" "unprognostic (7.37e-2)" "unprognostic (2.05e-2)" "unprognostic (5.95e-2)" "unprognostic (2.11e-3)" "unprognostic (7.79e-3)" "unprognostic (2.49e-2)" "unprognostic (1.87e-3)" "unprognostic (1.31e-1)" 1.9 0.8 37.4 0.9 78.7 1.0 2.7 40.6 62.2 3.7 13.6 6.9 1.6 1.0 0.2 7.6 1.1 7.0 175.3 54.0 31.6 64.4 14.2 8.5 1.1 13.9 19.8 0.3 1.8 8.9 55.6 0.4 15.6 35.4 8.4 54.7 20.6 0.2 13.4 4.1 2.6 0.3 14.1 0.3 1.3 5.1 20.5 0.3 0.4 0.9 3.8 21.8 3.6 31.3 0.2 4.0 0.0 0.0 0.2 0.4 0.7 0.0 2.1 0.1 0.2 0.2 0.2 0.3 1.0 0.0 1.8 0.6 5.4 0.0 0.0 0.0 0.8 23.2 0.1 2.3 0.0 0.1 2.2 0.8 0.0 0.8 1.0 0.0 0.0 0.5 0.0 0.4 0.7 0.3 0.0 0.9 9.7 1.6 0.1 0.1 0.0 0.5 100.3 0.1 3.7 5.2 0.2 0.1 2.6 4.8 0.1 0.0 0.0 0.5 0.7 6.8 0.0 0.2 0.0 0.5 16.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.1 3.9 0.0 0.0 0.3 0.0 0.0 82.0 0.0 1.2 37.4 78.7 40.6 62.2 54.0 31.6 13.9 19.8 15.6 14.1 20.5 31.3 0.3 0.0 20.1 5.2 4.1 2.3 25.4 16.3 0.0 6.3 0.4 11.7 126.0 2.8 56.1 14.7 4.2 0.0 11.4 7.1 17.6 0.1 19.7 3.2 1.5 3.0 13.1 4.8 43.8 0.0 0.0 7.1 6.1 7.7 1.3 1.3 0.4 8.3 0.1 1.7 5.9 20.6 114.0 1.6 0.7 12.4 0.0 1.5 33.8 10.3 0.7 640.7 0.0 7.1 6.6 0.4 2.8 0.0 0.3 19.0 7.5 190.1 19.9 26.2 0.0 0.2 4.3 6.7 7.3 0.2 1.3 0.1 1.1 0.1 8.2 68.0 CSDC2 PIPPin ENSG00000172346 "Cold shock domain containing C2" Q9Y534 22 41561010-41577741 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 143.8;heart muscle: 288.2;ovary: 133.6" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 75.0;Distal tubular cells: 19.6;Granulosa cells: 30.7;Muller glia cells: 51.7;Proximal tubular cells: 42.5;Sertoli cells: 72.3;Smooth muscle cells: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HeLa: 12.4;U-2 OS: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003073, HPA076549" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 9: U-2 OS - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Cytosol "HPA003073: AB_1078578, HPA076549: AB_2686807" "unprognostic (9.42e-2)" "unprognostic (5.52e-2)" "unprognostic (3.66e-3)" "unprognostic (1.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.52e-1)" "unprognostic (3.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.70e-3)" "unprognostic (2.35e-2)" "unprognostic (1.93e-1)" "unprognostic (3.72e-1)" "prognostic favorable (6.42e-4)" "unprognostic (8.86e-3)" "unprognostic (6.08e-2)" "unprognostic (1.02e-1)" "unprognostic (9.09e-3)" 6.8 143.8 29.4 1.6 21.8 0.1 3.2 64.5 32.1 69.9 4.1 16.5 0.8 83.5 1.4 3.2 24.1 2.3 288.2 30.5 35.3 40.4 2.6 11.5 0.2 44.4 41.0 133.6 51.1 0.0 20.5 0.4 36.9 26.2 0.5 5.2 1.0 10.4 2.7 2.1 3.2 10.9 26.1 1.1 4.5 31.3 44.9 0.0 2.5 2.7 0.0 27.4 29.0 22.7 0.0 0.2 1.5 0.2 0.0 0.0 0.1 3.4 0.2 0.1 0.1 0.9 0.0 0.0 0.5 4.7 0.5 0.1 0.0 0.0 0.0 0.0 2.9 0.0 12.4 1.5 3.5 0.0 0.0 1.9 0.1 0.0 0.0 3.5 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.6 0.0 0.3 0.1 1.1 0.2 0.0 0.1 0.1 1.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.1 41.8 0.3 0.1 0.2 0.2 0.0 0.8 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 29.4 21.8 64.5 32.1 30.5 35.3 44.4 41.0 36.9 26.1 44.9 22.7 0.1 0.0 0.0 4.6 0.5 0.3 0.2 0.3 0.6 9.9 0.1 0.6 75.0 0.0 0.0 7.3 2.1 0.1 0.0 0.0 19.6 0.3 1.5 0.2 6.0 0.9 0.0 0.0 6.8 10.4 0.1 5.1 0.0 0.1 0.0 30.7 0.4 0.2 0.2 6.7 11.0 0.0 0.0 0.0 0.0 5.1 5.3 0.3 1.8 0.0 0.0 51.7 0.0 1.0 0.6 2.4 0.0 2.6 0.0 0.2 0.0 42.5 0.7 3.2 72.3 0.4 19.9 2.1 0.3 0.0 0.1 0.3 0.2 0.3 0.0 0.0 CYGB "HGB, STAP" ENSG00000161544 Cytoglobin Q8WWM9 17 76527356-76551175 "Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 104.4" "Cell type enhanced" "Detected in many" "Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6" "Cancer enhanced" "Detected in all" "melanoma: 34.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017757, HPA061642" Approved Approved Supported "Nuclear speckles,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Nuclear speckles" Cytosol "HPA017757: AB_1847410, HPA061642: AB_2684573" "unprognostic (6.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.97e-2)" "prognostic favorable (2.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.36e-2)" "unprognostic (3.31e-3)" "unprognostic (2.01e-1)" "unprognostic (7.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.08e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.34e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (7.76e-2)" 79.6 20.8 10.1 12.0 10.7 1.7 55.1 20.6 13.6 27.7 14.1 27.1 21.1 19.6 4.6 12.8 20.4 13.2 104.4 9.5 15.8 12.4 19.0 27.8 7.2 17.5 26.0 13.8 12.8 11.7 10.9 8.9 26.8 29.9 9.3 77.6 14.2 11.0 19.3 19.5 26.6 5.9 10.1 12.2 22.9 5.3 14.3 5.3 50.1 9.6 2.6 50.7 25.6 9.8 0.2 1.1 1.8 0.4 79.6 23.1 26.1 0.7 2.0 0.3 0.9 0.0 0.3 0.2 24.1 2.4 0.3 0.7 0.1 33.7 0.1 0.1 0.2 0.4 0.4 61.7 120.7 0.0 0.0 95.4 7.2 2.5 2.5 0.4 0.3 0.8 0.3 0.1 1.2 0.8 0.2 0.4 0.3 0.0 1.4 0.5 0.3 0.2 0.4 0.1 0.6 129.8 0.1 0.0 2.7 5.9 0.2 0.6 0.2 3.1 1.6 0.3 0.0 1.2 0.3 0.3 0.2 0.3 9.9 0.0 0.1 0.1 0.2 0.1 0.1 1.6 0.1 0.0 0.1 2.2 0.2 0.5 0.9 1.0 0.0 0.0 0.2 0.2 10.1 10.7 20.6 13.6 9.5 15.8 17.5 26.0 26.8 10.1 14.3 9.8 94.3 3.2 2.0 2.0 3.5 10.8 1.3 17.3 3.4 38.5 1.4 5.7 6.1 0.0 6.7 0.0 0.0 1.4 1.9 0.1 0.0 0.8 0.7 2.9 4.2 23.1 0.0 0.0 2.4 0.2 0.6 87.6 1.5 0.7 0.0 0.2 2.2 1.2 0.4 8.4 12.3 0.0 0.0 0.0 13.3 2.5 95.7 2.6 78.2 3.7 0.0 22.1 0.0 1.0 1.0 0.1 0.0 23.3 0.6 0.8 0.0 0.2 21.1 12.9 92.1 21.8 95.6 1.6 1.4 0.7 6.7 2.9 2.6 9.2 0.0 1.0 DAND5 "CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3" ENSG00000179284 "DAN domain BMP antagonist family member 5" Q8N907 19 12965159-12974760 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "heart muscle: 8.5" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 17.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 19.8" "Not detected" "Not detected" "HPA043493, HPA049472" Uncertain Approved Mitochondria "Secreted in other tissues" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "HPA043493: AB_2732505, HPA049472: AB_2680781" "unprognostic (1.18e-2)" "unprognostic (4.63e-2)" "unprognostic (7.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.82e-2)" "unprognostic (8.71e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-1)" "unprognostic (5.95e-3)" "unprognostic (7.27e-3)" "unprognostic (8.17e-2)" "unprognostic (2.15e-1)" "unprognostic (2.48e-10)" "unprognostic (4.43e-1)" "unprognostic (2.48e-2)" "unprognostic (6.77e-2)" "unprognostic (1.37e-1)" 0.1 0.9 0.4 0.1 0.4 0.7 0.3 0.9 0.4 0.1 1.6 2.0 0.2 0.1 0.2 0.1 0.1 0.3 8.5 0.4 0.3 0.1 0.0 0.1 0.1 0.5 0.2 0.1 0.2 0.8 0.1 0.0 0.7 0.1 0.3 0.7 0.4 0.0 0.1 0.3 0.3 0.3 0.2 0.0 0.3 0.3 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.8 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.7 0.4 1.2 0.0 0.4 0.3 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.0 1.0 19.8 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.1 1.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.4 1.5 0.4 0.1 0.4 0.0 0.1 0.4 0.4 0.9 0.4 0.4 0.3 0.5 0.2 0.7 0.2 0.5 0.8 0.5 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.7 1.3 17.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.5 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.3 0.3 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.0 2.1 0.5 0.1 0.2 0.3 0.3 0.0 0.1 0.1 0.5 0.1 DIRAS1 "Di-Ras1, GBTS1, RIG" ENSG00000176490 "DIRAS family GTPase 1" O95057 19 2714567-2721372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.8;heart muscle: 105.0;tongue: 51.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 18.0;Distal tubular cells: 31.3;Excitatory neurons: 20.4;Horizontal cells: 89.2;Inhibitory neurons: 25.9" "Cancer enhanced" "Detected in many" "glioma: 17.4;melanoma: 13.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 43.4;REH: 49.2;SH-SY5Y: 27.8;THP-1: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050164 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 62: Horizontal cells - Visual perception" "Vesicles, Plasma membrane" Nucleoplasm "HPA050164: " "unprognostic (7.43e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (4.19e-3)" "unprognostic (8.01e-3)" "unprognostic (2.68e-1)" "unprognostic (5.62e-2)" "unprognostic (3.60e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.00e-1)" "unprognostic (1.79e-3)" "unprognostic (5.47e-3)" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (6.91e-4)" 1.8 2.5 10.5 1.2 20.7 0.7 1.9 16.1 84.8 7.0 0.0 1.4 1.2 12.7 2.5 5.4 6.6 0.7 105.0 19.8 16.9 4.8 0.1 0.6 0.6 17.1 17.4 2.7 6.7 17.0 22.4 0.3 14.5 3.3 1.1 11.5 6.7 1.8 2.7 1.9 2.2 7.4 0.0 4.2 3.5 6.0 45.2 0.1 0.5 51.8 0.7 4.0 2.4 34.8 0.1 2.2 7.0 24.1 0.9 3.1 0.1 8.2 2.8 0.4 0.1 1.4 0.4 0.0 1.0 21.9 12.2 0.1 10.1 0.0 0.0 0.0 15.6 0.5 0.8 0.9 1.0 0.0 43.4 1.4 5.1 0.1 0.1 4.6 0.0 0.2 15.0 7.2 2.8 3.6 0.2 0.4 15.2 0.0 3.3 49.2 0.0 11.7 0.0 0.0 3.1 27.8 0.3 1.1 15.6 1.2 1.1 34.2 0.0 5.3 6.6 0.2 2.6 16.4 12.4 8.9 11.8 0.5 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 20.7 16.1 84.8 19.8 16.9 17.1 17.4 14.5 0.0 45.2 34.8 0.0 0.0 0.0 1.6 6.9 1.1 0.8 0.2 2.2 7.9 2.6 2.8 18.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 31.3 1.4 0.4 0.1 2.2 0.3 0.0 1.3 20.4 2.0 0.5 0.9 0.0 0.3 0.0 2.3 0.0 0.0 5.7 89.2 25.9 0.0 0.0 0.0 3.6 1.1 1.2 0.5 3.6 4.7 0.1 4.6 0.0 2.0 3.4 1.5 0.0 0.0 0.6 0.9 0.0 0.1 0.0 6.1 0.0 0.7 2.1 0.7 0.4 0.3 0.4 0.3 0.1 0.0 0.0 0.2 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11956207-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 1224.0" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 884.3;Muller glia cells: 1960.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 6.2;memory CD8 T-cell: 3.8" "Lineage enriched" "Detected in single" 62 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 18000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 31.2 79.1 110.7 10.0 183.6 0.2 26.0 12.6 135.2 89.7 104.8 53.2 14.6 47.0 16.7 29.7 23.0 67.0 1224.0 147.7 80.2 17.0 5.6 123.7 8.5 95.1 54.3 38.1 18.2 34.2 38.2 25.0 46.8 59.4 13.0 204.1 30.9 78.1 7.8 29.7 24.6 43.1 83.9 33.2 31.7 30.9 99.9 4.7 16.4 18.8 5.4 40.9 48.3 121.6 1.5 13.1 18.1 0.1 15.3 29.7 0.6 418.9 643.0 182.4 205.5 9.6 3.2 0.0 44.8 614.4 96.8 64.4 1.5 181.9 69.5 0.1 0.5 0.0 1.7 0.0 113.6 0.0 0.3 45.3 60.0 61.9 151.3 370.2 195.3 0.0 0.2 0.4 256.4 0.0 0.1 0.4 8.6 0.0 0.5 0.1 1.2 0.1 62.5 0.6 0.5 53.2 2.0 0.0 0.2 47.9 0.2 0.5 349.7 107.5 82.8 11.2 110.3 0.1 0.0 0.3 18.1 0.0 103.5 0.0 0.0 0.0 0.5 0.0 6.2 0.0 0.6 3.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 110.7 183.6 12.6 135.2 147.7 80.2 95.1 54.3 46.8 83.9 99.9 121.6 5.8 3.2 3.0 94.3 0.1 45.6 59.5 70.3 93.4 31.6 3.2 103.2 884.3 0.0 12.8 0.0 12.5 0.5 0.4 0.0 0.0 0.8 104.3 0.7 8.4 32.9 1.8 0.0 90.4 0.2 0.8 106.1 7.1 0.6 1.3 17.0 66.8 0.4 20.4 13.5 83.7 0.1 0.0 1.3 12.5 88.5 20.5 1.4 64.0 38.4 0.0 1960.4 0.0 27.6 14.7 1.1 0.1 57.6 1.7 32.8 0.0 0.2 2.9 67.5 190.7 12.7 83.4 1.2 3.2 5.8 14.8 0.8 4.1 0.5 0.3 3.0 DPYSL4 "CRMP3, DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186948-132205759 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;heart muscle: 33.7;retina: 15.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.9;Cardiomyocytes: 20.1;Cone photoreceptor cells: 58.4;Horizontal cells: 33.7;Oligodendrocytes: 18.4" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.2;AN3-CA: 70.0;SH-SY5Y: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" "Vesicles, Mitochondria" "HPA049066: AB_2680619" "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.11e-4)" 1.3 2.2 18.4 0.7 18.6 0.1 1.5 10.3 25.9 2.5 2.4 1.6 0.1 3.3 0.7 0.6 1.5 0.7 33.7 20.3 12.6 0.6 0.3 1.2 0.3 14.8 15.0 5.3 0.9 0.0 10.4 0.2 15.1 4.9 0.0 15.9 2.6 2.0 2.0 1.2 0.9 1.1 12.1 1.2 1.3 7.9 16.4 0.0 1.0 0.2 0.2 1.0 1.3 18.1 0.1 15.2 53.2 70.0 0.1 0.4 0.0 4.6 0.6 2.9 0.6 0.0 0.4 0.0 1.8 2.4 5.1 0.0 10.4 10.3 0.3 0.0 2.0 0.0 0.1 5.7 9.3 0.0 10.6 4.7 4.9 1.7 0.2 0.9 5.4 0.0 0.0 0.5 7.7 4.5 0.0 0.0 9.1 0.9 5.1 0.0 0.0 8.7 0.0 1.1 8.3 72.0 1.7 0.1 9.7 3.1 0.2 0.1 9.0 13.1 21.7 0.0 12.8 0.1 3.9 0.0 22.0 0.0 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.3 0.1 0.0 0.0 0.1 18.4 18.6 10.3 25.9 20.3 12.6 14.8 15.0 15.1 12.1 16.4 18.1 0.3 0.0 0.0 7.2 0.1 0.5 0.5 0.1 0.6 64.9 0.4 0.6 20.1 0.0 0.1 0.0 58.4 0.0 0.1 0.0 0.0 0.3 5.3 0.1 5.0 1.2 1.8 0.0 12.2 0.0 0.1 2.7 2.0 0.3 0.0 0.7 0.0 0.0 0.2 33.7 13.6 0.0 0.0 0.0 0.8 9.0 4.1 0.1 1.8 0.0 0.1 7.5 0.0 12.1 18.4 0.5 0.0 4.5 0.0 0.7 0.0 0.0 0.0 13.8 0.0 1.0 5.7 7.0 5.2 0.3 0.1 0.0 0.5 4.5 0.0 0.2 DYNC1I1 "DNCI1, DNCIC1" ENSG00000158560 "Dynein cytoplasmic 1 intermediate chain 1" O14576 7 95772506-96110322 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 457.5;Inhibitory neurons: 374.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 213.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 14.0;SH-SY5Y: 10.3;U-266/84: 9.5;WM-115: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061689 Enhanced Supported NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA061689: AB_2684586" "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" "unprognostic (3.83e-2)" "prognostic favorable (3.79e-4)" "unprognostic (6.27e-2)" "unprognostic (2.11e-4)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (2.18e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.86e-2)" "unprognostic (2.24e-4)" "unprognostic (2.25e-4)" "unprognostic (1.63e-1)" "unprognostic (7.81e-4)" "unprognostic (1.10e-2)" 2.5 12.7 27.0 1.5 30.2 1.1 2.7 36.3 53.8 2.4 18.5 19.1 1.4 2.7 5.0 3.4 2.6 2.0 19.0 30.9 34.2 2.2 0.3 1.0 0.8 36.1 41.6 7.8 2.0 0.6 19.6 0.8 52.5 7.4 3.0 27.4 1.4 8.2 9.6 2.6 2.3 3.6 7.6 1.4 5.5 2.4 13.4 3.8 2.9 12.4 0.6 19.8 3.5 31.0 0.4 0.3 0.1 1.3 0.2 0.1 0.5 0.2 0.0 0.7 0.2 1.7 1.1 0.5 14.0 1.9 1.0 0.6 4.9 0.3 0.3 0.1 1.1 3.5 0.6 0.0 0.1 0.4 4.6 0.2 0.3 0.3 0.5 0.6 0.3 2.1 0.6 0.5 2.2 3.2 0.4 0.6 0.9 0.3 2.9 0.8 0.4 2.0 1.8 1.6 1.8 10.3 0.1 0.2 2.3 7.5 1.0 0.9 0.4 4.0 2.8 2.2 2.2 7.3 9.5 0.4 4.6 0.5 9.2 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.2 1.4 0.6 0.1 0.8 0.2 0.2 27.0 30.2 36.3 53.8 30.9 34.2 36.1 41.6 52.5 7.6 13.4 31.0 1.6 0.0 0.0 21.5 0.2 0.8 1.3 0.0 1.2 49.6 3.6 1.3 30.9 0.0 0.0 0.0 50.1 1.3 0.0 0.0 0.0 0.3 6.8 22.3 1.7 4.2 1.8 0.0 457.5 1.1 0.1 6.7 0.0 24.4 0.0 3.8 15.0 0.5 0.5 1.7 374.1 0.0 0.0 0.3 0.8 5.2 19.0 3.0 21.4 30.9 0.1 83.5 0.0 91.0 213.8 0.9 0.0 11.7 1.4 0.7 0.0 0.3 0.0 24.8 6.6 19.4 9.1 1.2 4.0 0.4 1.1 0.1 0.4 1.2 0.0 0.6 EIF1B GC20 ENSG00000114784 "Eukaryotic translation initiation factor 1B" O60739 3 40309707-40312424 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 362.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (1.54e-1)" "unprognostic (1.06e-2)" "unprognostic (1.31e-2)" "unprognostic (3.20e-3)" "unprognostic (7.64e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.02e-2)" "unprognostic (1.13e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.33e-1)" "unprognostic (1.23e-1)" "unprognostic (1.82e-1)" "unprognostic (8.87e-2)" 81.6 92.0 88.1 47.8 90.5 221.8 66.7 97.3 134.4 64.2 76.7 78.2 41.2 66.8 59.9 41.9 75.1 61.3 362.7 90.7 123.2 118.4 92.4 73.9 67.7 110.8 98.4 103.3 60.3 77.2 91.0 53.0 106.6 52.3 42.2 94.5 47.9 56.5 157.4 47.7 55.5 59.1 93.3 62.6 70.9 83.3 92.3 62.7 59.2 146.5 59.8 89.9 53.7 99.7 41.1 33.1 110.0 62.9 130.2 127.0 65.6 82.1 107.6 79.8 103.0 52.1 54.1 83.7 44.5 56.4 47.8 27.3 75.9 40.4 80.8 127.6 76.9 135.5 33.4 120.4 206.3 82.4 66.8 93.0 121.8 70.2 119.2 112.5 85.2 55.9 115.5 100.5 93.2 26.1 66.7 89.2 149.5 36.3 87.0 45.4 61.4 68.1 78.3 51.6 46.7 76.5 59.4 34.1 238.6 103.4 43.6 82.8 65.8 45.8 47.3 93.6 58.5 92.5 177.2 121.4 57.3 89.7 66.6 93.0 48.5 138.1 36.4 57.8 43.6 95.1 44.4 47.0 45.3 83.8 51.8 45.8 133.2 40.9 55.7 73.2 58.4 41.0 88.1 90.5 97.3 134.4 90.7 123.2 110.8 98.4 106.6 93.3 92.3 99.7 178.9 93.0 63.1 15.7 216.5 190.0 226.5 133.8 227.1 108.6 94.7 119.0 454.8 81.5 83.3 88.3 54.2 113.9 125.0 114.3 293.5 97.2 167.3 139.6 146.0 115.5 117.5 294.1 45.2 114.6 120.2 207.4 69.8 141.5 130.0 104.3 102.1 75.1 128.5 149.7 50.9 82.1 99.7 172.0 135.4 71.5 109.0 192.1 149.4 20.6 138.0 157.5 118.4 23.1 33.4 85.0 183.6 91.7 76.9 119.8 138.7 292.1 81.5 189.8 92.1 161.7 187.6 493.0 268.2 137.8 147.8 115.6 143.4 80.9 88.7 206.7 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 50.7" "Cell type enhanced" "Detected in many" "Astrocytes: 210.3;Excitatory neurons: 351.1;Inhibitory neurons: 393.6;Microglial cells: 286.7;Oligodendrocyte precursor cells: 288.5;Oligodendrocytes: 863.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: AB_2674218, HPA063991: AB_2685168" "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 11.3 13.4 22.3 4.2 32.7 1.2 8.6 18.8 23.9 12.6 3.2 8.6 7.3 10.1 6.0 15.1 7.8 6.5 50.7 20.7 25.7 7.2 3.8 7.2 3.1 23.9 25.7 15.0 5.0 13.2 6.1 13.0 23.3 8.0 5.7 14.1 7.7 8.9 11.1 26.5 9.1 10.0 16.4 5.2 6.9 6.9 22.2 4.4 10.2 11.5 6.4 9.7 13.0 40.9 21.7 16.3 14.7 17.8 41.2 16.9 25.3 15.6 21.9 13.2 8.6 22.3 3.3 5.6 9.5 26.2 19.6 35.4 12.4 25.7 18.9 4.2 10.1 16.7 11.0 12.8 22.2 2.4 5.5 14.6 36.6 14.9 23.1 20.6 21.8 8.7 1.8 0.0 17.6 7.5 6.4 2.9 15.3 14.9 9.0 3.4 26.4 2.3 12.7 50.1 7.3 6.3 26.7 8.2 10.9 16.1 5.7 2.3 24.3 15.2 12.8 13.1 9.6 5.5 5.9 0.0 17.7 1.2 12.4 1.3 0.5 0.0 0.7 0.4 0.5 0.7 0.5 0.4 0.4 0.7 0.6 0.9 0.0 0.5 0.6 0.1 0.8 0.4 22.3 32.7 18.8 23.9 20.7 25.7 23.9 25.7 23.3 16.4 22.2 40.9 17.8 0.0 4.1 210.3 4.1 26.1 10.2 9.8 14.8 17.4 5.2 5.2 87.1 12.8 5.1 9.2 25.0 15.1 5.0 10.2 5.9 9.3 62.9 5.6 14.5 14.1 3.0 2.1 351.1 11.5 13.2 12.4 30.5 9.2 8.2 11.6 11.4 5.6 4.6 16.8 393.6 6.0 4.1 12.0 7.1 8.2 8.4 5.0 5.4 286.7 2.0 9.9 1.0 288.5 863.3 11.0 8.6 7.5 3.7 8.1 28.2 5.5 8.4 11.1 0.0 13.5 14.7 12.0 4.9 13.1 37.4 24.6 4.7 5.5 4.5 10.7 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 59.8;Rod photoreceptor cells: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA012531: AB_2732403, HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favorable (1.92e-5)" "prognostic unfavorable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 3.9 5.1 5.5 4.0 5.4 3.9 3.4 7.9 7.0 5.2 3.4 4.9 2.0 4.7 3.5 2.6 3.8 3.5 12.9 5.9 5.1 3.7 3.4 3.8 6.0 5.1 5.7 3.9 3.9 3.3 5.6 2.9 4.5 4.8 3.2 5.3 3.2 3.6 3.2 1.9 4.4 4.5 4.1 5.5 3.6 3.9 5.9 5.0 4.5 3.2 4.7 4.4 3.5 6.4 4.3 7.6 8.7 7.6 5.7 8.4 3.5 13.9 8.7 11.6 12.9 6.8 4.3 15.1 3.5 5.5 3.3 4.3 11.0 4.7 9.8 17.5 10.2 11.4 12.7 7.6 7.0 12.7 9.5 6.4 5.2 10.3 5.4 5.5 16.2 8.6 5.2 9.9 18.2 2.9 8.6 4.2 8.3 3.7 9.8 5.8 4.6 6.7 6.0 5.5 4.0 2.0 8.5 2.1 3.8 3.9 2.9 6.1 13.3 9.5 7.2 10.8 11.2 5.7 10.3 13.3 7.4 10.9 7.1 0.9 10.0 4.5 26.6 9.8 23.8 60.3 25.8 26.4 7.2 47.1 25.9 25.2 0.6 27.8 11.6 14.4 12.9 5.5 5.5 5.4 7.9 7.0 5.9 5.1 5.1 5.7 4.5 4.1 5.9 6.4 9.8 6.4 4.5 15.3 24.9 2.9 6.5 13.4 8.0 49.9 4.4 3.7 33.0 7.2 5.8 11.0 56.3 12.3 23.8 5.4 0.0 8.5 3.7 3.2 9.7 12.9 16.9 13.7 23.5 5.3 2.1 10.8 4.6 3.6 1.3 14.0 9.7 5.7 7.0 40.4 29.1 7.5 10.2 8.3 6.2 3.7 27.1 6.0 12.4 15.0 16.0 13.0 59.8 31.7 23.5 6.4 7.4 17.7 19.1 5.5 4.3 4.0 8.0 78.3 13.1 11.6 9.5 36.5 28.0 4.6 1.0 1.9 22.9 14.0 9.7 6.3 F8 "DXS1253E, F8C, FVIII, HEMA" ENSG00000185010 "Coagulation factor VIII" P00451 X 154835788-155026940 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Disease variant, FDA approved drug targets, Hemophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 53.2" "Group enriched" "Detected in many" 10 "Adipocytes: 118.6;Endothelial cells: 120.4;Hepatic stellate cells: 371.2" "Cancer enhanced" "Detected in all" "renal cancer: 7.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB018777 Enhanced "Secreted to blood" NA NA 25000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "CAB018777: AB_640320" "unprognostic (2.09e-1)" "unprognostic (5.66e-4)" "unprognostic (4.94e-2)" "unprognostic (8.32e-5)" "unprognostic (1.26e-1)" "unprognostic (5.05e-2)" "unprognostic (6.05e-2)" "unprognostic (8.27e-2)" "unprognostic (6.58e-2)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (5.58e-2)" "unprognostic (1.24e-2)" "unprognostic (2.16e-3)" "unprognostic (1.69e-1)" "unprognostic (1.17e-2)" "unprognostic (4.44e-2)" 29.4 15.2 7.8 2.5 8.6 2.1 19.3 7.4 11.2 7.5 9.9 9.6 2.9 10.9 9.1 4.0 7.9 5.0 53.2 8.2 8.5 14.1 20.1 16.7 4.7 8.6 8.4 14.5 11.6 5.6 6.4 3.3 8.6 9.0 3.8 6.2 4.7 7.5 20.6 3.6 5.0 6.3 7.8 17.9 5.7 6.1 8.9 3.2 10.9 28.1 3.7 8.1 3.7 7.8 6.1 4.5 0.9 2.1 6.5 10.1 0.7 2.9 1.8 2.0 3.4 0.3 6.8 12.0 9.5 3.0 4.7 0.8 1.0 1.0 1.8 5.1 1.9 2.4 2.8 0.2 3.0 2.1 5.6 7.2 0.6 1.8 2.4 3.5 1.2 5.7 1.1 9.0 10.0 2.7 1.7 1.9 1.6 1.8 4.5 1.4 1.5 1.8 1.8 1.3 3.7 2.8 7.0 0.8 3.9 1.0 2.1 4.9 1.5 10.3 5.5 16.6 3.7 5.3 5.1 6.0 9.4 12.3 5.5 4.6 2.8 0.9 5.2 2.4 10.3 2.1 3.1 5.5 2.7 1.9 1.6 4.1 4.4 3.3 2.4 0.4 4.6 2.7 7.8 8.6 7.4 11.2 8.2 8.5 8.6 8.4 8.6 7.8 8.9 7.8 118.6 0.0 6.3 13.1 2.3 1.8 2.5 1.6 4.0 8.1 3.7 4.2 17.7 7.2 1.9 3.7 2.1 0.9 2.0 0.6 7.9 3.1 1.4 1.5 1.5 120.4 0.0 8.4 7.2 0.7 0.7 6.8 0.0 1.5 1.3 8.2 371.2 11.8 3.2 6.7 5.0 0.6 0.0 19.9 1.1 3.3 11.5 3.0 0.0 8.4 2.4 6.8 2.1 7.5 6.0 4.5 0.1 5.3 2.0 1.4 0.9 11.4 2.4 3.5 6.6 11.1 13.0 2.3 3.4 1.5 1.1 0.1 4.0 4.3 0.4 2.1 FAM155B "CXorf63, TED, TMEM28" ENSG00000130054 "Family with sequence similarity 155 member B" O75949 X 69504326-69532508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "heart muscle: 43.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 23.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;HAP1: 16.2;Hep G2: 6.1;NTERA-2: 24.3;OE19: 6.5;SCLC-21H: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036093 Uncertain NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 5: NTERA-2 - Transcription" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA036093: AB_10673613" "prognostic unfavorable (4.61e-5)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (5.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.49e-2)" "unprognostic (3.09e-4)" "unprognostic (7.07e-2)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (4.94e-3)" "prognostic unfavorable (1.83e-4)" "prognostic favorable (6.63e-4)" "unprognostic (1.46e-2)" "unprognostic (3.50e-2)" "unprognostic (2.21e-1)" "unprognostic (8.21e-2)" 0.1 0.8 2.2 0.0 2.1 0.0 0.2 3.0 2.6 0.2 0.5 0.3 0.1 0.3 0.4 0.1 0.7 0.2 43.5 2.1 2.7 0.9 0.2 0.1 0.1 2.4 3.1 0.1 1.8 3.1 2.4 0.0 3.4 0.9 0.2 0.4 1.1 4.9 0.1 0.0 0.2 0.1 2.0 0.7 1.1 1.5 3.5 0.1 8.0 0.0 0.1 0.2 0.1 2.3 0.0 2.7 0.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.7 0.0 5.2 0.0 0.0 0.0 16.2 0.6 0.0 0.0 5.0 0.0 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.2 0.0 0.0 24.3 6.5 0.0 0.0 0.0 0.0 0.2 0.0 11.3 0.8 0.1 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.1 3.0 2.6 2.1 2.7 2.4 3.1 3.4 2.0 3.5 2.3 0.2 0.0 0.0 1.3 0.0 0.0 0.3 1.6 0.0 0.4 0.6 0.1 23.7 0.0 0.8 1.8 0.0 0.0 0.0 0.5 0.0 0.5 0.0 2.0 0.5 0.7 1.2 0.0 0.8 1.2 0.0 0.4 0.0 4.4 0.0 0.0 0.4 0.3 0.1 0.0 0.9 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.8 0.2 0.0 0.0 1.2 0.0 0.5 0.3 0.8 0.0 0.1 0.2 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139390-192767764 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Growth factor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 35.8;heart muscle: 131.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 413.7;Excitatory neurons: 1213.5;Inhibitory neurons: 1925.1;Oligodendrocyte precursor cells: 1668.3" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.1;NTERA-2: 10.3;SCLC-21H: 23.9;U-251 MG: 14.7;WM-115: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA071557: AB_2686417" "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.9 35.8 8.5 0.2 14.1 0.0 1.3 0.5 21.3 0.5 0.0 1.1 0.7 1.0 0.2 1.7 1.5 0.5 131.3 17.5 14.2 2.5 0.6 1.1 0.2 11.1 1.0 0.8 7.7 1.6 5.3 0.4 9.9 1.3 0.3 15.4 5.9 6.0 1.1 0.3 0.3 0.7 0.0 11.6 0.6 2.1 3.5 0.1 1.5 0.8 0.2 0.5 0.7 2.8 0.1 1.1 15.1 0.0 0.0 0.0 0.1 0.0 0.1 1.4 1.7 0.0 0.1 0.8 7.2 0.3 0.3 0.2 0.0 0.0 1.6 0.1 0.2 3.2 6.3 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 3.7 0.2 0.0 0.1 0.1 0.0 4.4 0.0 0.0 10.3 7.1 0.3 0.0 0.1 0.0 4.7 1.8 23.9 0.0 0.0 0.6 0.0 1.7 1.1 0.2 0.4 6.2 3.2 0.0 14.7 0.2 2.5 0.0 1.3 0.0 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 14.1 0.5 21.3 17.5 14.2 11.1 1.0 9.9 0.0 3.5 2.8 17.8 0.0 0.0 42.7 0.1 0.6 4.2 0.0 0.6 100.2 0.9 1.7 413.7 0.0 1.9 5.5 4.2 0.2 0.0 0.0 7.9 0.7 20.9 1.6 1.6 13.2 0.0 0.0 1213.5 13.1 0.4 18.6 0.5 0.5 0.0 9.0 16.4 0.0 0.1 33.7 1925.1 0.0 0.0 0.3 0.3 38.5 6.8 0.1 1.8 46.9 0.0 3.8 0.0 1668.3 28.2 2.7 1.2 1.2 0.5 1.1 0.0 0.4 0.8 14.2 0.0 0.7 4.8 4.0 8.0 0.4 0.1 0.0 0.1 38.7 0.1 1.7 FGF18 "FGF-18, ZFGF5" ENSG00000156427 "Fibroblast growth factor 18" O76093 5 171419647-171457626 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 16.1" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 19.8;Cardiomyocytes: 24.4;Endometrial ciliated cells: 13.0;Glandular and luminal cells: 24.9" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.0;ovarian cancer: 21.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 55 "EFO-21: 188.2" "Low region specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" HPA018795 Uncertain "Secreted in other tissues" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "HPA018795: AB_1848523" "unprognostic (3.01e-1)" "unprognostic (2.38e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-3)" "unprognostic (6.62e-3)" "unprognostic (1.50e-1)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (2.98e-3)" "unprognostic (3.65e-2)" "unprognostic (3.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.37e-8)" "unprognostic (7.33e-2)" "unprognostic (2.58e-1)" "unprognostic (3.19e-1)" "unprognostic (2.76e-2)" 4.2 0.3 1.1 0.3 1.2 0.0 2.1 1.1 2.1 1.0 1.1 0.9 0.6 0.9 0.1 0.3 1.5 0.7 16.1 1.1 1.2 0.7 0.1 2.6 0.3 1.4 1.3 0.4 0.5 0.1 1.6 0.5 1.6 1.2 0.1 0.1 1.1 0.3 3.8 1.6 0.7 0.4 1.1 0.5 0.6 0.8 1.5 0.3 1.9 0.4 0.2 0.8 0.5 1.2 0.0 0.3 0.3 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.1 3.4 0.4 0.2 188.2 0.0 0.2 0.2 0.0 0.1 0.0 3.1 0.3 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.9 0.1 3.4 0.0 0.1 0.0 0.3 2.1 0.1 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.5 0.1 0.5 0.0 0.2 0.6 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.1 2.1 1.1 1.2 1.4 1.3 1.6 1.1 1.5 1.2 6.9 6.4 0.0 0.0 2.0 2.4 2.6 0.5 6.2 0.1 6.6 19.8 24.4 1.5 1.3 1.8 0.0 0.1 3.4 0.5 0.0 0.0 6.2 13.0 3.1 4.2 1.8 0.0 0.8 0.0 0.3 9.4 0.5 24.9 0.0 0.0 2.9 0.0 0.1 0.0 2.1 1.0 0.0 0.0 2.1 0.7 0.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.4 3.2 1.1 0.0 0.0 0.0 0.0 5.4 4.6 0.7 1.6 5.6 3.1 0.0 2.4 0.5 1.8 0.9 FHL2 "DRAL, SLIM3" ENSG00000115641 "Four and a half LIM domains 2" Q14192 2 105357712-105438513 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "heart muscle: 1421.4;ovary: 535.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1077.5;Extravillous trophoblasts: 585.9;Granulosa cells: 851.4;Leydig cells: 567.0;Peritubular cells: 1049.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 5.7" "Group enriched" "Detected in many" 6 "granulocytes: 5.7;T-cells: 2.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 534.6;RPTEC TERT1: 489.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005922, HPA006028, CAB008368" Enhanced Enhanced "Actin filaments,Focal adhesion sites" NA Yes 14000 "Cluster 18: Basophils - Vesicular transport" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 22: Epithelial cell types - Mixed function" "Actin filaments, Focal adhesion sites" "CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858" "unprognostic (1.04e-1)" "unprognostic (1.63e-3)" "unprognostic (3.30e-1)" "unprognostic (3.42e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (2.80e-2)" "unprognostic (1.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.42e-2)" "unprognostic (3.34e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (6.42e-5)" "unprognostic (2.06e-1)" "unprognostic (3.49e-1)" "unprognostic (9.92e-3)" "unprognostic (4.73e-2)" 68.3 70.2 10.4 28.9 13.2 17.0 65.4 7.6 18.2 101.9 15.0 75.2 48.5 105.1 33.8 55.4 55.8 81.5 1421.4 18.9 7.4 55.2 22.1 17.5 17.2 6.7 7.2 535.4 9.1 8.2 29.3 79.3 7.0 88.8 56.8 8.5 45.3 63.8 67.5 44.2 50.4 91.5 7.5 20.1 94.9 50.9 7.9 22.8 41.3 118.6 13.9 105.5 47.2 12.2 156.8 36.1 20.9 0.8 65.2 81.7 196.4 289.3 75.9 182.2 216.7 65.6 237.6 0.4 23.7 353.6 223.8 47.7 31.4 262.4 204.2 6.5 23.9 108.7 42.9 49.0 257.6 0.4 23.5 171.7 142.2 286.0 188.1 360.8 374.4 18.0 29.0 8.9 534.6 5.6 25.8 1.0 44.1 108.3 113.2 0.4 31.6 4.3 489.8 108.4 1.0 6.9 109.2 48.1 76.9 20.5 60.7 3.9 183.1 130.4 134.1 146.4 236.0 3.3 0.6 0.7 208.1 0.6 138.5 5.7 0.4 0.4 1.1 0.2 0.7 0.6 0.9 2.0 0.4 0.5 0.7 1.5 2.2 0.7 0.2 0.6 2.7 1.5 10.4 13.2 7.6 18.2 18.9 7.4 6.7 7.2 7.0 7.5 7.9 12.2 15.7 9.6 5.1 0.7 1.0 468.5 1077.5 342.5 389.9 9.5 59.8 126.2 362.1 15.7 91.0 29.5 2.1 220.4 1.7 212.6 3.9 100.7 5.7 44.8 40.4 27.4 58.2 63.5 46.3 117.9 585.9 96.1 186.1 32.5 10.2 851.4 17.2 9.2 25.3 0.0 4.9 169.8 73.2 0.6 31.8 17.3 567.0 10.4 23.2 25.3 2.7 1.6 0.0 0.5 1.6 234.5 258.2 1049.0 6.7 198.2 51.7 28.1 19.1 13.0 216.9 60.6 171.0 9.1 17.7 124.5 296.9 178.7 7.7 193.5 55.8 536.2 FHOD3 "FHOS2, FLJ22297, FLJ22717, KIAA1695" ENSG00000134775 "Formin homology 2 domain containing 3" Q2V2M9 18 36297714-36780055 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 172.8" "Cell type enhanced" "Detected in many" "Astrocytes: 104.5;Cone photoreceptor cells: 87.6;Excitatory neurons: 132.2;Granulosa cells: 84.9;Inhibitory neurons: 186.5;Oligodendrocyte precursor cells: 114.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.3;HDLM-2: 80.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021827, HPA024696" Uncertain "Intracellular and membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA021827: AB_1848571, HPA024696: AB_1848573" "unprognostic (8.46e-2)" "unprognostic (8.76e-2)" "unprognostic (6.34e-2)" "unprognostic (3.44e-1)" "unprognostic (8.96e-2)" "unprognostic (8.30e-2)" "unprognostic (4.11e-4)" "unprognostic (2.73e-2)" "unprognostic (2.81e-1)" "unprognostic (2.44e-2)" "unprognostic (2.16e-3)" "unprognostic (4.55e-2)" "prognostic favorable (1.19e-5)" "unprognostic (1.64e-2)" "unprognostic (4.10e-2)" "unprognostic (3.00e-3)" "unprognostic (1.20e-1)" 3.4 32.1 13.2 2.4 14.3 0.1 6.1 8.7 17.7 5.6 13.9 14.5 1.6 3.0 42.2 9.4 11.2 7.2 172.8 13.8 12.3 23.2 1.4 1.5 1.3 37.9 15.1 6.9 2.1 1.0 10.5 1.3 36.8 27.9 3.4 36.1 11.3 62.8 49.5 6.5 5.5 10.1 11.5 1.3 3.2 4.1 8.5 2.4 3.6 20.5 4.0 14.6 5.2 13.5 15.5 5.4 34.3 8.2 0.2 0.0 2.6 34.1 72.3 6.7 6.5 0.0 24.5 2.8 8.9 16.3 19.2 19.5 11.4 14.8 4.0 80.1 4.0 0.0 1.0 0.1 0.4 0.0 1.1 4.5 7.1 3.6 1.5 36.6 0.2 0.0 0.0 0.2 8.0 0.0 0.1 0.2 7.5 0.0 4.9 0.0 0.0 18.9 32.5 17.0 19.0 44.6 7.4 0.1 4.6 3.0 0.2 0.1 39.6 21.3 1.6 0.9 29.5 31.8 0.0 0.0 23.8 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 14.3 8.7 17.7 13.8 12.3 37.9 15.1 36.8 11.5 8.5 13.5 0.4 0.0 0.0 104.5 0.0 3.2 0.9 8.9 14.8 6.5 2.3 11.4 38.0 0.0 2.7 12.9 87.6 0.1 0.0 0.2 3.9 1.3 1.7 10.2 1.7 0.6 0.0 0.4 132.2 0.9 11.3 7.9 1.1 0.6 0.0 84.9 0.0 0.0 0.2 0.0 186.5 0.2 6.1 0.0 0.6 0.4 0.0 0.3 10.6 11.2 0.0 7.3 0.0 114.1 3.4 3.3 0.1 0.4 0.0 0.6 0.0 7.9 15.3 33.6 0.0 11.2 6.3 2.2 2.8 1.6 0.6 0.4 0.4 29.9 0.3 0.3 FITM2 "C20orf142, dJ881L22.2, FIT2" ENSG00000197296 "Fat storage inducing transmembrane protein 2" Q8N6M3 20 44302840-44311202 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid metabolism" Hydrolase "Deafness, Disease variant, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 67.4" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 153.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (2.92e-2)" "unprognostic (7.61e-2)" "unprognostic (2.27e-2)" "unprognostic (2.10e-3)" "unprognostic (1.02e-1)" "unprognostic (3.57e-3)" "unprognostic (1.63e-2)" "unprognostic (3.90e-2)" "unprognostic (8.43e-2)" "unprognostic (5.19e-2)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "prognostic favorable (8.98e-12)" "unprognostic (2.07e-1)" "unprognostic (2.54e-1)" "unprognostic (3.38e-3)" "unprognostic (2.49e-3)" 11.4 11.1 4.8 2.9 5.0 1.2 7.0 5.7 6.3 4.2 5.9 5.2 4.3 4.0 8.7 3.3 3.7 3.2 67.4 4.8 5.9 7.9 6.4 4.1 2.2 6.9 5.9 4.6 7.4 13.6 5.2 1.9 7.4 6.4 6.0 6.7 6.5 4.4 9.2 5.7 3.9 5.3 4.2 2.6 4.6 3.8 5.4 1.7 6.3 16.8 2.6 4.5 3.1 4.7 7.2 10.9 4.5 6.6 31.4 12.8 4.6 11.5 8.4 8.9 4.9 13.5 5.1 4.9 6.5 13.0 14.3 15.8 5.7 7.7 9.6 1.4 2.7 1.6 6.5 22.9 6.6 3.1 4.0 9.7 17.2 6.2 4.7 4.9 6.4 3.1 2.7 14.2 9.1 22.4 1.2 3.4 1.1 10.8 13.9 1.9 8.4 4.9 5.1 6.7 2.7 3.2 24.4 13.5 10.3 2.0 16.5 2.4 7.9 28.2 12.6 16.6 6.8 5.2 14.4 1.3 12.6 4.9 14.4 0.7 1.0 0.6 1.1 1.0 1.2 0.6 1.2 0.9 1.0 0.6 2.0 1.6 0.4 1.4 0.8 0.6 1.2 0.9 4.8 5.0 5.7 6.3 4.8 5.9 6.9 5.9 7.4 4.2 5.4 4.7 2.8 6.4 9.7 1.3 3.6 6.9 3.5 2.8 1.2 6.4 5.0 3.4 153.9 11.5 4.3 5.5 6.2 2.0 1.0 5.1 1.9 5.2 4.6 2.2 5.0 4.4 9.1 0.8 2.3 8.6 3.5 9.4 4.1 2.1 0.0 4.4 8.2 14.1 3.4 6.7 2.1 4.8 0.0 3.8 2.2 1.2 7.8 1.7 7.2 1.0 2.3 6.6 2.1 4.0 0.9 5.7 4.1 7.5 3.1 3.1 5.9 6.2 4.0 5.9 0.0 5.6 6.3 9.1 6.0 2.7 8.1 1.5 2.1 16.3 9.2 2.2 FRMD5 MGC14161 ENSG00000171877 "FERM domain containing 5" Q7Z6J6 15 43870761-44195271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 38.7;heart muscle: 46.6;retina: 20.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 375.2;Inhibitory neurons: 646.2;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 2000.1" "Cancer enhanced" "Detected in many" "glioma: 6.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 26.4;U-251 MG: 21.8;WM-115: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 17: WM-115 - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (9.54e-2)" "unprognostic (2.16e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (7.26e-7)" "unprognostic (3.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" "unprognostic (5.00e-3)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.01e-2)" "unprognostic (2.92e-4)" "unprognostic (1.21e-1)" "unprognostic (7.31e-2)" "unprognostic (1.18e-1)" "unprognostic (3.31e-1)" 0.2 8.3 14.8 0.5 24.2 0.8 0.4 18.0 20.5 0.3 4.5 1.4 0.2 0.1 0.4 0.3 1.0 0.4 46.6 15.1 18.9 0.3 0.0 0.1 0.3 22.1 21.2 0.3 0.2 0.8 2.0 0.0 20.6 0.5 0.8 20.0 1.1 0.3 0.0 0.3 0.5 0.2 15.6 0.3 1.3 3.4 19.5 0.0 0.3 0.0 0.0 0.4 0.4 38.7 6.6 3.5 2.3 1.3 2.6 0.2 0.4 1.4 2.1 3.9 7.4 11.2 6.6 0.5 1.3 0.9 10.6 7.3 3.3 7.0 3.3 0.4 3.7 1.0 3.1 4.4 0.3 0.1 0.4 0.0 0.7 10.6 20.8 7.6 26.4 5.7 0.2 0.7 4.1 0.6 1.0 0.1 1.9 21.3 3.8 0.1 4.7 0.0 3.6 2.3 14.3 4.8 0.8 0.1 15.0 1.8 0.2 0.2 1.0 7.1 13.4 1.8 21.8 0.5 2.0 0.8 10.4 0.4 61.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 14.8 24.2 18.0 20.5 15.1 18.9 22.1 21.2 20.6 15.6 19.5 38.7 0.0 0.0 0.0 134.8 0.0 0.4 0.0 0.8 0.6 11.4 0.1 0.3 14.8 0.0 0.1 0.0 2.1 0.0 0.0 0.3 0.0 2.8 14.7 0.3 0.1 0.2 1.2 0.0 375.2 6.0 0.0 1.1 7.1 0.1 0.0 3.9 0.0 0.0 0.1 0.0 646.2 0.8 0.0 0.0 0.3 5.2 0.3 0.0 0.0 14.0 0.0 17.5 0.0 298.6 2000.1 8.6 0.3 0.0 0.3 0.4 0.0 1.0 0.1 4.4 0.0 0.1 0.7 6.6 3.9 0.2 0.0 0.0 0.1 0.0 1.3 0.1 GALNT16 "GalNAc-T16, GALNTL1, KIAA1130" ENSG00000100626 "Polypeptide N-acetylgalactosaminyltransferase 16" Q8N428 14 69259277-69357033 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8;heart muscle: 45.0" "Cell type enhanced" "Detected in many" "Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059136, HPA075325" Approved Approved Vesicles,Cytosol NA NA 370000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Cytosol" "HPA059136: AB_2683919, HPA075325: " "unprognostic (9.71e-3)" "unprognostic (7.47e-2)" "unprognostic (4.02e-1)" "unprognostic (2.30e-2)" "unprognostic (6.71e-2)" "unprognostic (5.72e-3)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-4)" "unprognostic (1.31e-2)" "prognostic favorable (5.23e-6)" "unprognostic (5.38e-3)" "unprognostic (3.34e-2)" "unprognostic (3.93e-2)" "unprognostic (7.96e-5)" 14.4 11.6 25.7 2.0 24.4 0.1 12.0 14.7 28.4 7.6 6.5 6.5 2.2 7.3 2.8 3.6 5.6 3.4 45.0 27.0 35.5 7.7 2.0 3.4 3.2 19.6 22.5 2.1 4.3 2.5 4.7 0.4 19.9 4.0 2.2 1.3 23.5 4.6 4.4 7.5 3.7 8.6 16.4 12.1 3.2 3.5 40.8 2.2 4.9 5.8 1.3 3.1 5.0 21.3 0.0 0.8 8.5 0.3 11.7 5.3 0.0 1.3 0.1 1.5 2.3 0.4 0.0 0.0 0.2 1.4 0.8 0.0 3.0 0.0 0.3 0.1 6.0 0.0 0.2 0.5 0.1 0.0 0.5 0.5 0.0 17.0 0.0 17.2 0.9 0.0 0.0 0.0 2.8 0.5 0.0 0.0 1.7 0.0 0.1 0.0 4.8 0.0 0.5 0.0 8.7 3.0 1.8 0.4 0.0 0.3 0.3 0.0 0.1 1.7 19.9 2.2 2.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 24.4 14.7 28.4 27.0 35.5 19.6 22.5 19.9 16.4 40.8 21.3 4.0 0.0 0.0 16.6 0.0 4.1 0.4 0.0 0.0 2.8 3.1 3.0 46.7 0.0 0.0 0.0 2.1 0.1 0.2 0.0 3.9 0.1 9.7 0.2 0.4 1.7 0.0 0.0 27.6 0.0 0.0 24.0 0.5 0.2 0.0 0.3 0.0 0.0 0.2 0.0 23.8 0.1 0.0 0.0 6.1 11.2 0.9 0.3 3.6 5.6 0.0 0.1 0.0 8.0 1.6 0.0 0.0 3.8 0.0 0.5 0.1 0.1 0.0 0.8 6.6 10.1 14.8 0.6 2.1 0.3 3.3 0.0 0.3 11.2 0.6 0.4 GJA3 "CX46, CZP3" ENSG00000121743 "Gap junction protein alpha 3" Q9Y6H8 13 20138255-20161052 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 7.8;parathyroid gland: 4.0;placenta: 2.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 13.6" "Group enriched" "Detected in some" 4 "head and neck cancer: 1.3;melanoma: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 4.4;CAPAN-2: 7.7;HL-60: 6.6;U-266/84: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA014821 Supported NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA014821: AB_2669097" "unprognostic (2.32e-1)" "unprognostic (1.01e-1)" "unprognostic (4.37e-2)" "unprognostic (2.58e-3)" "unprognostic (2.98e-2)" "unprognostic (1.04e-2)" "unprognostic (6.87e-3)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (7.52e-2)" "unprognostic (7.70e-2)" "unprognostic (4.02e-2)" "unprognostic (9.65e-8)" "unprognostic (2.87e-1)" "unprognostic (1.91e-1)" "unprognostic (2.55e-2)" "unprognostic (8.04e-3)" 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 7.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.1 0.0 1.0 0.0 0.2 0.0 4.4 0.2 0.0 3.7 0.1 1.1 0.0 0.5 3.5 0.6 0.7 0.4 7.7 0.0 0.1 1.3 1.2 0.1 2.5 2.1 0.5 0.2 1.9 1.8 0.0 0.0 0.0 6.6 0.0 0.2 1.2 0.1 0.3 0.0 0.0 2.8 0.5 0.0 0.1 0.0 0.0 0.0 0.5 0.1 1.5 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 3.7 0.1 0.8 1.4 0.0 0.0 0.0 1.5 0.2 1.7 4.7 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.2 0.0 0.0 0.0 13.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 2.7 0.3 0.0 0.0 0.1 0.0 0.0 0.1 GPR22 ENSG00000172209 "G protein-coupled receptor 22" Q99680 7 107470018-107475684 "G-protein coupled receptors, Predicted membrane proteins" "Cilium biogenesis/degradation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7;cervix: 2.1;heart muscle: 8.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 15.3;Cardiomyocytes: 57.9;Excitatory neurons: 49.9;Inhibitory neurons: 51.2;Oligodendrocyte precursor cells: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "SH-SY5Y: 2.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "hippocampal formation: 60.4" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (4.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (5.52e-2)" "unprognostic (7.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.27e-3)" "unprognostic (1.62e-1)" "unprognostic (8.76e-3)" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (5.85e-4)" "unprognostic (1.55e-1)" "unprognostic (7.53e-3)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" 0.0 0.9 1.0 0.0 1.9 0.0 0.0 2.5 2.7 2.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.2 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.5 2.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.9 0.1 0.3 0.0 0.0 0.0 15.3 0.0 0.0 57.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.5 1.8 0.4 0.0 0.0 49.9 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.1 5.0 51.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 6.5 0.0 0.7 0.0 12.5 7.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 GPR3 ACCA ENSG00000181773 "G protein-coupled receptor 3" P46089 1 27392622-27395814 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.8;heart muscle: 5.4" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Basal squamous epithelial cells: 2.8;Cardiomyocytes: 2.8;Enteroendocrine cells: 4.8;Horizontal cells: 5.0;Inhibitory neurons: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB006254 Uncertain NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "CAB006254: AB_425462" "unprognostic (4.42e-2)" "unprognostic (2.22e-1)" "unprognostic (4.05e-2)" "unprognostic (1.55e-2)" "unprognostic (1.38e-2)" "unprognostic (1.27e-1)" "unprognostic (7.30e-3)" "unprognostic (6.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-1)" "unprognostic (5.94e-2)" "unprognostic (1.97e-1)" "unprognostic (1.46e-1)" "unprognostic (8.17e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (1.03e-2)" 1.9 0.6 1.5 0.7 1.7 1.0 1.3 4.2 7.8 0.6 0.4 0.7 0.2 0.5 0.0 0.5 0.8 0.7 5.4 2.2 3.1 1.5 0.4 2.2 0.2 4.0 3.1 0.4 0.6 0.5 4.4 0.4 3.9 0.9 0.2 1.5 0.5 0.1 0.5 0.6 0.5 0.6 2.5 0.2 0.8 0.2 2.2 0.2 1.8 1.5 0.1 0.8 0.4 2.5 1.9 1.0 5.3 5.9 0.2 0.6 0.7 3.4 4.0 5.2 3.8 1.6 1.1 0.3 0.8 1.6 5.3 1.3 1.4 4.2 4.0 0.1 0.2 1.5 0.3 3.4 0.6 3.4 4.5 0.7 0.0 7.3 1.6 0.5 1.6 2.3 4.3 5.8 6.4 2.7 0.7 4.8 7.8 2.7 8.4 9.2 4.2 2.5 2.2 0.4 1.0 2.5 1.7 0.7 6.6 2.2 0.1 0.7 1.0 3.9 7.1 23.0 4.2 0.7 4.3 0.5 5.9 1.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.7 4.2 7.8 2.2 3.1 4.0 3.1 3.9 2.5 2.2 2.5 5.5 0.0 0.0 0.7 0.1 0.1 2.3 1.0 2.8 1.6 0.7 0.5 2.8 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.6 0.3 1.4 4.8 0.0 2.6 0.0 0.3 1.4 1.1 0.6 0.0 0.0 0.0 0.0 0.2 5.0 4.6 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.0 1.7 1.0 0.0 0.1 0.7 0.0 0.1 0.1 0.1 0.5 0.4 GSG1L "KTSR5831, MGC18079, PRO19651" ENSG00000169181 "GSG1 like" Q6UXU4 16 27787528-28063714 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.5;heart muscle: 23.0" "Group enriched" "Detected in some" 7 "Excitatory neurons: 26.0;Oligodendrocyte precursor cells: 89.5" "Cancer enriched" "Detected in some" 7 "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 8.3;THP-1: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014479 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA014479: AB_2247974" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (2.38e-1)" "unprognostic (7.06e-4)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-2)" "unprognostic (6.68e-2)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" "unprognostic (6.66e-2)" "unprognostic (1.55e-1)" "unprognostic (3.13e-1)" "unprognostic (6.35e-2)" "unprognostic (9.77e-2)" 0.2 0.2 15.6 0.1 19.4 0.2 0.1 9.4 19.5 0.2 4.4 0.4 0.3 0.3 0.3 0.1 1.5 0.0 23.0 17.9 11.0 0.3 0.4 0.4 0.1 21.8 20.0 0.1 0.1 0.0 0.5 0.9 19.0 0.2 0.1 2.4 0.2 0.1 0.3 0.8 0.4 0.0 12.5 0.3 1.1 1.6 22.5 0.0 0.3 0.0 0.0 0.4 0.1 11.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.3 0.5 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 3.2 0.7 0.0 0.5 0.0 0.1 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.6 19.4 9.4 19.5 17.9 11.0 21.8 20.0 19.0 12.5 22.5 11.8 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.1 8.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.8 7.4 0.1 0.0 0.0 26.0 0.0 0.0 1.8 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.7 7.4 0.4 0.0 0.0 0.0 3.6 0.0 0.1 0.0 4.7 0.0 0.2 0.0 89.5 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 3.7 0.3 0.5 1.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 HEY2 "bHLHb32, HERP1, HESR2" ENSG00000135547 "Hes related family bHLH transcription factor with YRPW motif 2" Q9UBP5 6 125747664-125761269 "Predicted intracellular proteins, Transcription factors, Transporters" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 30.7" "Cell type enhanced" "Detected in many" "Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030205, HPA074851" Approved Approved "Nuclear bodies,Aggresome" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" Aggresome "HPA030205: AB_10600712, HPA074851: AB_2686718" "unprognostic (5.10e-2)" "unprognostic (4.34e-2)" "unprognostic (1.41e-3)" "unprognostic (2.43e-3)" "unprognostic (1.99e-1)" "unprognostic (2.52e-3)" "unprognostic (2.56e-1)" "unprognostic (1.38e-2)" "unprognostic (2.01e-1)" "unprognostic (9.10e-3)" "unprognostic (7.34e-2)" "unprognostic (6.20e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (6.74e-2)" "unprognostic (1.51e-3)" "unprognostic (1.19e-1)" 6.5 0.9 8.8 1.0 12.0 0.1 5.7 9.4 7.6 8.0 3.0 2.5 1.3 7.5 16.4 1.8 13.5 1.7 30.7 7.2 10.4 3.1 5.3 3.2 0.5 12.7 10.0 7.1 3.3 2.6 5.5 3.7 10.6 2.1 1.3 5.7 2.0 2.7 16.2 2.4 2.1 1.7 14.1 1.9 2.0 6.6 11.8 0.7 3.1 4.9 0.6 2.7 4.7 12.2 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.5 7.1 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.6 0.0 0.4 0.0 0.0 3.2 0.0 0.3 0.5 0.6 0.9 0.0 0.1 2.3 0.0 0.0 0.0 6.6 3.2 1.9 0.0 14.8 0.3 0.0 0.1 0.8 17.6 0.3 0.1 0.6 0.0 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.8 12.0 9.4 7.6 7.2 10.4 12.7 10.0 10.6 14.1 11.8 12.2 2.8 3.2 1.1 12.4 0.7 3.8 0.5 8.7 3.4 0.4 9.8 5.7 21.5 0.0 2.7 0.0 8.4 0.0 1.4 0.1 9.8 0.1 49.9 46.1 4.2 6.0 0.0 2.7 0.1 1.8 0.1 3.3 1.1 36.8 0.0 73.9 1.8 8.0 0.1 1.7 0.4 0.0 2.0 0.8 3.0 80.6 6.5 0.6 3.6 5.6 0.0 34.8 3.1 2.5 23.4 1.1 0.1 23.3 3.1 0.3 0.0 6.4 5.4 5.2 52.6 17.5 41.8 16.2 15.1 7.7 2.0 0.0 2.0 2.8 0.1 0.3 INSYN1 "C15orf59, LOC388135, MGC131524" ENSG00000205363 "Inhibitory synaptic factor 1" Q2T9L4 15 73735458-73753351 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.6;heart muscle: 48.5" "Cell type enriched" "Detected in single" 24 "Cardiomyocytes: 14.7" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol No NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favorable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 3.5 2.6 32.6 0.9 30.1 0.1 1.9 27.2 42.8 7.9 1.6 6.6 0.8 4.2 3.4 12.0 7.8 1.9 48.5 38.9 28.8 15.5 0.4 2.7 0.2 26.9 56.6 13.5 1.4 2.9 5.2 0.5 27.7 10.6 0.6 3.9 3.3 11.0 4.6 13.3 2.4 3.2 22.8 0.7 3.7 4.5 46.3 0.2 2.1 2.6 0.9 6.4 16.9 34.7 0.0 0.0 1.8 1.2 8.7 0.1 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.5 5.8 1.0 2.1 1.9 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.4 4.7 0.4 1.3 2.0 0.1 0.0 1.3 4.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 32.6 30.1 27.2 42.8 38.9 28.8 26.9 56.6 27.7 22.8 46.3 34.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNIP2 KCHIP2 ENSG00000120049 "Potassium voltage-gated channel interacting protein 2" Q9NS61 10 101825974-101843920 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 227.4;brain: 139.6;heart muscle: 307.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 54.3;Cardiomyocytes: 135.7;Cone photoreceptor cells: 25.0;Excitatory neurons: 23.3;Horizontal cells: 48.8;Inhibitory neurons: 41.9" "Cancer enhanced" "Detected in many" "glioma: 3.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 21.3;HMC-1: 12.7" "Group enriched" "Detected in all" 4 "amygdala: 96.8;basal ganglia: 234.9;cerebral cortex: 106.9;hippocampal formation: 142.6;olfactory bulb: 144.0" "Low region specificity" "Detected in all" HPA066717 Approved Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA066717: " "unprognostic (5.92e-2)" "unprognostic (2.16e-1)" "unprognostic (3.48e-3)" "unprognostic (5.77e-4)" "unprognostic (1.34e-1)" "unprognostic (1.31e-3)" "unprognostic (8.80e-2)" "unprognostic (9.11e-3)" "unprognostic (1.14e-1)" "unprognostic (5.34e-2)" "unprognostic (3.18e-2)" "unprognostic (7.20e-2)" "unprognostic (1.49e-9)" "unprognostic (9.85e-2)" "unprognostic (1.81e-1)" "unprognostic (3.27e-1)" "unprognostic (8.37e-4)" 227.4 6.8 74.5 3.5 139.6 0.9 67.1 48.8 84.5 7.4 40.5 5.0 1.8 4.1 4.1 2.5 4.9 3.1 307.5 98.8 50.6 2.8 2.3 2.5 8.1 47.5 51.6 11.5 2.4 1.7 19.7 2.9 48.1 5.2 4.7 52.6 9.9 3.5 8.0 5.9 5.3 2.6 50.3 5.7 2.7 8.5 57.1 2.3 3.5 5.4 8.3 4.8 4.4 60.8 1.7 2.6 2.5 3.2 1.0 1.1 0.6 1.2 1.0 0.6 0.9 3.6 3.4 1.6 0.9 0.8 0.7 1.7 0.9 0.4 0.6 2.4 2.0 21.3 3.0 1.9 0.9 1.4 12.7 2.6 1.7 1.0 1.4 3.7 1.0 4.7 6.3 1.8 1.0 1.2 0.8 4.0 0.8 0.7 0.6 1.0 0.2 1.4 1.0 1.1 7.4 1.2 0.8 0.6 2.4 1.5 2.2 0.9 2.3 1.3 2.0 0.6 1.2 1.7 1.9 1.7 1.4 5.3 0.2 0.0 0.0 0.7 0.0 0.5 0.1 0.9 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 74.5 139.6 48.8 84.5 98.8 50.6 47.5 51.6 48.1 50.3 57.1 60.8 0.4 0.0 0.0 8.5 2.3 0.4 0.1 0.3 0.0 54.3 0.3 0.5 135.7 0.0 0.1 1.8 25.0 0.2 0.0 0.8 0.0 0.2 6.6 0.0 0.2 1.6 0.0 0.0 23.3 0.0 0.2 5.8 0.0 0.0 0.0 0.8 0.4 0.1 2.2 48.8 41.9 0.4 0.0 0.6 0.8 5.2 1.8 0.3 0.0 1.0 0.5 8.3 0.0 5.5 3.7 0.3 0.2 0.7 0.3 0.1 0.5 0.1 0.2 4.7 0.0 0.1 1.3 2.5 5.5 0.5 0.0 0.3 0.1 0.5 0.3 0.1 KCNJ4 "HIR, hIRK2, HRK1, IRK3, Kir2.3" ENSG00000168135 "Potassium inwardly rectifying channel subfamily J member 4" P48050 22 38426327-38455199 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 28.9;heart muscle: 33.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.3;Excitatory neurons: 14.3;Horizontal cells: 10.1;Inhibitory neurons: 11.1;Microglial cells: 3.7;Muller glia cells: 6.2" "Cancer enhanced" "Detected in some" "glioma: 2.1;liver cancer: 1.8" "Group enriched" "Detected in many" 5 "amygdala: 10.5;basal ganglia: 18.9;cerebral cortex: 28.9;hippocampal formation: 21.9;white matter: 10.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 11.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 14 "amygdala: 5.9;basal ganglia: 13.7;cerebral cortex: 14.7;hippocampal formation: 12.3;olfactory bulb: 15.9" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (4.76e-2)" "unprognostic (2.60e-3)" "unprognostic (2.21e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (9.68e-3)" "unprognostic (3.12e-1)" "unprognostic (8.96e-2)" "unprognostic (2.07e-1)" "unprognostic (3.15e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-1)" "unprognostic (5.41e-2)" 0.1 0.2 10.5 0.0 18.9 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.8 0.6 33.3 21.9 3.5 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.1 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.4 0.8 0.0 0.3 0.1 0.0 1.7 0.0 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 18.9 0.0 28.9 21.9 3.5 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 11.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 3.7 0.0 6.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KIF5B "KNS, KNS1" ENSG00000170759 "Kinesin family member 5B" P33176 10 32009015-32056425 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009846, HPA037589, HPA037590" Approved Enhanced "Centriolar satellite,Cytosol" NA Yes 97000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 10: Non-specific - Unknown function" "Centriolar satellite, Cytosol" "CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (4.00e-2)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.70e-1)" "unprognostic (6.37e-3)" "unprognostic (2.03e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.43e-2)" "unprognostic (2.39e-1)" "unprognostic (8.06e-2)" "unprognostic (1.76e-1)" 59.7 41.8 110.0 46.7 128.2 84.9 45.3 107.7 149.7 47.3 75.6 66.4 52.0 54.1 30.3 52.7 39.2 59.8 87.4 85.8 100.2 44.7 31.9 52.5 39.9 121.9 123.8 27.6 41.8 91.6 22.9 54.4 120.6 65.9 63.6 45.1 39.1 52.0 65.0 38.9 54.7 81.3 128.1 48.1 51.4 64.4 116.8 44.0 50.5 67.3 36.6 60.8 29.8 143.4 115.8 96.4 127.3 89.9 89.2 97.7 54.4 155.6 73.3 117.6 99.6 106.6 124.0 78.7 65.8 185.8 66.9 93.3 117.6 99.4 156.4 68.4 64.1 100.2 87.9 104.5 102.5 70.5 105.6 79.9 138.0 135.8 94.0 93.4 152.8 68.2 122.9 80.5 164.7 69.7 74.0 39.7 20.7 110.1 43.4 95.7 237.2 32.6 90.6 79.5 123.3 89.9 120.4 47.5 117.3 88.0 57.5 99.4 128.4 118.7 111.0 139.3 117.2 24.2 29.8 90.9 113.2 142.2 114.1 41.8 25.9 44.0 19.1 33.0 18.7 23.7 24.0 20.6 24.7 24.3 21.1 20.8 51.1 24.3 35.7 47.9 29.4 18.4 110.0 128.2 107.7 149.7 85.8 100.2 121.9 123.8 120.6 128.1 116.8 143.4 160.3 182.7 206.8 49.3 86.3 213.1 177.7 200.6 66.0 181.9 119.0 103.8 396.0 115.8 198.4 104.8 100.1 121.0 125.5 145.0 45.0 209.4 185.5 167.8 171.4 181.0 132.3 69.2 44.6 176.0 134.9 141.2 85.6 158.9 91.2 159.7 88.5 46.2 132.7 151.4 56.0 227.3 213.6 111.8 129.1 51.8 59.0 137.2 101.4 84.3 169.3 160.5 82.4 61.9 83.3 202.2 164.9 130.9 84.2 254.1 120.2 59.5 206.1 123.8 85.5 176.0 244.8 566.0 195.6 87.6 236.7 331.9 116.0 137.4 208.1 246.8 KIFAP3 "FLA3, KAP-1, KAP3, SMAP" ENSG00000075945 "Kinesin associated protein 3" Q92845 1 169921326-170085208 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 193.9;Excitatory neurons: 190.5;Inhibitory neurons: 192.4;Late spermatids: 200.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023738, HPA023742" Supported Approved Microtubules NA NA "Cluster 44: Non-specific - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Microtubules "HPA023738: AB_1857285, HPA023742: AB_1857286" "unprognostic (5.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (6.05e-2)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (7.17e-3)" "unprognostic (7.74e-2)" "unprognostic (1.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.15e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-3)" "unprognostic (4.39e-3)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (2.22e-2)" 17.8 34.8 46.8 11.9 50.0 6.9 16.4 37.4 60.0 18.8 27.7 19.9 11.6 17.3 23.3 12.6 19.4 15.4 51.1 50.8 55.7 23.5 16.6 15.4 13.1 50.0 43.3 19.2 14.0 27.1 29.1 14.5 52.0 14.4 15.9 56.4 13.0 16.2 22.4 14.1 14.5 15.6 39.2 10.8 10.0 35.1 44.2 18.8 16.7 23.1 13.9 13.5 18.1 49.9 13.0 11.8 17.6 19.0 41.0 43.2 9.9 16.1 19.9 19.7 24.2 5.8 20.5 23.2 23.1 33.3 9.1 27.6 37.7 22.6 18.5 49.3 19.9 56.3 13.8 5.3 20.4 16.6 9.4 30.5 30.3 34.7 30.1 23.3 22.6 29.5 47.7 17.1 24.9 3.5 31.2 9.8 3.8 33.7 10.7 12.3 15.5 14.8 37.2 4.8 20.8 32.0 22.1 17.9 25.1 40.5 16.7 10.4 24.1 42.0 9.7 26.7 19.5 33.0 23.9 21.2 19.6 6.0 27.3 16.8 3.8 14.8 13.0 10.6 15.0 7.5 13.2 14.9 8.8 7.6 14.9 15.3 1.4 22.3 19.3 7.6 18.6 8.4 46.8 50.0 37.4 60.0 50.8 55.7 50.0 43.3 52.0 39.2 44.2 49.9 33.2 32.1 27.8 64.6 14.4 9.1 11.9 12.3 12.0 56.5 13.8 18.2 37.3 28.6 27.6 29.5 43.8 14.2 22.8 14.5 9.8 25.9 193.9 51.5 35.4 20.9 32.2 25.9 190.5 8.2 16.0 32.4 9.2 25.5 31.0 15.5 12.8 13.6 9.8 48.8 192.4 12.5 24.4 13.4 5.9 200.7 38.5 17.1 10.6 51.5 8.6 42.7 29.9 84.4 65.0 12.0 9.4 21.8 27.8 4.9 13.2 37.3 64.3 70.7 0.0 34.5 31.1 77.8 64.0 14.6 10.7 8.8 20.3 17.4 17.0 9.9 KRBA1 KIAA1862 ENSG00000133619 "KRAB-A domain containing 1" A5PL33 7 149714781-149734575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 40.2" "Cell type enhanced" "Detected in many" "Muller glia cells: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021237, HPA050448" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm Cytosol "HPA021237: AB_2134145, HPA050448: AB_2681129" "unprognostic (2.19e-2)" "unprognostic (9.01e-2)" "unprognostic (8.06e-2)" "unprognostic (7.48e-3)" "unprognostic (6.75e-3)" "unprognostic (5.59e-2)" "unprognostic (1.01e-5)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (2.77e-4)" "unprognostic (2.55e-1)" "unprognostic (6.33e-3)" "unprognostic (9.62e-2)" "unprognostic (4.29e-2)" "unprognostic (1.47e-1)" "unprognostic (9.31e-2)" 4.1 6.0 6.0 5.0 6.7 3.9 5.4 4.3 10.1 9.2 1.8 9.0 1.5 9.6 2.3 5.7 7.0 4.3 40.2 6.5 4.2 7.6 2.6 4.7 4.6 7.6 4.7 8.9 7.6 6.0 25.2 2.3 4.8 8.9 1.3 4.9 12.9 5.6 6.3 6.9 5.3 6.4 2.6 6.8 7.4 6.8 5.6 3.9 6.1 4.1 3.7 8.1 7.5 7.1 8.0 4.9 9.5 20.0 4.2 4.1 8.3 4.2 5.1 6.6 7.5 0.5 2.1 2.4 8.6 5.3 13.3 7.8 7.2 14.0 3.3 11.1 13.7 4.4 7.5 4.7 5.2 0.0 12.0 9.2 6.5 4.6 2.5 7.8 6.1 13.0 18.4 2.5 3.4 3.2 11.7 6.8 11.4 3.7 4.7 12.2 3.8 1.3 5.1 6.3 7.5 12.7 6.4 18.3 4.5 4.3 3.2 6.8 6.2 8.0 3.4 0.0 5.8 11.7 4.1 10.7 4.7 7.6 8.5 0.0 0.7 0.1 1.4 0.7 0.9 0.6 0.7 0.8 1.0 1.3 1.2 1.0 0.5 0.1 1.6 1.4 1.6 0.7 6.0 6.7 4.3 10.1 6.5 4.2 7.6 4.7 4.8 2.6 5.6 7.1 2.0 0.0 3.2 9.4 1.9 1.8 2.6 2.7 4.6 7.9 4.4 3.9 10.3 5.7 1.6 3.7 4.2 1.2 4.8 0.0 0.0 4.9 0.6 0.8 2.0 1.6 0.0 0.4 6.9 2.7 2.3 3.0 2.6 0.9 0.0 6.3 1.4 1.2 5.2 8.4 6.5 0.1 0.0 2.8 0.9 1.2 4.1 1.8 0.0 1.9 1.6 11.7 2.1 5.5 3.3 1.3 0.0 3.4 1.1 3.0 0.0 1.8 1.6 4.2 6.6 2.8 2.2 1.8 3.5 1.2 1.8 1.2 2.8 3.0 0.1 1.9 LRRC10 "HRLRRP, LRRC10A" ENSG00000198812 "Leucine rich repeat containing 10" Q5BKY1 12 69608564-69610907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "heart muscle: 40.0" "Cell type enriched" "Detected in some" 19 "Cardiomyocytes: 39.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (3.76e-4)" "unprognostic (4.59e-1)" 0.1 0.0 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 40.0 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC49 FLJ20156 ENSG00000137821 "Leucine rich repeat containing 49" Q8IUZ0 15 70853239-71053658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 56.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 85.0;Cardiomyocytes: 145.1;Early spermatids: 92.8;Excitatory neurons: 79.1;Inhibitory neurons: 88.4;Late spermatids: 105.3;Spermatocytes: 91.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 24.2;SH-SY5Y: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015596 Uncertain NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA015596: AB_2669230" "unprognostic (9.74e-2)" "unprognostic (7.94e-2)" "unprognostic (3.25e-3)" "unprognostic (1.15e-2)" "unprognostic (6.10e-2)" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (1.72e-1)" "unprognostic (3.36e-2)" "unprognostic (9.43e-2)" "unprognostic (7.66e-4)" "unprognostic (3.02e-1)" "unprognostic (5.29e-2)" "unprognostic (7.60e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.09e-2)" 2.4 2.8 7.9 0.8 10.4 0.3 2.7 13.7 11.2 6.6 7.3 3.9 0.4 8.7 29.6 1.9 9.0 3.7 56.3 6.7 10.7 4.6 0.5 2.7 0.7 12.2 10.5 11.1 1.4 9.1 11.6 1.0 13.2 5.3 1.7 26.8 1.8 4.8 1.1 1.7 1.7 5.0 5.1 0.8 2.7 11.9 18.8 1.0 4.8 1.7 0.8 4.5 3.8 6.1 2.1 3.9 8.5 14.9 3.8 6.4 0.1 3.6 6.3 2.4 5.8 1.3 1.6 0.0 2.6 1.5 6.0 3.5 8.4 4.3 2.0 0.0 4.5 1.0 4.1 0.1 24.2 0.1 0.5 2.9 1.5 7.2 12.3 12.5 6.5 0.0 0.1 0.0 3.6 0.7 0.0 0.7 5.0 0.3 2.8 0.0 5.7 0.0 8.0 4.5 17.2 18.0 4.3 2.0 4.0 3.1 4.6 1.4 5.9 2.9 9.0 5.4 6.2 1.1 4.3 0.0 6.8 0.2 2.2 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 10.4 13.7 11.2 6.7 10.7 12.2 10.5 13.2 5.1 18.8 6.1 4.3 3.2 3.7 63.3 0.7 2.3 22.9 11.5 5.7 85.0 2.2 3.0 145.1 1.5 13.0 7.3 62.6 0.1 0.1 1.5 5.9 7.0 92.8 30.8 8.0 7.2 18.5 0.0 79.1 0.9 0.1 11.6 2.6 4.3 0.0 8.0 2.5 0.0 0.1 30.3 88.4 1.9 0.0 0.3 0.7 105.3 5.6 0.7 0.0 19.7 0.0 10.9 0.0 63.8 34.1 1.7 1.6 9.8 0.2 11.7 0.3 3.5 54.8 37.3 0.0 7.4 8.0 91.9 11.4 0.7 1.6 0.3 0.8 2.5 1.2 8.0 LSM1 "CASM, YJL124C" ENSG00000175324 "LSM1 homolog, mRNA degradation associated" O15116 8 38163335-38176730 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024601 Approved "Cytosol,Cytoplasmic bodies" NA NA 22000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 51: Myeloid cells - Hemostasis" "Cytoplasmic bodies" Cytosol "HPA024601: AB_1853379" "unprognostic (1.19e-2)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" "unprognostic (9.59e-2)" "unprognostic (7.26e-2)" "unprognostic (1.69e-1)" "unprognostic (2.08e-3)" "unprognostic (2.18e-2)" "unprognostic (1.95e-2)" "unprognostic (2.48e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (3.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (2.97e-1)" 30.0 31.9 42.1 27.6 43.0 34.4 28.0 44.1 49.2 25.1 43.4 31.0 25.3 27.5 39.6 27.5 22.9 26.7 61.1 41.5 44.0 36.1 36.7 20.4 33.9 42.8 43.2 20.0 28.3 29.5 22.1 34.6 43.0 27.3 29.4 21.4 32.4 34.1 34.8 24.7 25.4 31.7 43.0 22.4 27.0 20.9 44.1 34.8 28.7 35.0 31.8 37.8 22.5 43.2 66.8 72.1 47.6 54.2 78.1 71.8 41.2 78.6 81.9 74.9 78.3 51.3 45.7 32.2 69.4 96.9 75.3 33.1 61.2 67.0 83.7 49.0 71.8 102.9 52.2 65.4 68.1 36.4 65.3 70.1 60.9 62.0 51.2 57.1 66.1 65.0 83.2 78.7 94.7 66.7 110.7 70.4 68.7 100.9 73.9 53.2 49.2 38.1 102.9 78.8 80.3 67.1 34.3 51.0 98.7 48.3 43.3 76.2 65.1 63.9 77.1 96.0 65.0 82.2 123.2 66.2 74.8 73.7 67.3 161.5 65.7 105.0 58.6 75.0 61.1 59.8 64.6 64.9 66.0 52.4 58.4 67.2 50.5 62.9 78.8 111.1 82.1 78.8 42.1 43.0 44.1 49.2 41.5 44.0 42.8 43.2 43.0 43.0 44.1 43.2 40.8 12.8 24.6 5.2 49.5 66.3 45.6 101.7 26.2 26.6 58.5 42.4 5.9 48.6 61.7 68.0 10.4 109.3 78.4 40.7 180.0 90.6 9.0 65.0 47.1 42.9 46.7 36.2 9.3 119.2 138.9 40.7 25.5 53.0 24.1 29.5 42.5 58.5 84.9 13.5 11.6 48.8 75.3 51.5 46.9 8.4 61.5 58.6 48.0 12.2 104.8 55.0 125.7 7.5 12.4 120.0 54.5 56.8 57.1 92.1 59.8 121.4 51.1 24.1 52.6 39.0 58.0 64.7 129.3 40.8 70.3 102.2 57.8 67.3 49.9 87.3 MAPRE2 "EB1, EB2, RP1" ENSG00000166974 "Microtubule associated protein RP/EB family member 2" Q15555 18 34976928-35143470 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 163.3;Oligodendrocytes: 435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 124.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016738, HPA016739" Enhanced Uncertain Nucleoplasm NA NA 13000000 "Cluster 44: Non-specific - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA016738: AB_1853571, HPA016739: AB_1853570" "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (2.55e-2)" "unprognostic (5.30e-3)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (8.53e-2)" "unprognostic (1.09e-2)" "unprognostic (2.29e-1)" "unprognostic (2.93e-2)" "unprognostic (5.40e-2)" "unprognostic (2.22e-3)" "unprognostic (5.83e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (3.99e-3)" 22.4 58.7 54.2 29.1 65.2 22.1 16.6 58.5 89.4 19.3 1.9 24.5 15.0 14.0 18.9 17.4 12.7 41.1 89.1 68.8 56.9 18.4 33.4 27.2 35.8 74.0 61.0 24.9 12.8 19.2 16.3 28.3 70.6 16.1 24.6 49.1 20.2 17.2 50.4 26.1 19.6 23.8 70.0 27.8 30.6 6.4 68.2 74.4 21.7 91.9 32.6 27.2 14.4 109.0 0.8 26.3 28.9 15.4 17.1 15.9 2.0 18.7 44.7 22.3 37.2 2.0 9.9 87.8 21.3 41.1 23.5 35.0 22.8 15.2 39.8 51.5 21.3 88.9 26.9 52.8 12.6 49.5 72.3 19.6 4.0 30.4 10.5 21.2 124.0 61.4 28.3 37.7 28.8 1.7 104.6 16.4 22.5 28.8 5.2 41.6 35.2 20.0 11.9 0.4 35.9 23.9 14.0 0.7 15.5 27.2 3.2 29.0 21.0 24.1 13.4 14.2 12.7 19.9 50.8 50.8 41.4 65.1 38.2 69.0 30.0 46.7 63.8 37.7 49.5 60.8 44.4 58.3 33.4 55.5 50.6 61.5 21.5 74.4 51.6 47.3 52.9 76.9 54.2 65.2 58.5 89.4 68.8 56.9 74.0 61.0 70.6 70.0 68.2 109.0 27.0 22.4 18.3 104.8 73.0 23.7 5.1 2.0 38.1 109.6 18.9 19.7 105.6 12.8 4.8 5.5 25.0 0.6 107.9 13.3 5.9 9.8 12.4 11.9 12.6 29.4 29.3 25.0 163.3 12.8 9.7 28.5 42.3 14.6 27.3 4.6 33.5 26.1 26.1 52.2 141.7 25.8 4.1 44.7 38.3 6.8 19.3 44.6 30.2 70.3 17.1 40.3 52.5 97.5 435.9 10.1 15.6 21.1 31.6 2.9 12.0 5.1 6.5 12.5 78.9 25.4 74.9 1.9 10.6 9.1 27.6 0.8 76.1 15.0 11.1 3.5 MARCHF2 "HSPC240, MARCH-II, MARCH2, RNF172" ENSG00000099785 "Membrane associated ring-CH-type finger 2" Q9P0N8 19 8413270-8439017 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.1;Cardiomyocytes: 42.3;Extravillous trophoblasts: 11.6;Hofbauer cells: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014063 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Endoplasmic reticulum" Cytosol "HPA014063: AB_1853576" "unprognostic (1.15e-2)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.48e-4)" "prognostic favorable (1.05e-5)" "unprognostic (3.00e-1)" "prognostic favorable (8.29e-4)" "unprognostic (3.43e-2)" "unprognostic (6.95e-2)" "unprognostic (3.06e-3)" "unprognostic (2.32e-1)" "prognostic favorable (6.21e-4)" "unprognostic (2.01e-1)" "unprognostic (3.52e-1)" "unprognostic (1.01e-1)" "unprognostic (3.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.80e-2)" 65.7 33.0 102.2 20.3 101.5 29.4 49.8 99.5 106.6 24.2 66.4 96.2 15.7 34.4 53.9 32.4 27.1 15.3 101.1 90.9 94.3 35.6 59.1 41.9 19.5 113.7 102.5 15.8 19.2 15.3 30.5 19.8 106.0 40.8 14.0 9.1 25.5 28.8 89.5 34.5 31.4 30.1 109.2 51.2 32.9 18.9 105.1 14.2 47.9 48.6 14.5 49.8 26.1 96.7 11.4 14.2 6.3 29.5 37.9 12.6 10.7 12.3 14.7 9.5 9.8 7.0 5.5 4.4 34.8 26.7 12.6 8.1 8.2 17.5 7.3 22.7 20.3 34.2 6.6 15.9 20.5 5.0 49.6 14.7 20.1 9.2 8.1 13.9 38.2 17.8 4.9 24.5 7.5 21.5 7.0 16.7 13.3 14.0 34.2 11.0 2.0 11.4 22.4 13.9 3.1 17.7 0.8 12.9 24.2 21.5 10.2 10.8 38.9 13.3 8.4 44.5 10.4 21.7 28.2 5.0 21.6 10.2 10.7 52.6 18.5 31.3 10.6 28.6 10.8 7.2 10.6 8.6 13.1 7.3 7.2 9.6 23.4 7.9 25.7 51.8 14.9 17.4 102.2 101.5 99.5 106.6 90.9 94.3 113.7 102.5 106.0 109.2 105.1 96.7 23.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.0 0.0 0.0 0.0 8.1 9.9 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 11.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 66.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 5.7 1.5 0.0 0.0 0.0 MGAT5 "GNT-V, MGAT5A" ENSG00000152127 "Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase" Q09328 2 134119983-134454621 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 109.5;Inhibitory neurons: 134.5;Microglial cells: 141.5;Oligodendrocyte precursor cells: 124.7;Oligodendrocytes: 495.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010919 Approved "Intracellular and membrane" NA NA 440000 "Cluster 37: B-cells - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA010919: AB_10601864" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.21e-2)" "unprognostic (3.65e-1)" "unprognostic (3.76e-1)" "unprognostic (4.45e-3)" "unprognostic (3.41e-3)" "unprognostic (5.68e-2)" "unprognostic (8.63e-3)" "unprognostic (1.59e-1)" "unprognostic (2.64e-1)" "unprognostic (5.97e-2)" "unprognostic (1.81e-2)" "unprognostic (9.27e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-1)" 9.4 10.4 15.4 15.0 25.2 15.5 7.9 29.6 17.9 9.1 8.5 12.6 16.1 8.8 6.6 9.0 19.0 11.1 39.0 13.3 32.1 15.3 3.7 10.4 24.6 30.5 32.9 12.0 10.9 16.3 6.2 15.1 32.1 8.4 15.0 11.6 14.6 9.4 2.2 6.8 18.1 11.2 18.4 16.2 16.9 7.2 24.2 19.1 11.3 4.6 25.4 13.2 5.0 26.4 27.9 11.0 27.3 19.7 23.8 45.3 19.1 36.4 55.0 14.4 12.0 4.7 13.4 44.3 27.1 29.2 16.4 9.7 21.6 17.0 27.3 43.9 12.7 25.0 13.7 58.0 15.5 24.5 85.1 12.5 17.4 30.3 18.6 19.6 108.7 22.1 13.0 29.6 26.3 17.9 13.3 11.6 12.5 28.9 27.0 16.2 32.3 28.6 11.1 33.7 45.1 55.4 11.7 9.9 69.3 18.3 7.7 16.8 49.5 45.1 24.0 33.1 19.3 8.3 4.1 16.5 37.8 34.4 73.1 0.6 0.4 1.0 0.8 0.3 1.3 3.0 1.5 1.0 0.3 3.7 0.6 0.8 1.1 1.3 0.4 0.9 1.0 0.6 15.4 25.2 29.6 17.9 13.3 32.1 30.5 32.9 32.1 18.4 24.2 26.4 13.2 3.2 2.4 66.6 63.2 8.0 5.7 10.3 8.0 43.6 11.6 9.9 67.3 8.6 8.5 1.8 2.1 3.2 14.9 36.9 0.0 9.0 15.6 22.6 7.6 12.5 7.2 4.4 109.5 9.0 26.3 9.0 37.2 21.0 0.0 23.1 11.7 3.0 15.5 16.8 134.5 20.3 30.5 13.5 9.9 15.1 4.4 12.9 14.2 141.5 5.3 11.4 9.2 124.7 495.5 13.0 13.2 9.4 9.0 9.7 17.6 2.4 22.6 5.2 0.0 8.8 14.3 0.6 6.1 7.3 7.2 5.3 22.4 16.6 9.9 14.5 MLLT11 AF1Q ENSG00000213190 "MLLT11 transcription factor 7 cofactor" Q13015 1 151060397-151069544 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 109.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 54.1;Early spermatids: 76.9;Excitatory neurons: 57.9;Late spermatids: 215.6" "Cancer enriched" "Detected in all" 4 "glioma: 29.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 216.7;EFO-21: 164.9;SH-SY5Y: 238.6;U-698: 207.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol No No "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA000540: AB_2666024" "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 5.3 19.0 59.4 4.7 61.8 2.0 2.5 41.1 109.3 4.5 8.8 7.2 1.6 10.7 1.3 4.0 6.2 6.0 38.1 66.2 80.6 3.8 2.0 3.8 2.1 63.1 50.5 8.2 3.1 16.2 10.4 1.0 66.1 4.3 3.6 35.6 3.8 1.5 11.3 2.6 4.9 13.8 29.9 4.6 5.1 2.8 49.7 20.6 3.8 10.8 2.1 4.0 3.9 57.1 6.3 31.0 216.7 34.4 3.5 5.8 1.4 11.6 15.2 13.2 24.0 3.0 12.6 10.0 164.9 10.6 35.9 4.5 54.3 13.0 7.6 65.8 14.5 28.9 17.7 0.9 6.9 0.8 1.0 9.9 1.6 73.5 2.9 42.2 100.1 43.3 30.8 2.3 43.6 1.4 106.4 19.0 95.7 0.6 4.4 99.8 28.1 0.6 25.5 1.7 132.8 238.6 0.8 1.3 6.9 142.5 5.3 2.7 65.9 27.0 29.0 9.2 24.7 2.4 3.2 207.1 70.0 0.6 51.7 1.1 0.3 1.4 5.9 0.6 2.7 2.5 3.9 6.2 0.7 1.9 5.3 9.1 1.6 4.0 0.9 1.4 4.1 3.2 59.4 61.8 41.1 109.3 66.2 80.6 63.1 50.5 66.1 29.9 49.7 57.1 1.4 0.0 1.1 11.8 4.2 3.6 5.0 14.6 4.6 54.1 2.5 4.8 10.2 1.5 2.2 3.7 8.4 2.9 15.3 0.1 17.6 3.9 76.9 0.8 11.3 5.2 10.7 6.3 57.9 1.2 2.5 17.5 2.0 0.9 4.5 4.3 4.2 0.4 6.0 37.0 40.6 0.1 16.2 6.6 14.5 215.6 2.1 12.3 5.4 10.3 33.3 20.6 19.6 16.1 14.4 3.0 0.2 3.8 4.8 1.3 0.2 2.4 0.6 26.3 0.0 3.4 30.0 8.6 12.3 2.8 3.4 7.4 9.9 3.0 0.2 4.3 MRAS "M-RAs, R-RAS3, RRAS3" ENSG00000158186 "Muscle RAS oncogene homolog" O14807 3 138347648-138405534 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 202.3;heart muscle: 132.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "non-classical monocyte: 25.0" "Lineage enriched" "Detected in many" 9 "monocytes: 25.0" "Cell line enhanced" "Detected in many" "BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042728 Approved Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol Vesicles "HPA042728: AB_10796582" "unprognostic (1.96e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.69e-1)" "unprognostic (5.32e-2)" "unprognostic (8.96e-2)" "unprognostic (3.85e-3)" "unprognostic (1.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (3.18e-3)" "unprognostic (1.78e-2)" "unprognostic (6.25e-2)" "unprognostic (2.21e-1)" "unprognostic (4.23e-2)" 91.9 67.7 112.7 10.8 130.6 1.7 46.7 118.2 105.5 17.3 48.9 24.2 3.3 28.7 7.1 7.9 26.4 12.0 132.9 105.6 132.8 22.9 5.5 18.4 5.2 126.1 135.9 48.6 5.7 8.2 17.7 10.6 112.9 15.3 4.1 15.9 13.4 15.0 80.4 12.2 8.7 23.2 110.3 12.2 12.0 9.6 202.3 4.9 26.4 48.0 3.3 29.1 12.1 97.8 0.8 7.9 15.8 24.5 59.6 29.2 40.0 92.9 16.0 7.3 8.2 3.3 3.1 0.3 113.7 70.4 18.6 0.1 9.0 1.8 6.1 7.7 3.1 0.5 4.8 20.1 15.9 0.0 1.9 41.5 5.9 0.7 1.4 13.6 1.3 0.0 10.7 0.8 31.4 3.7 0.0 20.4 19.1 0.0 2.7 1.1 33.8 0.2 30.4 2.0 18.6 42.0 62.8 0.7 45.9 10.9 16.1 37.7 0.6 23.7 25.3 24.3 2.4 0.1 1.0 1.2 21.4 0.1 11.4 0.2 2.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.8 25.0 0.1 0.0 0.8 112.7 130.6 118.2 105.5 105.6 132.8 126.1 135.9 112.9 110.3 202.3 97.8 8.9 9.6 1.5 54.2 0.8 2.2 3.0 3.4 1.2 5.6 28.8 34.8 121.7 2.8 3.5 9.2 10.4 20.1 0.2 0.0 58.7 8.6 11.6 1.0 21.4 14.5 1.8 0.0 25.5 3.2 3.2 23.0 2.0 1.5 6.3 35.2 12.8 1.6 26.3 28.6 20.6 0.0 2.0 15.1 18.4 40.0 23.3 18.2 28.4 20.6 12.2 24.3 0.0 28.6 11.0 3.8 0.0 34.3 0.1 3.3 0.0 27.5 1.3 9.6 6.6 20.8 18.9 7.3 18.6 0.4 1.0 14.4 0.8 59.1 0.0 0.6 MT1HL1 MT1P2 ENSG00000244020 "Metallothionein 1H like 1" P0DM35 1 237004103-237004441 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "heart muscle: 5.9" "Cell type enhanced" "Detected in some" "Distal tubular cells: 7.9;Hepatocytes: 14.7;Paneth cells: 8.8;Proximal tubular cells: 48.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (5.79e-2)" "unprognostic (2.78e-1)" "unprognostic (2.65e-1)" "unprognostic (3.77e-2)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 7.9 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 2.0 0.5 0.0 1.5 0.0 0.0 0.4 14.7 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 1.4 4.1 48.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.9 0.0 MTUS2 "CAZIP, ICIS, KIAA0774, TIP150" ENSG00000132938 "Microtubule associated scaffold protein 2" Q5JR59 13 28820339-29505947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 50.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 548.4;Inhibitory neurons: 671.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 0.9" "Region enhanced" "Detected in many" "cerebral cortex: 9.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 13.2;HeLa: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031473, HPA031474, HPA031475" Enhanced Supported "Microtubules,Cytokinetic bridge" Yes NA "Cluster 49: Eosinophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Microtubules, Cytokinetic bridge" "HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442" "unprognostic (1.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.96e-1)" "unprognostic (3.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.22e-2)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (1.30e-3)" "unprognostic (3.45e-2)" "unprognostic (3.91e-5)" "unprognostic (2.51e-2)" "unprognostic (5.46e-2)" "unprognostic (5.93e-2)" "unprognostic (9.62e-2)" 0.2 0.2 0.4 0.1 1.7 0.1 0.1 1.2 9.7 0.6 1.8 0.9 0.1 1.5 0.0 0.3 0.8 0.1 50.2 1.0 0.0 0.1 0.9 0.1 0.6 0.0 0.1 7.5 4.8 0.0 6.1 0.0 0.0 0.3 0.2 4.6 1.0 0.1 0.1 0.2 0.4 1.2 2.2 0.5 1.3 1.2 1.0 0.2 0.5 0.1 0.1 1.3 0.2 2.4 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 13.2 0.4 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.0 0.0 2.3 1.6 0.1 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 1.7 1.2 9.7 1.0 0.0 0.0 0.1 0.0 2.2 1.0 2.4 0.1 0.0 0.5 10.4 0.1 0.5 0.7 0.1 0.0 0.0 0.3 0.4 145.8 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.4 0.3 1.0 0.7 0.0 0.8 548.4 0.6 0.0 5.9 0.0 1.1 0.0 1.2 0.4 0.5 0.1 0.0 671.8 0.7 0.0 0.0 0.8 3.3 0.9 0.2 1.8 15.0 0.1 0.0 0.0 18.1 16.2 0.4 0.0 0.0 0.1 0.2 0.0 0.0 3.6 0.0 0.0 1.6 1.0 0.1 4.1 1.8 0.1 0.3 0.3 19.6 0.0 1.1 MXRA7 "FLJ46603, PS1TP1, TMAP1" ENSG00000182534 "Matrix remodeling associated 7" P84157 17 76672551-76711016 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 203.7;Muller glia cells: 365.7;Rod photoreceptor cells: 163.8;Theca cells: 218.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 663.8" "HPA044819, HPA075316" Uncertain Enhanced "Endoplasmic reticulum" "Secreted to blood" NA NA 100000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 5: Muller glia cells - Visual perception" "Endoplasmic reticulum" "HPA044819: AB_10964134, HPA075316: " "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.32e-1)" "unprognostic (2.92e-1)" "unprognostic (1.19e-1)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.70e-4)" "unprognostic (3.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.51e-3)" "unprognostic (2.07e-2)" "unprognostic (8.33e-2)" "unprognostic (5.39e-3)" "unprognostic (4.67e-3)" "unprognostic (6.21e-2)" "unprognostic (4.63e-3)" "prognostic unfavorable (1.80e-5)" 189.2 244.3 111.9 53.4 175.1 13.5 133.5 114.5 136.5 149.4 263.7 310.7 37.5 268.3 208.8 157.0 181.0 103.6 526.4 123.4 118.4 83.0 29.9 124.9 31.8 130.3 122.7 185.4 90.3 235.7 48.8 102.8 125.3 154.3 76.1 514.6 62.0 314.8 68.8 73.0 89.4 284.4 122.1 149.7 124.0 115.7 115.4 44.6 272.1 75.9 33.3 250.5 123.1 120.4 19.1 56.1 82.4 155.3 424.0 384.4 41.0 263.8 212.8 188.8 182.8 75.1 2.9 0.5 116.8 368.0 196.8 75.7 92.5 146.5 306.4 1.4 91.7 48.7 39.2 126.8 258.4 22.9 5.9 241.1 171.2 219.3 178.7 421.8 282.0 12.3 35.2 1.2 440.8 5.3 2.9 15.9 26.5 30.0 156.7 43.2 322.2 16.5 153.1 4.8 28.8 207.3 78.5 1.0 152.6 231.6 51.5 29.3 348.5 422.7 90.1 174.3 282.6 24.5 4.9 1.4 663.8 9.9 62.5 1.3 2.8 0.5 4.0 0.8 3.1 2.3 2.1 4.5 2.1 0.4 1.3 2.9 1.1 5.4 0.3 2.4 0.5 3.4 111.9 175.1 114.5 136.5 123.4 118.4 130.3 122.7 125.3 122.1 115.4 120.4 128.3 16.0 14.6 8.5 2.0 10.3 27.0 15.0 13.6 142.0 9.4 42.5 117.3 2.8 10.3 31.3 95.9 1.4 62.6 1.3 1.9 25.5 3.5 48.7 203.7 56.1 6.7 0.8 19.3 4.1 8.1 97.2 2.0 63.9 2.5 64.7 52.5 4.2 3.5 111.0 27.9 7.5 10.2 5.0 13.3 12.4 101.2 7.4 14.2 10.3 1.3 365.7 6.2 15.1 8.9 6.5 0.3 143.3 11.0 21.2 1.6 8.1 10.2 163.8 13.1 132.1 83.6 2.3 10.7 6.0 8.8 0.8 19.7 218.5 1.5 21.1 MYBPC3 "CMH4, cMyBP-C, FHC" ENSG00000134571 "Myosin binding protein C3" Q14896 11 47331406-47352702 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 584 "heart muscle: 1725.4" "Cell type enriched" "Detected in some" 42 "Cardiomyocytes: 1876.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "U-937: 6.4" "Region enriched" "Detected in some" 33 "cerebellum: 34.4" "Low region specificity" "Detected in many" "HPA040147, HPA043898" Enhanced NA NA 21000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 32: U-937 - Innate immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA040147: AB_2676861, HPA043898: AB_2678720" "unprognostic (1.06e-1)" "unprognostic (1.47e-6)" "unprognostic (2.17e-1)" "unprognostic (6.16e-2)" "unprognostic (3.00e-3)" "unprognostic (1.40e-4)" "unprognostic (7.47e-2)" "unprognostic (2.72e-2)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (9.53e-2)" "unprognostic (4.22e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (1.96e-1)" "unprognostic (4.15e-1)" "unprognostic (3.21e-2)" 0.4 2.9 0.0 0.7 0.0 1.5 0.7 0.2 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.4 1725.4 0.0 0.0 0.3 0.3 2.0 0.5 0.2 0.1 0.1 0.7 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.6 0.0 0.4 0.2 0.3 0.1 0.0 2.8 2.8 1.4 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.9 0.0 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1876.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 28.3 0.0 0.0 14.3 0.0 0.0 0.2 0.0 0.0 43.9 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.2 0.8 0.0 0.8 0.0 19.2 0.3 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.1 0.9 0.0 0.0 0.3 0.0 17.4 0.6 0.0 MYBPHL ENSG00000221986 "Myosin binding protein H like" A2RUH7 1 109292365-109307011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "heart muscle: 105.8" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 156.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;RH-30: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA077633 Approved Vesicles NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Vesicles "HPA077633: " "unprognostic (6.07e-3)" "unprognostic (1.43e-1)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.24e-2)" "unprognostic (5.53e-2)" "unprognostic (5.89e-1)" "unprognostic (5.22e-3)" "unprognostic (4.10e-1)" "unprognostic (7.05e-9)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (5.81e-2)" "unprognostic (2.64e-1)" 0.0 0.1 0.6 0.0 1.2 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.3 0.0 105.8 2.2 0.5 0.0 0.0 1.2 0.0 0.6 0.6 0.0 0.0 0.0 3.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 0.0 0.5 0.5 0.6 0.0 0.0 0.6 0.0 0.1 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.4 2.8 2.2 0.5 0.6 0.6 0.6 0.3 0.6 2.4 0.0 0.0 5.1 0.3 0.0 0.0 0.1 0.7 0.0 1.8 0.1 0.1 156.7 0.0 1.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 3.1 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 2.2 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.8 11.1 0.0 25.0 1.6 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.4 MYH6 ENSG00000197616 "Myosin heavy chain 6" P13533 14 23381982-23408273 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "heart muscle: 2882.7" "Cell type enriched" "Detected in some" 17 "Cardiomyocytes: 8051.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "NTERA-2: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001239, HPA001349, CAB075723, CAB075724, CAB075725" Enhanced Uncertain "Focal adhesion sites" NA NA 25000000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 5: NTERA-2 - Transcription" "Cluster 54: Cardiomyocytes - Muscle contraction" "Focal adhesion sites" "CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437" "unprognostic (2.09e-2)" "unprognostic (8.53e-4)" "unprognostic (1.80e-2)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.09e-1)" "unprognostic (1.66e-1)" "unprognostic (5.73e-2)" "unprognostic (1.44e-2)" "unprognostic (5.34e-3)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-2)" 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2882.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.9 5.8 0.0 0.0 0.5 0.1 0.9 0.0 0.0 1.9 0.0 53.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 50.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8051.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 31.7 0.0 2.7 0.1 0.0 0.0 449.6 0.0 0.0 0.0 0.3 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 60.3 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MYL4 "ALC1, AMLC, GT1, PRO1957" ENSG00000198336 "Myosin light chain 4" P12829 17 47200446-47223679 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Atrial fibrillation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 47 "heart muscle: 6347.0" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 2426.3" "Cancer enriched" "Detected in some" 5 "thyroid cancer: 11.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 9 "dendritic cells: 1.8" "Cell line enriched" "Detected in some" 4 "HEL: 552.8" "Group enriched" "Detected in all" 6 "amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9" "Not detected" "Not detected" "HPA046859, HPA051884, HPA063034" Enhanced Approved "Plasma membrane" NA NA 3100000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane" "HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927" "unprognostic (2.43e-2)" "unprognostic (9.57e-2)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.33e-1)" "unprognostic (4.12e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.52e-2)" "unprognostic (2.10e-2)" "unprognostic (7.37e-2)" "unprognostic (1.00e-6)" "unprognostic (1.92e-4)" "unprognostic (2.54e-1)" "unprognostic (6.51e-3)" "unprognostic (1.50e-1)" 2.1 0.5 0.2 0.4 0.3 134.6 2.7 0.2 0.4 0.4 0.4 0.8 0.8 0.8 0.0 0.6 0.5 1.0 6347.0 0.3 0.4 1.3 1.4 9.4 0.9 0.3 0.3 0.8 8.6 0.3 0.5 9.1 0.4 1.1 0.3 42.2 3.0 0.2 3.5 1.2 1.3 0.8 0.2 3.1 3.4 15.5 0.3 2.4 11.0 6.4 0.4 0.9 0.8 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.9 0.3 0.0 0.2 0.0 0.9 0.1 1.6 0.9 0.0 0.4 0.0 0.1 0.0 0.0 3.0 0.2 552.8 0.1 0.0 0.0 0.0 0.3 21.2 0.0 0.3 0.1 0.0 1.0 1.4 133.3 0.3 0.2 0.0 10.0 0.1 0.3 0.0 0.4 0.3 12.9 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 24.3 0.0 0.2 4.5 0.0 0.3 0.1 0.0 0.3 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.2 0.3 0.2 0.4 0.3 0.4 0.3 0.3 0.4 0.2 0.3 0.4 3.2 3.2 0.0 0.0 0.7 0.8 0.0 0.0 0.0 5.5 0.0 0.0 2426.3 0.0 0.0 0.0 64.6 0.5 2.7 0.1 0.0 0.1 23.3 0.1 0.0 23.2 0.0 412.8 0.1 0.0 3.9 150.7 1.5 0.1 0.0 0.3 1.8 0.5 1.9 1.7 0.0 0.8 0.0 0.6 0.6 54.6 3.4 34.0 12.4 0.0 1.5 7.9 4.1 0.0 0.1 0.1 0.0 1.5 0.8 0.0 10.9 0.2 0.0 24.4 0.0 0.6 36.5 9.9 0.5 0.0 0.9 1.4 0.3 0.2 1.0 0.0 MYL7 "MYL2A, MYLC2A" ENSG00000106631 "Myosin light chain 7" Q01449 7 44138864-44141332 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1061 "heart muscle: 23165.6" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 10772.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "BEWO: 35.6;CACO-2: 124.6;SuSa: 47.6" "Not detected" "Not detected" "HPA013331, CAB033884, HPA039262" Enhanced NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418" "unprognostic (1.00e-2)" "unprognostic (7.99e-2)" "unprognostic (4.36e-3)" "unprognostic (2.31e-1)" "unprognostic (2.51e-1)" "unprognostic (1.28e-1)" "unprognostic (7.85e-2)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" 3.2 1.1 3.9 0.0 3.5 0.0 6.4 3.6 4.1 1.2 3.0 1.9 0.0 1.4 0.2 1.1 0.8 0.6 23165.6 3.3 4.1 1.0 2.3 21.8 0.8 3.6 3.8 4.3 18.4 0.4 9.7 2.2 3.6 2.0 0.0 0.2 11.6 0.3 3.0 2.3 2.0 0.0 3.3 0.9 1.3 1.0 4.4 0.0 3.5 0.0 0.0 0.4 1.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.4 0.0 124.6 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.1 0.5 0.0 0.0 0.0 0.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.9 0.4 0.0 47.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.5 3.6 4.1 3.3 4.1 3.6 3.8 3.6 3.3 4.4 3.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.4 30.5 10772.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 78.5 0.0 2.7 0.3 0.0 0.2 695.9 0.0 0.0 0.0 24.9 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 160.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYZAP "GCOM1, Gup, Gup1, MYOZAP" ENSG00000263155 "Myocardial zonula adherens protein" P0CAP1 15 57591904-57685364 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "heart muscle: 588.9" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 481.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.4;naive CD4 T-cell: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 137.3;hTERT-HME1: 24.0;HUVEC TERT2: 28.3;OE19: 47.5;RT4: 25.1;TIME: 33.1" HPA039827 Approved NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA039827: AB_10673364" "unprognostic (1.30e-2)" "unprognostic (1.25e-1)" "unprognostic (2.44e-1)" "unprognostic (1.66e-1)" "unprognostic (9.26e-3)" "unprognostic (1.49e-1)" "unprognostic (6.10e-3)" "unprognostic (5.19e-2)" "unprognostic (8.92e-2)" "unprognostic (2.30e-2)" "unprognostic (1.26e-1)" "unprognostic (9.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (1.07e-1)" "unprognostic (3.86e-2)" "unprognostic (1.77e-2)" 65.3 54.7 2.0 2.6 2.4 4.0 22.3 6.3 1.8 17.3 1.3 18.1 16.8 29.4 1.8 41.4 4.7 4.8 588.9 1.8 2.5 5.7 2.4 31.8 6.0 6.7 2.8 5.1 35.1 0.6 1.7 56.6 7.7 19.8 11.8 1.3 18.3 38.2 11.6 9.6 15.4 17.2 1.6 12.4 23.4 2.5 3.5 1.4 3.7 15.5 8.6 84.1 26.9 1.7 6.0 1.7 0.0 10.5 2.3 0.1 3.2 0.9 8.6 1.4 1.7 7.3 4.1 0.1 0.7 0.0 8.9 2.6 0.0 4.4 1.7 0.0 0.2 137.3 1.7 0.1 0.4 0.0 0.1 0.0 3.1 0.3 24.0 0.1 28.3 0.2 1.9 0.0 0.7 2.3 0.0 0.1 0.1 47.5 2.4 0.0 11.4 0.3 0.0 25.1 0.0 4.1 0.6 5.9 0.0 1.2 7.9 0.1 33.1 0.1 2.6 0.4 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.0 0.0 3.4 2.0 0.0 0.5 0.0 0.8 0.0 0.2 2.4 2.0 2.4 6.3 1.8 1.8 2.5 6.7 2.8 7.7 1.6 3.5 1.7 22.9 9.6 0.6 0.0 0.3 0.0 10.2 0.0 0.0 0.3 3.0 1.0 481.4 5.7 0.6 25.8 0.0 4.4 0.0 26.9 7.9 32.5 0.1 1.1 3.0 15.1 1.8 1.3 0.0 18.9 2.4 9.8 7.1 3.5 0.0 65.1 4.6 0.2 1.4 0.0 0.0 7.9 0.0 7.9 0.0 0.7 4.7 8.7 0.0 0.0 3.4 0.6 0.0 0.0 0.0 21.5 24.9 17.0 0.0 11.0 18.1 0.3 0.7 0.2 0.0 0.2 8.1 0.0 1.6 0.0 0.0 1.2 0.2 13.2 6.6 22.4 NAPG ENSG00000134265 "NSF attachment protein gamma" Q99747 18 10525905-10552764 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008208, HPA011389" Enhanced Approved "Plasma membrane" NA NA 8800 "Cluster 49: Eosinophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane" "HPA008208: AB_1854305, HPA011389: AB_1854306" "unprognostic (1.23e-1)" "unprognostic (7.64e-3)" "unprognostic (6.96e-2)" "unprognostic (1.53e-1)" "unprognostic (9.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.28e-1)" "unprognostic (4.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (1.46e-3)" "unprognostic (5.85e-2)" "prognostic favorable (8.14e-4)" "unprognostic (3.81e-2)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (6.96e-2)" 11.3 14.8 18.4 9.7 18.6 7.2 11.8 21.1 25.3 10.5 13.9 11.9 9.3 10.7 12.0 12.1 11.0 13.4 19.9 25.9 20.8 16.4 13.6 9.7 9.6 30.3 20.1 7.5 12.6 12.4 9.9 13.9 32.6 13.7 13.7 12.6 11.7 10.7 10.2 9.9 10.7 11.8 19.4 9.4 13.7 7.4 20.1 9.0 14.5 14.6 11.2 14.3 10.1 21.7 9.4 5.6 9.6 8.3 27.1 18.4 14.0 19.8 28.1 19.0 24.0 12.4 14.1 12.3 15.5 27.3 17.4 9.0 12.7 17.7 26.9 11.0 7.8 9.2 9.8 12.8 25.9 26.0 16.6 20.3 20.6 21.8 16.2 12.4 18.0 16.0 15.1 29.0 28.2 13.2 20.0 11.1 7.7 72.3 8.3 8.7 15.8 21.2 22.5 22.0 38.3 10.1 16.1 16.9 23.1 15.5 7.7 17.2 20.5 29.8 14.4 27.8 21.2 18.8 20.4 13.6 20.1 17.7 14.2 12.5 4.9 14.1 5.1 6.1 4.7 7.5 4.1 5.2 3.8 3.3 5.6 4.8 8.1 5.8 6.1 4.1 4.4 3.1 18.4 18.6 21.1 25.3 25.9 20.8 30.3 20.1 32.6 19.4 20.1 21.7 32.2 28.9 34.7 33.6 29.1 24.3 31.1 26.9 21.6 62.0 21.8 17.4 35.1 21.5 27.5 27.6 12.5 23.6 32.9 30.8 41.1 53.3 18.1 27.9 33.2 23.4 23.4 33.2 68.5 42.5 30.3 25.3 28.5 49.5 45.0 13.6 20.0 21.7 25.4 45.4 53.8 22.3 28.5 22.1 16.1 4.6 7.8 24.5 26.6 30.9 22.4 31.3 22.6 34.7 52.9 77.7 34.1 21.1 36.2 34.8 20.8 39.5 20.8 34.0 26.3 30.5 29.6 26.6 39.9 30.8 21.2 45.1 26.2 28.4 19.0 56.5 NAV2 "FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1" ENSG00000166833 "Neuron navigator 2" Q8IVL1 11 19350724-20121601 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.7;heart muscle: 61.2" "Cell type enhanced" "Detected in many" "Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011755, HPA011891" Approved Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA011755: AB_1854319, HPA011891: AB_1854318" "unprognostic (7.71e-2)" "unprognostic (2.37e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (3.01e-2)" "unprognostic (3.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (1.84e-1)" "unprognostic (2.83e-2)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (6.43e-2)" "unprognostic (3.28e-2)" 7.4 1.6 11.6 3.3 18.8 1.8 12.0 16.1 10.8 6.3 3.5 16.2 4.4 7.6 11.1 6.5 4.4 1.8 61.2 9.6 13.8 9.5 14.9 9.5 1.8 55.7 43.7 3.1 8.8 6.0 5.1 14.8 36.5 6.2 4.9 8.7 15.0 9.3 2.6 6.7 4.1 8.5 39.3 1.4 7.2 0.9 27.7 2.5 16.9 9.4 3.9 5.7 7.4 35.6 16.2 4.7 10.2 1.4 33.7 21.6 11.0 13.3 22.6 17.2 13.0 18.2 2.1 0.1 0.6 20.1 28.0 1.9 0.6 10.4 20.1 3.8 1.2 0.4 25.1 20.9 6.1 0.0 0.5 14.1 26.5 8.3 89.9 12.7 23.2 0.1 1.9 8.0 50.2 17.2 0.0 0.1 26.4 5.3 13.1 0.1 47.1 2.6 14.8 4.6 18.2 81.9 10.3 7.9 14.8 54.2 0.3 0.0 65.2 39.6 6.3 47.7 12.7 2.7 2.0 0.1 13.5 0.8 12.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.6 18.8 16.1 10.8 9.6 13.8 55.7 43.7 36.5 39.3 27.7 35.6 5.5 64.1 22.6 466.8 1.4 4.2 23.6 13.8 14.2 4.6 33.6 31.0 14.3 8.6 18.3 20.2 0.0 31.8 0.8 2.8 13.7 20.3 2.6 34.4 4.6 14.5 10.8 0.0 333.8 21.3 23.3 16.5 11.2 62.1 1.3 152.4 11.7 47.0 10.7 26.9 525.7 10.1 18.3 1.4 5.0 7.9 0.9 3.2 16.0 194.9 1.0 28.9 0.0 863.6 354.4 37.5 0.8 4.1 0.4 33.7 1.8 0.4 24.0 2.4 0.0 30.7 17.8 1.5 0.6 23.1 3.7 14.6 1.7 54.7 9.2 17.8 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 290.1;heart muscle: 145.5" "Cell type enhanced" "Detected in many" "Astrocytes: 530.8;Excitatory neurons: 461.4;Inhibitory neurons: 441.2;Oligodendrocyte precursor cells: 939.0;Oligodendrocytes: 1013.5" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "NK-cell: 53.7" "Lineage enriched" "Detected in many" 15 "NK-cells: 53.7" "Cell line enhanced" "Detected in many" "HEL: 61.3;RH-30: 132.5;SCLC-21H: 107.4;SH-SY5Y: 52.7;U-138 MG: 72.8;WM-115: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 1200000 2300000000 "Cluster 48: NK-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705" "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favorable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 4.6 65.7 124.0 3.9 169.1 1.5 2.7 118.1 140.3 35.1 0.0 47.8 4.6 62.7 3.5 7.0 40.4 4.8 145.5 135.6 179.1 3.2 2.9 1.8 1.3 140.4 134.2 43.8 2.6 0.0 22.2 0.5 147.4 14.9 6.6 117.7 3.6 17.7 31.2 2.1 18.3 46.9 129.7 4.7 23.0 5.0 137.0 0.4 30.2 29.5 1.0 34.8 24.3 290.1 0.1 0.0 20.8 0.3 0.2 0.5 0.3 1.0 0.0 0.7 1.2 0.3 0.3 3.1 18.2 20.1 0.8 0.3 0.1 0.0 0.0 0.4 12.1 61.3 0.1 0.0 2.1 0.0 9.5 12.4 0.1 0.1 18.6 0.1 0.0 0.1 0.0 1.0 20.8 0.0 0.2 5.2 1.8 0.0 0.4 0.1 132.5 10.0 0.0 0.0 107.4 52.7 0.1 0.5 0.1 2.0 0.2 0.8 0.2 72.8 33.4 0.3 31.8 0.1 0.5 0.1 8.3 28.4 79.0 0.0 0.2 0.0 3.6 0.0 1.2 0.0 0.1 0.5 0.1 0.0 0.0 1.4 0.7 53.7 0.0 0.0 0.2 1.9 124.0 169.1 118.1 140.3 135.6 179.1 140.4 134.2 147.4 129.7 137.0 290.1 13.7 0.0 0.0 530.8 0.4 1.7 0.5 0.0 0.0 123.5 5.7 0.6 131.7 0.0 0.0 0.0 37.5 0.6 27.7 0.1 1.9 18.3 6.7 0.3 2.4 2.8 5.4 0.0 461.4 0.0 0.2 12.8 5.1 0.5 1.3 11.7 7.1 0.7 0.4 175.0 441.2 0.0 8.2 4.7 3.8 5.9 15.2 1.8 0.0 35.6 1.2 216.6 59.8 939.0 1013.5 1.3 0.0 10.1 5.6 0.4 0.0 0.2 0.7 98.0 0.0 107.5 4.8 1.0 2.8 0.4 1.7 0.1 13.4 5.6 0.0 0.2 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 380.7;heart muscle: 352.7" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 433.0;Horizontal cells: 516.5" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 32.5;GAMG: 28.6;hTERT-RPE1: 26.8;HUVEC TERT2: 21.0;SCLC-21H: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 16.4 128.8 122.7 2.9 136.0 0.1 11.4 239.4 248.6 25.3 0.0 6.5 3.7 25.5 6.8 20.8 8.0 3.6 352.7 195.0 170.4 1.6 1.0 17.7 4.1 379.4 113.0 1.8 2.7 12.0 71.6 2.0 380.7 3.1 3.2 115.5 5.3 30.2 8.7 21.5 3.9 13.3 41.6 21.9 4.1 48.1 190.9 4.5 2.7 3.6 4.0 3.7 57.5 91.7 0.2 16.9 15.8 3.1 0.4 2.9 1.3 5.2 8.2 2.5 1.7 6.5 4.3 0.4 32.5 4.0 28.6 1.5 1.2 0.9 2.2 0.0 3.3 0.7 3.3 4.7 4.4 0.3 0.3 3.6 0.3 1.6 0.0 26.8 21.0 0.1 0.3 0.2 2.4 4.3 1.7 0.2 1.4 0.6 12.4 0.4 4.4 0.4 0.7 10.6 49.2 18.4 0.5 1.4 0.1 2.0 0.6 0.2 7.7 2.1 6.0 0.6 0.8 0.9 0.5 5.7 11.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122.7 136.0 239.4 248.6 195.0 170.4 379.4 113.0 380.7 41.6 190.9 91.7 8.9 0.0 1.9 53.5 0.2 2.0 6.8 0.6 1.2 52.3 0.7 1.5 433.0 0.0 0.3 0.0 4.2 0.0 0.1 0.6 0.0 4.0 5.9 4.0 5.6 17.0 1.8 0.0 95.7 0.2 0.1 10.1 1.5 11.5 0.0 13.6 29.3 0.3 0.0 516.5 94.3 0.1 2.0 1.0 1.2 10.8 4.4 0.3 7.2 22.5 0.0 82.6 0.0 29.7 14.1 3.7 0.0 2.6 0.0 4.9 0.0 0.2 0.2 33.4 6.6 3.5 6.7 4.8 6.5 14.5 5.8 0.0 0.3 0.3 0.0 8.8 NEBL "bA165O3.1, C10orf113, LASP2, LNEBL" ENSG00000078114 Nebulette O76041 10 20779973-21293011 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "heart muscle: 312.0" "Cell type enhanced" "Detected in many" "Astrocytes: 951.0;Cardiomyocytes: 2413.0;Excitatory neurons: 359.0;Inhibitory neurons: 436.6;Oligodendrocyte precursor cells: 352.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.4;SCLC-21H: 31.0;SH-SY5Y: 7.2;SK-BR-3: 8.0;TIME: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013994, HPA013995" Approved NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA013994: AB_1854359, HPA013995: AB_1854360" "unprognostic (3.79e-2)" "unprognostic (1.92e-3)" "unprognostic (3.44e-2)" "unprognostic (3.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.25e-2)" "unprognostic (1.05e-1)" "unprognostic (6.20e-3)" "unprognostic (2.36e-2)" "unprognostic (8.42e-2)" "prognostic favorable (2.77e-8)" "unprognostic (3.51e-1)" "unprognostic (8.11e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.56e-4)" 2.4 2.6 26.3 0.2 25.8 0.0 6.1 29.9 19.1 5.9 0.1 1.3 0.0 0.6 0.1 16.1 0.6 0.4 312.0 26.6 29.6 13.1 1.2 16.2 0.2 31.0 35.2 1.1 7.0 1.2 22.1 3.7 27.5 8.7 1.0 2.6 18.0 2.9 0.6 14.9 1.3 0.4 28.6 0.2 3.2 2.7 35.2 0.6 21.5 0.4 1.2 2.1 12.8 24.9 0.4 3.5 3.8 0.1 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.9 0.5 0.5 5.5 0.0 0.1 2.5 0.2 0.0 0.0 0.0 3.5 0.0 1.8 0.0 2.9 0.0 0.0 3.3 3.6 0.0 0.6 0.0 0.0 0.2 0.3 0.5 0.0 3.5 0.1 0.0 1.0 0.7 1.9 0.0 0.0 0.1 0.3 0.6 31.0 7.2 1.5 8.0 0.0 0.2 4.7 0.0 6.6 0.0 0.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 25.8 29.9 19.1 26.6 29.6 31.0 35.2 27.5 28.6 35.2 24.9 17.2 218.0 67.2 951.0 0.0 18.4 12.6 6.1 0.0 91.4 51.6 24.8 2413.0 15.7 19.9 33.1 39.6 15.3 1.0 7.5 29.4 2.9 331.4 17.4 3.9 20.8 18.0 0.0 359.0 7.1 11.1 61.0 8.6 47.3 0.0 1.0 0.7 0.2 2.1 146.4 436.6 19.5 14.2 0.6 2.3 61.7 3.7 1.2 12.4 206.1 5.9 4.0 0.0 352.3 9.0 12.9 25.7 4.9 0.0 17.3 5.5 7.7 39.1 10.3 0.0 0.8 14.8 2.8 1.1 33.8 46.2 36.8 1.8 4.5 13.7 33.9 NEK7 ENSG00000151414 "NIMA related kinase 7" Q8TDX7 1 198156994-198322420 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 140.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 554.5;fHDF/TERT166: 753.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015520, HPA018193" Approved Supported Nucleoplasm Yes No "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA015520: AB_1854371, HPA018193: AB_1854372" "unprognostic (2.08e-1)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (5.38e-2)" "unprognostic (4.26e-2)" "unprognostic (3.00e-2)" "unprognostic (2.14e-2)" "unprognostic (5.47e-2)" "unprognostic (4.77e-2)" "unprognostic (3.21e-1)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-2)" "unprognostic (1.56e-1)" 63.8 49.9 48.3 29.3 58.7 11.1 27.7 45.9 53.3 26.1 35.7 30.0 21.1 26.6 19.7 31.2 22.3 27.2 140.4 39.5 56.1 29.3 30.0 41.6 30.8 61.1 51.3 29.6 20.3 25.1 12.3 42.1 60.0 27.1 23.3 19.6 22.3 36.5 56.6 14.9 25.3 32.2 59.7 32.1 20.1 13.7 49.1 27.7 26.8 63.7 23.6 30.9 20.1 64.2 47.8 12.3 14.8 6.0 37.5 42.6 17.4 554.5 227.6 218.7 102.9 23.0 46.2 17.1 39.4 753.3 12.6 29.0 22.7 30.3 220.8 56.0 32.7 23.6 48.7 9.6 45.3 40.2 46.3 26.7 25.3 144.8 43.5 82.2 42.4 140.0 18.8 41.2 102.3 15.1 34.7 23.4 8.4 37.5 9.9 18.5 36.5 30.7 37.3 24.5 9.5 17.0 92.1 53.0 63.5 20.6 38.8 36.0 95.7 61.8 52.0 178.6 58.9 29.3 28.5 11.8 26.9 36.3 48.7 1.8 2.2 3.3 2.9 1.8 12.8 1.4 3.2 4.1 2.0 1.9 2.7 3.1 6.0 3.6 1.6 1.3 6.0 1.4 48.3 58.7 45.9 53.3 39.5 56.1 61.1 51.3 60.0 59.7 49.1 64.2 34.3 28.9 30.7 78.0 32.4 51.4 15.0 10.2 33.6 8.2 22.8 18.2 172.6 10.0 18.7 18.4 14.6 15.0 32.9 25.8 11.7 10.6 2.8 21.6 20.9 29.3 19.8 32.6 17.0 19.6 15.9 30.0 18.8 19.6 8.8 11.8 40.4 23.5 17.5 3.3 34.6 19.5 8.2 49.5 51.6 3.3 29.2 35.5 30.2 124.6 29.0 11.4 15.5 131.2 153.5 50.1 19.3 38.4 28.5 30.6 25.1 16.6 27.9 24.2 19.7 28.1 35.9 7.7 6.0 29.2 49.2 64.3 41.6 28.7 15.6 33.1 NES FLJ21841 ENSG00000132688 Nestin P48681 1 156668763-156677407 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 161.6" "Group enriched" "Detected in many" 4 "Adipocytes: 102.2;Cardiomyocytes: 279.9;Endothelial cells: 105.5;Sertoli cells: 105.2;Smooth muscle cells: 70.5" "Cancer enhanced" "Detected in all" "glioma: 147.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 627.3;HUVEC TERT2: 321.5;LHCN-M2: 512.6;RH-30: 518.3;SuSa: 340.7;WM-115: 247.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005889, HPA006286, HPA007007, HPA026111, CAB058692" Enhanced Enhanced "Intermediate filaments" No No 100000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Intermediate filaments" "CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382" "unprognostic (7.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (1.36e-1)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (4.40e-2)" "unprognostic (7.56e-2)" "unprognostic (9.84e-2)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.02e-7)" "unprognostic (2.87e-1)" "unprognostic (2.48e-1)" "unprognostic (6.67e-2)" "unprognostic (8.11e-3)" 40.0 8.5 24.4 13.8 24.8 0.0 28.2 27.2 22.7 27.1 16.5 16.8 5.3 41.1 12.9 8.2 30.3 11.3 161.6 21.1 26.5 35.2 4.8 42.1 4.8 32.8 27.1 10.1 5.6 10.4 12.8 16.7 25.8 21.2 6.6 8.2 9.7 36.1 55.7 8.6 12.5 30.3 30.0 49.1 10.8 6.2 26.4 2.7 19.9 47.3 2.3 24.2 19.0 30.9 0.2 2.5 627.3 134.7 1.3 33.4 0.6 154.7 120.7 2.3 3.4 102.5 1.9 0.6 35.8 14.9 0.1 2.8 63.9 0.0 1.8 0.0 1.1 0.9 9.7 47.3 5.5 0.3 37.1 28.5 0.0 5.7 0.0 5.3 321.5 0.1 4.9 0.2 512.6 4.3 0.0 0.3 102.3 6.0 88.1 0.7 518.3 0.4 0.6 0.0 1.6 100.4 3.6 4.5 124.9 340.7 1.3 0.9 235.1 0.8 34.5 4.1 8.8 0.2 24.0 0.2 13.4 0.1 247.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 24.8 27.2 22.7 21.1 26.5 32.8 27.1 25.8 30.0 26.4 30.9 102.2 0.0 4.4 0.0 0.7 2.4 0.4 0.2 0.6 0.5 9.4 32.9 279.9 0.0 0.6 18.4 0.0 0.2 1.0 0.6 0.0 2.1 0.4 2.1 31.9 105.5 0.0 0.0 0.3 0.0 1.9 29.4 0.5 2.7 0.0 0.2 26.7 0.1 1.8 0.0 0.6 0.2 0.0 0.8 3.1 0.1 8.1 1.7 1.8 12.2 1.0 17.4 0.0 3.0 2.2 0.3 0.1 4.1 0.1 0.5 0.0 0.1 0.0 1.5 105.2 10.9 70.5 0.5 5.0 1.2 2.4 0.1 1.1 1.4 0.3 0.5 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515008 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 52.4;Basal squamous epithelial cells: 36.5;Ionocytes: 89.5;Leydig cells: 96.0;Muller glia cells: 151.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.2" "Group enriched" "Detected in some" 7 "RH-30: 200.1;WM-115: 225.3" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 10.1" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 490000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 5: Muller glia cells - Visual perception" "Nucleoplasm, Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavorable (3.40e-4)" 36.8 20.7 4.1 8.2 12.1 0.4 20.3 17.3 63.6 13.1 1.4 16.8 2.4 12.0 4.0 6.5 20.2 9.4 40.9 3.2 25.1 8.0 22.8 2.9 5.0 16.9 15.2 4.1 10.9 1.3 10.5 14.7 15.1 19.1 2.4 45.1 21.2 7.6 4.8 15.9 8.0 8.2 10.9 23.0 7.9 7.7 17.2 2.0 28.9 1.3 3.9 15.3 13.2 27.8 0.0 0.1 6.3 10.2 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.1 0.0 2.1 0.1 3.4 4.8 1.5 4.6 0.0 0.4 0.7 0.4 0.0 3.8 0.4 0.3 0.3 20.9 0.3 0.6 1.5 0.1 0.0 0.0 0.0 0.1 29.5 0.6 0.0 0.1 3.8 0.0 0.2 3.9 200.1 0.2 0.0 0.0 1.9 1.3 0.1 0.0 14.0 7.4 0.4 0.2 0.0 0.1 3.4 0.6 10.2 0.2 0.3 0.1 0.2 1.9 225.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 4.1 12.1 17.3 63.6 3.2 25.1 16.9 15.2 15.1 10.9 17.2 27.8 1.2 0.0 0.0 0.0 1.1 3.6 33.1 52.4 36.5 4.8 2.4 10.9 0.7 0.0 3.8 0.0 4.2 0.5 4.0 0.0 0.0 0.1 0.7 0.2 0.6 1.3 0.0 0.0 0.1 0.0 0.5 7.3 0.5 0.2 0.0 0.0 1.8 0.2 0.1 0.0 0.0 0.0 89.5 0.0 3.1 2.9 96.0 0.7 16.0 0.0 0.0 151.7 0.0 0.0 6.5 0.0 0.0 27.8 1.0 3.7 0.0 0.1 1.7 7.0 32.9 1.7 12.9 0.4 0.9 1.8 1.7 0.1 2.3 0.4 0.0 2.9 NKX2-5 "CSX, CSX1, NKX2.5, NKX2E, NKX4-1" ENSG00000183072 "NK2 homeobox 5" P52952 5 173232109-173235311 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Atrial septal defect, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 229.0" "Cell type enriched" "Detected in some" 26 "Cardiomyocytes: 68.4" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 32.9;NTERA-2: 11.4;SK-MEL-30: 15.2;U-2 OS: 25.4;U-251 MG: 20.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA065034 Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Cytosol "HPA065034: AB_2685409" "unprognostic (3.81e-1)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (9.57e-3)" "unprognostic (3.22e-3)" "unprognostic (6.63e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-1)" "unprognostic (2.31e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.77e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 229.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 34.9 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 5.0 1.7 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 7.6 32.9 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.1 0.5 6.3 0.0 15.2 4.2 0.0 0.1 0.0 5.9 25.4 7.8 20.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 68.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.1 0.1 0.0 0.7 0.0 0.0 NKX2-6 "CSX2, NKX4-2" ENSG00000180053 "NK2 homeobox 6" A6NCS4 8 23701740-23706756 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "salivary gland: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTEC/SVTERT24-B: 5.6;JURKAT: 2.1;LHCN-M2: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA025288 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA025288: " "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPPA "ANP, PND" ENSG00000175206 "Natriuretic peptide A" P01160 1 11845709-11848345 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Atrial fibrillation, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 873 "heart muscle: 60060.6" "Cell type enriched" "Detected in some" 23 "Cardiomyocytes: 62235.0" "Cancer enriched" "Detected in some" 9 "glioma: 7.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 9.6;SH-SY5Y: 9.5" "Region enriched" "Detected in some" 7 "olfactory bulb: 22.8" "Low region specificity" "Detected in all" "HPA058269, HPA064007" Enhanced "Secreted to blood" NA NA 1200000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA058269: AB_2683660, HPA064007: " "unprognostic (1.27e-3)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (9.72e-3)" "unprognostic (2.21e-1)" "unprognostic (5.93e-4)" "unprognostic (2.31e-1)" "unprognostic (1.59e-1)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" 8.3 3.0 1.7 0.7 2.1 0.6 18.0 1.8 2.4 1.2 2.3 5.0 0.2 3.3 12.9 2.8 1.3 0.9 60060.6 2.2 1.5 2.6 5.0 58.1 1.2 1.7 1.5 12.1 68.7 0.9 3.9 5.9 1.4 5.1 0.0 0.4 28.5 0.0 8.9 5.8 6.1 0.7 1.3 3.1 3.6 3.9 1.7 0.5 7.1 0.0 0.0 1.2 3.9 2.0 0.5 0.2 0.3 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.9 0.6 0.8 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.4 1.0 0.3 1.8 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 1.2 0.0 0.3 0.3 1.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.6 9.6 9.5 0.0 0.0 0.5 0.3 0.3 0.1 0.0 0.4 0.7 0.6 0.1 0.4 0.8 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 2.1 1.8 2.4 2.2 1.5 1.7 1.5 1.4 1.3 1.7 2.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62235.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 339.1 0.0 0.0 0.3 0.0 0.0 2684.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 636.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPPB ENSG00000120937 "Natriuretic peptide B" P16860 1 11857464-11858945 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 767 "heart muscle: 5154.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 351.7;Ductal cells: 266.6;Pancreatic endocrine cells: 86.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Group enriched" "Detected in some" 4 "basal ganglia: 3.4;cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 135.5;CACO-2: 362.2;SuSa: 67.7" "Region enhanced" "Detected in single" "pons and medulla: 1.4" HPA077324 Approved Vesicles,Cytosol "Secreted to blood" NA NA 9680 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Vesicles Cytosol "HPA077324: " "unprognostic (3.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (4.23e-1)" "unprognostic (3.28e-2)" 1.0 0.3 0.3 0.1 3.4 0.0 0.7 0.4 1.8 0.3 0.1 0.3 0.0 0.3 0.3 0.2 0.0 0.6 5154.6 0.3 0.3 0.3 0.5 6.7 0.9 0.3 0.4 0.8 4.0 0.1 0.5 0.8 0.3 0.5 0.0 0.1 1.2 0.0 0.8 0.5 0.4 0.0 0.6 0.1 0.7 0.8 0.5 0.1 0.5 0.0 0.0 0.2 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 135.5 0.3 0.0 2.1 1.1 362.2 0.0 0.0 0.1 0.1 0.3 3.8 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 67.7 0.0 0.0 0.0 0.0 32.0 0.2 0.2 0.0 0.1 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.4 1.8 0.3 0.3 0.3 0.4 0.3 0.6 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 351.7 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 266.6 0.1 0.8 0.1 4.9 0.0 0.0 0.2 8.3 2.2 11.7 0.0 1.4 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.2 0.0 0.0 0.0 86.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 17.6 5.8 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.1 NT5DC2 FLJ12442 ENSG00000168268 "5'-nucleotidase domain containing 2" Q9H857 3 52524385-52535054 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 69.2;Peritubular cells: 135.4;Sertoli cells: 111.7;Smooth muscle cells: 83.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050683 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 48: Smooth muscle cells - ECM organization" "HPA050683: AB_2681215" "unprognostic (1.40e-1)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (2.99e-2)" "unprognostic (7.82e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (6.14e-2)" "unprognostic (1.35e-1)" "unprognostic (5.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (2.99e-3)" "unprognostic (1.44e-1)" "unprognostic (2.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.07e-2)" 30.3 73.2 26.0 18.6 25.2 15.5 27.9 38.6 29.8 48.0 43.2 18.3 13.7 36.3 27.5 69.4 29.5 12.1 117.5 26.0 30.2 30.6 7.8 33.6 16.3 41.8 46.6 45.3 15.6 16.5 50.8 32.7 64.0 74.9 12.7 8.5 43.5 39.3 10.3 49.0 16.2 20.8 26.8 18.6 16.4 49.7 27.6 9.9 26.3 10.9 22.9 40.7 38.7 25.9 138.8 73.7 238.9 128.4 186.2 252.3 188.3 139.6 121.2 95.4 78.0 216.5 66.8 174.4 15.1 177.9 76.0 47.3 194.9 179.8 90.0 71.0 123.8 104.1 122.1 337.4 274.9 0.1 88.8 333.0 40.9 162.9 49.4 175.4 203.0 125.2 194.9 57.5 112.0 145.5 72.7 179.2 318.1 125.6 234.6 104.6 100.3 168.8 52.7 35.5 111.1 323.3 54.7 101.2 71.8 178.6 96.0 98.5 95.1 123.7 153.8 123.8 298.9 25.9 47.3 129.4 369.4 0.7 152.1 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.1 26.0 25.2 38.6 29.8 26.0 30.2 41.8 46.6 64.0 26.8 27.6 25.9 20.9 9.6 11.5 2.6 12.9 7.8 26.6 15.2 30.1 18.4 54.6 69.2 14.0 5.7 13.0 12.9 0.0 3.4 3.3 3.1 17.6 10.1 6.9 5.3 20.0 12.6 12.6 8.0 0.9 2.3 24.8 24.8 8.6 10.8 18.4 36.4 11.0 1.2 10.4 1.7 1.2 6.0 10.2 10.1 8.8 19.7 49.7 7.8 16.0 1.9 2.8 36.6 1.0 5.0 1.5 7.0 0.6 135.4 21.4 23.4 0.6 9.3 2.7 4.7 111.7 18.6 83.4 6.2 37.9 23.5 13.8 2.3 2.8 15.8 7.2 12.7 NTN1 NTN1L ENSG00000065320 "Netrin 1" O95631 17 9021510-9244000 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.1;heart muscle: 59.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 137.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 27.5;T-47d: 16.6;U-2 OS: 14.4;U-251 MG: 22.1;WM-115: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056419 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" "Secreted to extracellular matrix" NA NA 110000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol "Nucleoplasm, Actin filaments" "HPA056419: AB_2683124" "unprognostic (2.72e-1)" "unprognostic (2.59e-2)" "unprognostic (7.12e-2)" "unprognostic (5.25e-2)" "unprognostic (2.51e-1)" "unprognostic (9.33e-3)" "unprognostic (9.42e-2)" "unprognostic (2.20e-1)" "unprognostic (1.63e-1)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.15e-1)" "unprognostic (2.49e-2)" "unprognostic (2.20e-2)" "unprognostic (2.60e-1)" "unprognostic (6.07e-3)" "unprognostic (8.31e-3)" 6.4 0.5 4.5 3.6 6.4 0.1 5.3 10.1 4.9 9.3 2.8 14.7 6.7 9.6 3.5 18.9 10.3 7.3 59.4 3.8 7.0 2.0 6.9 4.3 0.2 12.7 37.1 0.9 2.3 4.3 3.0 0.9 14.4 3.9 3.9 0.4 10.9 2.0 2.1 8.1 10.5 6.0 13.8 0.1 17.5 3.1 10.1 2.9 2.0 2.6 2.1 10.2 5.4 8.8 0.1 0.0 1.3 4.6 4.2 0.1 27.5 0.3 0.4 0.3 0.5 0.1 5.7 0.0 6.2 0.0 9.0 0.1 1.2 0.9 0.0 6.4 10.4 1.4 0.0 0.0 0.1 0.5 0.1 0.1 2.1 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.1 5.6 0.1 0.6 1.8 0.0 0.0 3.4 4.8 0.0 0.0 0.3 0.0 0.0 0.1 4.7 1.1 4.5 16.6 0.3 0.0 6.7 14.4 0.0 22.1 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 6.4 10.1 4.9 3.8 7.0 12.7 37.1 14.4 13.8 10.1 8.8 0.7 0.0 0.0 10.7 0.3 3.3 6.6 21.8 9.6 2.9 4.7 4.4 28.1 0.0 23.9 1.8 0.0 0.3 0.2 0.5 0.0 3.1 9.3 5.8 2.0 3.1 0.0 0.0 4.8 1.7 1.2 9.7 1.1 7.9 0.0 0.0 2.2 12.4 0.1 0.0 7.1 1.4 24.4 0.6 5.9 4.6 0.3 0.1 1.8 9.4 0.6 0.3 0.0 137.2 1.0 1.4 0.1 0.0 0.0 4.0 0.7 0.2 11.1 0.2 0.0 3.9 6.8 1.6 2.0 12.7 2.8 0.5 0.5 0.0 0.6 3.5 OXCT1 "OXCT, SCOT" ENSG00000083720 "3-oxoacid CoA-transferase 1" P55809 5 41730065-41870425 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 245.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 243.7;Distal tubular cells: 187.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 238.7;SiHa: 319.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012047, HPA061425" Enhanced Enhanced Mitochondria "Intracellular and membrane" NA NA 440000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA012047: AB_1854857, HPA061425: AB_2684515" "unprognostic (4.26e-2)" "unprognostic (2.10e-2)" "unprognostic (2.89e-2)" "unprognostic (1.51e-1)" "unprognostic (5.51e-2)" "unprognostic (1.82e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (7.42e-3)" "unprognostic (1.74e-3)" "unprognostic (1.67e-1)" "unprognostic (2.80e-2)" "unprognostic (3.62e-1)" "prognostic favorable (1.86e-8)" "unprognostic (2.66e-2)" "unprognostic (9.99e-2)" "unprognostic (5.86e-3)" "unprognostic (2.28e-3)" 52.7 15.8 30.4 16.6 34.9 13.3 18.5 23.9 32.7 13.5 15.9 19.2 8.3 14.9 17.6 26.8 12.4 15.2 245.9 36.2 27.1 53.1 1.3 8.0 21.7 19.5 21.4 13.8 5.3 48.6 14.7 5.0 20.0 25.5 21.1 23.6 18.9 29.8 28.5 23.1 12.8 36.6 19.3 11.0 34.2 13.2 25.7 76.8 27.3 42.6 25.9 15.1 13.8 24.5 35.3 1.6 27.9 33.6 84.7 45.0 0.1 62.1 38.9 50.3 30.4 5.7 23.5 91.2 15.0 47.5 25.8 20.5 77.5 55.9 58.5 78.5 9.1 63.9 238.7 11.9 36.8 125.8 20.9 42.7 15.3 49.3 82.2 24.6 46.4 81.6 13.3 114.0 58.1 4.5 105.5 6.1 6.4 0.0 24.5 82.8 78.9 68.7 41.7 2.9 27.9 28.8 319.5 0.3 38.3 2.5 0.4 27.4 28.3 39.7 51.9 68.6 50.6 18.6 16.5 3.6 59.9 90.9 30.9 1.4 1.4 4.7 11.6 1.5 13.8 10.0 11.5 12.7 6.3 7.5 13.6 10.9 0.4 11.3 2.5 2.4 21.5 6.6 30.4 34.9 23.9 32.7 36.2 27.1 19.5 21.4 20.0 19.3 25.7 24.5 8.4 6.4 9.2 37.5 19.2 14.8 11.7 12.4 17.6 14.1 18.8 14.2 243.7 7.2 14.3 11.0 2.1 7.0 18.3 5.0 187.9 5.4 19.1 11.7 18.8 9.8 13.2 23.1 71.5 0.7 11.9 21.3 20.4 31.2 9.5 8.7 6.8 0.3 38.2 13.5 84.2 18.6 12.2 1.3 7.0 8.6 6.2 5.2 16.0 26.2 4.4 11.8 10.3 66.4 46.8 4.8 5.3 7.5 31.3 12.1 2.9 27.4 5.6 21.6 13.1 9.7 24.6 35.6 19.7 27.6 21.6 6.8 26.6 8.6 18.1 9.0 PAM "PAL, PHM" ENSG00000145730 "Peptidylglycine alpha-amidating monooxygenase" P19021 5 102753981-103031105 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1560.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 1406.5;Enteroendocrine cells: 321.4;Inhibitory neurons: 487.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 529.9;fHDF/TERT166: 714.5;hTERT-RPE1: 562.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026119, HPA042260" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA 98000000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus, Cytosol" "CAB026119: , HPA042260: AB_2677919" "unprognostic (4.30e-3)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.63e-4)" "unprognostic (4.23e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (7.58e-2)" "unprognostic (6.62e-2)" "unprognostic (2.71e-1)" "unprognostic (9.91e-2)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.08e-1)" "unprognostic (9.79e-2)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" 119.3 202.5 71.6 34.6 81.4 10.1 99.0 50.7 82.5 595.0 96.2 125.1 52.6 140.9 678.2 69.4 87.6 97.3 1560.4 75.2 179.9 116.0 20.1 88.3 27.7 86.5 99.8 136.4 104.4 257.8 137.0 60.0 170.9 91.6 80.4 37.6 205.4 236.5 155.3 66.9 52.1 157.9 55.7 52.5 131.6 22.4 106.0 17.9 95.1 159.4 30.5 103.3 116.1 50.0 111.3 16.3 195.9 87.2 529.9 314.8 78.0 307.6 457.0 89.1 268.9 53.5 143.2 0.1 65.0 714.5 125.7 36.8 11.0 135.3 244.0 13.5 44.7 22.9 60.0 17.7 80.3 7.4 23.9 173.4 57.3 65.6 49.2 562.6 186.8 8.9 0.9 15.0 255.6 22.9 0.1 3.2 35.3 19.7 59.3 8.5 108.9 62.4 346.1 13.0 92.3 63.9 131.2 8.3 83.3 114.0 34.0 7.3 144.9 280.8 72.4 133.3 93.4 33.1 8.6 0.4 322.3 30.8 247.6 4.2 8.0 0.2 20.7 1.5 14.9 0.8 12.3 15.6 3.1 0.4 4.1 6.8 16.6 26.3 3.4 1.6 19.9 10.8 71.6 81.4 50.7 82.5 75.2 179.9 86.5 99.8 170.9 55.7 106.0 50.0 45.7 54.5 39.3 47.0 3.9 28.2 12.0 26.1 12.0 19.1 27.5 12.1 1406.5 0.0 30.4 60.7 2.1 1.6 12.6 13.7 7.9 12.6 8.8 47.6 48.6 63.5 321.4 3.4 229.2 21.5 40.6 220.4 26.0 83.0 9.5 68.3 74.6 3.5 5.9 8.4 487.7 13.8 18.3 10.3 48.3 8.1 60.3 9.3 37.4 192.0 9.5 11.6 22.6 154.8 9.3 30.6 6.3 58.6 12.1 26.4 4.8 43.8 19.2 3.8 19.7 36.4 44.9 2.6 5.6 8.0 23.7 6.7 16.6 19.3 6.3 18.2 PDE1C Hcam3 ENSG00000154678 "Phosphodiesterase 1C" Q14123 7 31751179-32428131 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 68.9;heart muscle: 58.5" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 1071.4" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 44.4;fHDF/TERT166: 148.3;hTERT-RPE1: 44.9;U-251 MG: 77.9;WM-115: 105.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052375 Approved Nucleoplasm NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA052375: AB_2681802" "unprognostic (1.29e-2)" "unprognostic (2.20e-5)" "unprognostic (1.68e-2)" "unprognostic (1.20e-3)" "unprognostic (2.29e-1)" "unprognostic (5.65e-2)" "unprognostic (4.06e-3)" "unprognostic (2.75e-1)" "unprognostic (6.79e-3)" "unprognostic (6.49e-2)" "unprognostic (3.88e-5)" "unprognostic (7.03e-2)" "unprognostic (3.09e-3)" "unprognostic (5.76e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.06e-3)" 2.4 1.8 19.2 2.5 43.0 0.0 4.3 21.4 39.9 0.7 0.0 3.0 1.4 2.4 6.0 6.4 10.5 1.5 58.5 18.9 24.2 4.2 0.1 4.9 0.6 29.4 27.9 3.8 2.6 0.3 1.3 3.2 27.7 2.0 1.8 7.4 1.8 3.2 0.6 0.4 3.3 5.0 16.4 0.6 4.0 3.8 28.6 1.6 3.1 4.0 0.1 9.8 1.4 68.9 0.3 5.8 15.5 0.0 0.6 0.4 0.2 44.4 18.3 20.8 17.1 0.0 0.0 0.0 0.2 148.3 0.0 1.2 0.0 0.0 27.1 0.0 0.0 1.3 1.4 0.0 0.1 0.0 31.9 1.9 0.0 4.3 0.2 44.9 7.1 0.0 0.1 0.1 1.7 0.0 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.0 22.5 0.0 6.8 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 22.8 8.6 0.4 77.9 0.4 0.0 0.0 2.4 0.5 105.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 43.0 21.4 39.9 18.9 24.2 29.4 27.9 27.7 16.4 28.6 68.9 1.2 0.0 0.0 7.5 0.1 0.0 0.7 0.1 1.2 69.5 2.8 17.1 136.0 0.0 0.7 1.8 52.1 0.0 0.1 0.0 0.0 4.8 53.4 0.2 0.1 3.9 0.0 0.0 70.8 0.4 0.0 8.7 0.0 0.4 8.8 0.2 0.0 0.0 0.1 3.3 169.2 0.0 59.0 0.0 0.2 50.3 0.3 0.5 0.0 15.9 0.0 0.9 0.0 196.6 1071.4 0.2 0.0 0.4 0.1 0.2 0.0 0.0 2.2 4.7 0.0 0.9 9.4 1.3 1.2 0.2 0.0 0.0 0.1 1.2 0.0 0.0 PFDN4 "C-1, C1, PFD4" ENSG00000101132 "Prefoldin subunit 4" Q9NQP4 20 54208087-54228052 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024055 Approved NA NA 220000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA024055: AB_1855236" "unprognostic (2.38e-2)" "unprognostic (1.49e-1)" "unprognostic (3.11e-1)" "unprognostic (5.18e-3)" "unprognostic (2.95e-2)" "prognostic unfavorable (9.40e-4)" "prognostic unfavorable (7.66e-5)" "unprognostic (7.87e-3)" "unprognostic (3.38e-1)" "unprognostic (2.33e-2)" "unprognostic (7.44e-3)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.47e-10)" "unprognostic (9.43e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-1)" "unprognostic (7.57e-2)" 5.5 6.2 12.6 4.8 12.9 5.3 6.0 12.5 19.0 5.8 10.7 3.7 2.0 8.0 5.8 5.3 4.7 5.8 14.2 13.1 14.4 6.4 4.0 3.9 6.8 13.3 13.9 7.9 3.7 5.8 2.6 6.6 13.8 5.4 4.2 3.4 4.1 5.2 8.8 4.4 2.7 6.3 12.7 3.2 2.3 7.6 13.2 4.8 6.9 8.2 4.9 5.8 2.7 13.1 9.9 3.4 11.6 3.8 8.1 19.4 11.5 9.2 7.1 21.8 9.6 12.6 9.9 7.2 30.1 10.4 12.6 8.4 13.3 11.9 36.7 7.2 10.0 6.1 13.1 42.6 10.5 12.5 6.8 10.3 16.8 9.4 17.3 11.3 13.8 8.9 11.6 8.2 20.0 38.8 12.8 29.5 14.1 6.2 16.5 9.9 4.1 13.2 18.7 12.7 13.6 14.4 11.2 30.3 31.9 10.5 9.4 25.4 6.9 15.5 18.8 21.8 20.8 5.1 8.1 11.0 15.4 11.0 13.7 3.6 5.4 2.6 4.4 5.8 6.2 6.0 5.9 5.3 7.8 5.2 6.1 5.7 0.8 7.6 5.5 8.6 12.5 5.0 12.6 12.9 12.5 19.0 13.1 14.4 13.3 13.9 13.8 12.7 13.2 13.1 46.7 28.9 32.9 6.2 47.3 91.1 86.4 190.5 59.7 16.5 67.6 82.2 73.6 52.9 68.7 40.5 0.0 124.4 53.2 45.5 107.6 147.5 196.9 67.6 53.5 65.3 71.2 77.2 14.7 137.9 147.1 66.6 19.9 82.1 43.1 52.1 84.6 71.6 95.3 13.5 14.6 56.7 85.5 104.3 104.8 35.7 78.9 46.8 62.2 8.4 172.5 41.7 52.5 12.1 11.9 145.8 68.5 68.1 35.1 69.0 42.7 135.4 66.6 15.7 105.2 55.5 64.6 181.4 92.8 57.3 88.5 93.4 53.6 48.5 66.5 76.7 PKIG ENSG00000168734 "CAMP-dependent protein kinase inhibitor gamma" Q9Y2B9 20 44531785-44624247 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "memory B-cell: 370.6;naive B-cell: 377.4" "Lineage enriched" "Detected in all" 11 "B-cells: 377.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 540.5;HSkMC: 211.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042703, HPA063690" Uncertain Approved Nucleoplasm,Cytosol No No "Cluster 37: B-cells - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "HPA042703: AB_10797018, HPA063690: AB_2685091" "unprognostic (3.15e-2)" "unprognostic (5.65e-2)" "unprognostic (8.07e-2)" "unprognostic (1.44e-3)" "unprognostic (3.16e-1)" "unprognostic (9.49e-2)" "unprognostic (3.96e-2)" "unprognostic (6.46e-3)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "prognostic favorable (4.90e-5)" "unprognostic (6.26e-2)" "unprognostic (9.08e-2)" "unprognostic (1.19e-2)" "unprognostic (1.35e-2)" "unprognostic (4.22e-1)" "unprognostic (3.96e-2)" 90.3 76.6 77.4 59.0 80.0 20.7 74.2 70.9 95.6 105.2 78.0 189.1 30.3 111.4 37.8 76.4 101.7 73.8 289.9 82.7 82.5 104.5 44.5 162.9 49.4 80.9 77.0 57.5 32.3 66.8 69.1 82.3 72.5 102.4 31.5 26.9 45.9 75.3 104.8 31.4 72.2 92.6 73.1 42.7 81.8 68.3 83.4 19.3 68.4 91.1 46.7 169.0 68.9 73.4 27.8 27.9 44.7 28.8 67.0 135.7 6.2 66.0 540.5 73.6 55.4 64.7 12.5 108.3 52.7 58.5 61.2 10.6 9.0 14.4 23.9 54.8 16.3 16.7 4.1 45.7 61.7 2.1 1.1 211.7 28.5 35.8 7.9 36.4 167.5 29.3 13.4 2.6 6.8 35.0 17.2 27.5 23.7 0.2 39.4 2.8 1.2 2.6 40.7 5.5 18.0 58.7 16.9 7.9 45.6 19.3 21.0 13.6 108.5 99.9 44.2 44.8 32.3 13.9 41.9 76.3 49.5 1.9 43.8 2.9 1.8 0.7 1.5 1.7 1.3 370.6 1.9 1.8 9.1 377.4 5.4 8.8 2.2 4.4 1.6 35.8 1.0 17.8 77.4 80.0 70.9 95.6 82.7 82.5 80.9 77.0 72.5 73.1 83.4 73.4 93.3 9.6 6.1 26.8 82.9 25.2 14.4 20.3 10.2 24.6 37.6 45.1 233.6 24.3 15.7 46.0 20.9 15.1 6.2 44.2 127.2 70.6 110.1 104.2 91.5 122.3 44.2 34.9 65.9 30.8 17.8 93.2 5.1 18.5 47.5 27.8 65.0 37.8 8.2 10.1 42.7 15.7 32.6 3.8 20.4 40.1 73.0 14.2 49.8 22.5 8.1 94.1 3.1 25.6 25.4 39.1 46.9 61.3 11.8 11.6 19.3 156.6 78.3 28.7 118.3 19.5 153.0 155.9 27.4 5.3 30.0 36.7 8.5 80.8 29.1 10.2 PLA2G5 ENSG00000127472 "Phospholipase A2 group V" P39877 1 20028179-20091911 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 132.7;ovary: 47.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 75.3;Cone photoreceptor cells: 70.9;Leydig cells: 81.4;Peritubular cells: 73.4;Sertoli cells: 263.0;Smooth muscle cells: 63.1" "Group enriched" "Detected in many" 5 "glioma: 13.0;prostate cancer: 3.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053361 Approved "Secreted in other tissues" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA053361: AB_2682127" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (5.68e-3)" "unprognostic (6.16e-2)" "unprognostic (2.01e-2)" "unprognostic (5.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.02e-1)" "unprognostic (2.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (1.70e-3)" "unprognostic (6.00e-5)" "unprognostic (2.87e-2)" "unprognostic (3.00e-1)" "unprognostic (1.54e-1)" "unprognostic (4.97e-3)" 8.9 1.5 8.7 1.4 10.9 0.0 3.4 10.5 14.4 1.2 22.1 33.7 0.7 1.8 0.9 4.4 6.4 2.0 132.7 9.1 9.7 0.1 6.1 8.0 0.6 10.2 10.9 47.6 0.9 0.0 0.8 4.7 9.2 14.9 2.3 18.9 2.7 7.7 0.5 1.7 3.0 3.3 9.5 1.6 6.3 10.1 11.8 0.0 2.4 0.3 1.2 17.6 1.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 10.9 10.5 14.4 9.1 9.7 10.2 10.9 9.2 9.5 11.8 8.6 0.7 0.0 0.5 25.8 0.0 0.4 0.0 0.0 0.0 11.6 0.2 1.3 75.3 0.0 0.0 0.0 70.9 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.1 0.0 0.0 0.2 0.0 0.1 30.8 0.0 0.0 0.0 6.7 10.8 0.1 0.3 0.0 0.2 0.0 0.0 1.2 0.7 4.9 81.4 0.5 0.0 1.9 0.0 30.8 0.0 0.5 0.1 0.0 0.0 73.4 0.0 1.3 0.0 0.0 0.0 32.1 263.0 0.5 63.1 0.6 0.7 0.0 0.4 0.3 0.1 0.0 0.0 0.1 PPM1K "BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm" ENSG00000163644 "Protein phosphatase, Mg2+/Mn2+ dependent 1K" Q8N3J5 4 88257620-88284769 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 92.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 512.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 58.0;Karpas-707: 48.6;U-698: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020066, HPA020862, HPA023891" Approved Supported Mitochondria No No "Cluster 24: B-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630" "unprognostic (2.38e-2)" "unprognostic (5.86e-2)" "unprognostic (7.42e-3)" "unprognostic (6.70e-3)" "unprognostic (1.18e-1)" "unprognostic (1.17e-3)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (5.50e-2)" "unprognostic (1.41e-2)" "unprognostic (9.25e-3)" "unprognostic (6.56e-2)" "unprognostic (9.82e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" 5.3 8.5 23.3 14.9 26.3 9.9 14.5 22.5 31.2 19.4 22.0 5.9 4.4 32.7 7.6 11.2 21.5 8.9 92.5 26.5 23.9 17.8 7.6 9.7 25.6 19.9 22.3 32.5 11.1 12.5 9.9 9.7 22.9 16.2 6.0 14.2 11.8 7.1 14.2 2.6 10.4 26.6 22.1 18.9 8.0 19.9 27.7 15.2 7.9 11.5 25.8 8.9 11.7 33.2 4.6 1.5 5.7 10.1 8.3 10.9 2.3 7.2 13.0 23.3 27.4 11.6 1.1 58.0 7.7 4.6 11.5 0.5 17.0 5.4 9.1 44.9 7.1 10.8 5.0 10.8 6.6 14.6 5.3 7.2 2.7 14.5 12.5 4.9 4.2 25.4 15.5 48.6 7.0 6.5 20.3 7.9 3.4 3.5 2.3 10.8 9.3 21.9 8.1 2.0 4.4 3.9 4.6 0.5 5.4 9.6 23.2 3.9 0.8 8.3 4.2 2.8 4.1 15.6 15.0 48.3 9.1 11.7 14.0 24.7 9.9 8.1 39.4 12.0 51.4 102.9 37.1 39.9 18.6 113.5 36.3 44.2 3.2 27.6 3.6 131.3 46.9 24.5 23.3 26.3 22.5 31.2 26.5 23.9 19.9 22.3 22.9 22.1 27.7 33.2 20.7 48.1 12.4 105.4 124.8 9.8 15.8 5.7 29.6 109.5 42.8 25.7 512.1 8.6 13.7 49.7 18.8 11.5 153.0 0.8 156.5 7.0 7.9 9.7 37.2 27.2 9.6 34.3 89.5 6.2 3.2 42.9 8.2 20.0 19.0 32.2 24.7 30.2 28.9 85.8 145.6 16.5 4.1 14.5 16.4 10.5 23.9 27.5 21.4 40.3 75.6 21.8 80.3 100.0 54.7 4.6 9.2 31.6 82.7 32.1 8.2 47.6 19.5 14.8 26.3 38.5 36.4 38.2 22.9 71.4 5.4 2.9 70.1 45.4 4.1 6.7 PRKAG2 "AAKG, AAKG2, CMH6, H91620p, WPWS" ENSG00000106617 "Protein kinase AMP-activated non-catalytic subunit gamma 2" Q9UGJ0 7 151556124-151877125 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 143.0" "Cell type enhanced" "Detected in all" "Excitatory neurons: 208.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 178.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004246, CAB018641" Uncertain Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "CAB018641: AB_2170355, HPA004246: AB_1078151" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.46e-2)" "unprognostic (9.29e-2)" "unprognostic (1.76e-1)" "unprognostic (4.33e-3)" "unprognostic (7.13e-2)" "unprognostic (8.09e-2)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (2.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.80e-1)" "unprognostic (3.61e-2)" "unprognostic (4.52e-1)" 27.1 7.7 21.7 12.8 20.3 8.1 18.4 16.7 22.8 16.2 11.1 25.8 24.4 19.8 14.3 16.2 17.9 12.8 143.0 23.7 21.1 22.5 36.1 14.2 11.6 19.3 17.4 10.9 10.9 9.2 9.5 16.1 19.7 25.3 18.9 2.9 15.0 19.5 15.0 13.5 26.2 16.5 15.8 17.6 26.7 12.8 18.5 7.9 16.6 21.7 9.8 47.9 17.5 19.6 46.6 13.6 9.1 10.6 36.4 28.6 14.4 21.5 19.5 22.7 22.3 8.6 52.5 0.0 34.0 28.9 178.2 13.9 5.7 22.4 30.0 15.8 6.2 11.5 1.8 0.9 60.8 8.5 11.4 16.5 49.7 21.8 21.0 34.1 40.2 14.9 4.1 5.6 66.2 17.2 3.5 6.7 9.7 18.8 37.5 5.6 6.9 9.7 39.2 10.9 38.5 6.7 10.7 19.9 10.0 22.9 4.0 13.6 52.8 5.0 4.3 2.8 13.1 3.5 5.1 0.0 63.5 29.8 45.9 26.2 9.3 10.9 5.3 7.0 4.1 9.6 4.9 4.8 6.5 4.0 4.8 7.3 11.1 4.4 6.4 6.0 2.9 5.3 21.7 20.3 16.7 22.8 23.7 21.1 19.3 17.4 19.7 15.8 18.5 19.6 19.2 6.4 19.8 37.5 24.8 10.6 39.9 25.0 19.9 22.3 20.6 14.5 122.3 8.6 22.9 46.0 8.4 3.9 43.8 29.5 64.6 14.1 49.3 75.1 16.9 20.4 13.1 3.8 208.5 22.7 31.2 24.9 21.9 98.1 22.2 4.6 18.9 76.8 17.7 3.3 85.2 34.5 105.8 57.2 48.2 35.8 7.5 50.9 16.0 73.1 62.9 14.7 37.0 39.2 4.4 27.5 21.9 7.9 23.4 45.7 77.7 19.7 14.2 6.1 13.1 6.9 27.3 4.0 32.3 12.8 10.9 50.6 27.3 5.0 28.0 45.2 PTGDR2 "CD294, CRTH2, DP2, GPR44" ENSG00000183134 "Prostaglandin D2 receptor 2" Q9Y5Y4 11 60850933-60855950 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.2;intestine: 8.2;stomach 1: 9.3" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Endothelial cells: 2.2;Fibroblasts: 4.1;granulocytes: 4.5;Intestinal goblet cells: 2.0;Langerhans cells: 2.4;Smooth muscle cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 178.1;eosinophil: 234.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 234.1" "Cell line enhanced" "Detected in some" "HEL: 9.6;Hep G2: 4.8;HMC-1: 5.9;K-562: 4.0;MOLT-4: 3.1;NB-4: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014259 Uncertain NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" "HPA014259: AB_1849304" "unprognostic (9.77e-2)" "unprognostic (1.35e-3)" "unprognostic (5.45e-3)" "unprognostic (1.69e-1)" "unprognostic (1.90e-1)" "unprognostic (1.85e-3)" "unprognostic (1.70e-1)" "unprognostic (2.30e-4)" "unprognostic (2.61e-1)" "unprognostic (7.92e-2)" "unprognostic (8.68e-3)" "unprognostic (1.52e-1)" "unprognostic (1.32e-2)" "unprognostic (1.52e-1)" "unprognostic (3.31e-1)" "unprognostic (1.49e-1)" "unprognostic (4.99e-2)" 0.6 0.0 4.3 0.6 4.2 0.0 0.6 3.3 11.2 0.4 2.3 8.2 4.4 0.4 0.2 0.8 0.6 0.5 6.7 3.4 3.6 0.1 0.5 0.6 0.1 3.7 4.2 0.1 0.5 3.4 0.3 1.0 3.9 0.5 4.1 0.1 0.1 0.1 7.3 0.4 6.9 0.3 3.0 0.5 9.3 0.3 4.2 5.0 0.1 3.9 0.1 0.5 0.2 3.4 0.0 0.0 0.1 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 9.6 0.0 4.8 1.0 0.0 5.9 1.9 0.1 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 3.1 14.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 178.1 0.1 234.1 0.0 10.9 0.0 0.0 1.5 1.1 5.2 0.0 0.0 0.0 0.7 0.1 35.8 1.1 1.6 2.3 4.3 4.2 3.3 11.2 3.4 3.6 3.7 4.2 3.9 3.0 4.2 3.4 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.1 0.1 0.6 0.0 0.0 0.0 2.1 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.0 2.2 1.2 0.0 0.2 0.0 0.0 4.1 0.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 2.4 0.0 0.3 0.5 0.0 1.9 0.6 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.9 6.8 0.1 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 PTPN11 "BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2" ENSG00000179295 "Protein tyrosine phosphatase non-receptor type 11" Q06124 12 112418351-112509918 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005377 Approved Supported "Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol" NA NA 74000 "Cluster 6: Non-specific - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Nucleoli rim" "Actin filaments, Cytosol" "CAB005377: AB_632401" "unprognostic (2.18e-3)" "unprognostic (1.73e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "unprognostic (4.25e-2)" "unprognostic (3.55e-2)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (8.85e-2)" "unprognostic (3.75e-3)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.62e-2)" "unprognostic (1.80e-2)" 62.9 36.6 74.6 34.7 91.7 46.3 37.6 72.7 115.7 37.9 38.4 32.5 27.6 37.8 28.7 38.9 24.3 29.4 68.7 66.1 85.6 39.7 53.0 34.4 35.6 79.0 84.1 26.2 31.6 53.4 16.1 38.0 85.7 35.2 30.6 51.8 25.9 42.4 75.1 32.1 26.1 45.7 83.4 26.7 30.4 18.2 81.7 35.5 46.8 64.0 32.5 40.1 23.5 106.3 116.9 107.6 77.0 73.4 109.7 106.1 92.7 136.4 148.2 105.5 78.5 107.7 43.4 124.5 69.4 127.4 66.7 68.1 100.1 121.6 173.8 93.1 85.0 181.5 102.6 59.8 109.2 145.8 108.0 86.6 119.6 113.6 159.8 101.3 88.7 92.0 140.2 41.3 103.3 83.2 101.0 69.7 94.1 112.3 73.4 102.4 114.6 70.5 97.3 126.7 53.3 66.1 133.7 99.8 85.2 77.6 114.8 97.8 108.1 122.9 110.0 74.2 121.8 79.4 141.6 120.2 102.2 99.7 117.7 32.2 11.7 16.8 14.8 10.2 14.0 18.1 13.3 12.4 13.6 20.8 15.3 11.9 10.7 12.6 13.7 18.3 10.9 7.2 74.6 91.7 72.7 115.7 66.1 85.6 79.0 84.1 85.7 83.4 81.7 106.3 49.0 60.9 68.2 27.7 25.8 25.6 39.9 25.3 20.5 29.9 40.5 32.4 131.6 24.3 41.8 36.8 16.7 23.5 34.2 25.4 33.2 37.5 63.1 31.3 92.6 46.2 13.1 21.7 67.6 42.8 25.3 35.8 21.9 40.9 28.4 33.1 26.0 101.5 26.8 13.5 54.7 22.0 18.3 33.3 21.6 28.5 51.6 31.8 14.2 40.3 31.1 59.8 29.9 32.6 73.0 59.3 19.6 79.7 37.0 73.4 16.6 39.8 23.5 22.2 32.9 58.2 49.2 7.1 6.6 37.5 27.4 35.2 31.7 30.5 22.2 66.8 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319577-51809445 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "heart muscle: 45.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 42.2;Early spermatids: 43.8;Excitatory neurons: 25.2;Inhibitory neurons: 68.8;Microglial cells: 16.9;Muller glia cells: 18.6;Spermatocytes: 24.2" "Group enriched" "Detected in some" 4 "breast cancer: 1.7;glioma: 0.7;renal cancer: 0.8;testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 7.7;Daudi: 5.9;SH-SY5Y: 6.1" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavorable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.6 0.1 0.2 0.2 0.1 0.0 0.2 0.2 0.6 0.1 0.0 0.1 0.0 0.1 9.4 0.2 0.0 0.1 45.3 0.2 0.3 1.6 0.0 0.2 0.3 0.5 0.6 0.1 0.0 0.2 0.0 0.0 0.8 0.2 0.1 2.9 0.3 0.0 1.4 0.2 0.2 0.0 0.1 0.4 0.0 5.0 0.2 0.5 0.3 2.1 0.5 0.0 0.0 0.4 0.5 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.6 0.2 0.3 0.5 0.6 0.8 0.1 0.2 0.4 0.3 0.0 0.0 10.7 0.0 0.1 0.1 0.0 0.0 1.2 3.7 0.1 42.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.9 0.0 43.8 0.0 0.0 0.3 0.0 0.0 25.2 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 68.8 0.0 0.0 0.0 0.0 6.3 0.0 0.1 0.0 16.9 0.0 18.6 0.0 14.1 14.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.8 24.2 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 PYGB ENSG00000100994 "Glycogen phosphorylase B" P11216 20 25248085-25298012 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 122.8;Distal enterocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 407.8;SK-MEL-30: 528.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031067 Approved Approved Cytosol NA NA 14000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA031067: AB_2673722" "unprognostic (6.13e-2)" "unprognostic (5.98e-2)" "unprognostic (1.21e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.37e-4)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.23e-3)" "unprognostic (8.39e-3)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "unprognostic (3.41e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.43e-4)" 50.8 36.4 78.2 27.7 77.9 14.1 61.1 84.1 82.4 37.0 35.4 140.9 27.0 51.9 21.4 106.6 37.8 39.1 163.9 77.3 74.9 43.7 14.6 32.1 19.1 85.4 80.8 25.9 25.4 18.1 61.5 11.5 81.2 107.9 72.6 25.4 125.1 106.3 18.7 85.3 44.8 59.8 84.7 22.6 51.3 25.2 80.3 18.4 45.2 10.5 17.3 154.2 53.0 84.8 31.5 220.1 39.1 38.3 97.9 182.7 28.7 62.2 80.9 51.4 43.0 50.1 38.0 37.1 71.8 83.6 96.1 123.9 44.5 165.8 27.9 21.1 27.5 29.5 18.6 86.9 115.7 44.7 40.0 107.1 152.4 130.5 191.3 63.5 66.6 23.0 16.5 91.4 73.0 87.1 45.1 34.6 35.2 38.2 407.8 33.7 71.0 49.8 280.5 56.8 58.4 36.5 42.7 74.0 528.7 31.0 51.9 28.4 147.4 60.3 36.5 65.1 128.7 35.2 58.8 14.4 67.9 34.8 335.3 4.6 14.1 7.1 10.2 19.4 9.9 5.4 8.1 9.2 14.5 4.6 10.3 12.9 3.3 11.2 23.4 7.1 9.6 23.4 78.2 77.9 84.1 82.4 77.3 74.9 85.4 80.8 81.2 84.7 80.3 84.8 10.0 9.6 34.6 43.1 8.7 11.9 23.1 20.7 22.2 35.8 31.6 43.6 122.8 11.5 14.6 25.8 37.5 7.1 10.7 185.2 11.7 17.6 3.5 12.7 17.2 13.5 28.2 8.6 22.9 16.5 7.2 15.3 40.2 21.6 6.3 16.2 8.9 5.8 10.8 18.5 26.9 47.3 57.0 13.8 10.7 9.2 27.4 18.5 35.6 15.0 16.6 21.3 15.5 11.6 19.1 27.0 68.5 86.5 22.9 17.6 20.9 11.1 11.9 9.3 0.0 13.5 23.1 2.0 8.5 15.3 10.1 4.4 12.9 20.3 72.0 9.7 RAB33A RabS10 ENSG00000134594 "RAB33A, member RAS oncogene family" Q14088 X 130171962-130184870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5;choroid plexus: 16.4;heart muscle: 15.2" "Cell type enhanced" "Detected in many" "granulocytes: 22.9;Melanocytes: 12.4;NK-cells: 22.6;Oligodendrocytes: 23.5;T-cells: 12.9" "Group enriched" "Detected in many" 6 "glioma: 10.7;melanoma: 2.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 111.4;Karpas-707: 126.8;U-266/70: 88.5;U-937: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059737 Uncertain Uncertain Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA059737: AB_2684115" "unprognostic (5.40e-2)" "unprognostic (6.64e-3)" "unprognostic (3.48e-2)" "unprognostic (8.47e-3)" "unprognostic (4.88e-2)" "unprognostic (1.17e-2)" "unprognostic (2.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.12e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-2)" "unprognostic (8.28e-2)" "unprognostic (7.00e-6)" "unprognostic (2.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.61e-1)" 2.3 1.3 23.6 4.0 28.2 6.3 1.3 27.9 31.6 2.3 16.4 0.9 0.7 1.7 0.5 0.5 1.6 2.6 15.2 24.4 24.4 1.7 0.9 1.7 11.6 29.0 24.7 1.4 0.2 2.0 2.2 1.4 29.7 0.4 1.0 7.6 0.5 0.1 0.1 1.1 2.2 0.7 27.8 2.5 1.4 0.6 25.7 4.8 0.6 0.2 12.3 1.7 0.8 41.5 0.3 0.2 7.5 0.0 3.2 1.0 0.1 1.0 2.2 1.9 3.2 0.1 0.8 5.8 0.1 0.6 0.5 0.2 9.4 0.2 2.0 30.2 0.1 35.0 0.1 0.0 31.3 28.4 111.4 1.0 0.2 0.6 1.3 1.0 0.8 34.7 0.1 126.8 0.3 0.3 13.1 9.7 1.1 0.1 1.3 0.0 0.0 1.6 0.2 0.0 24.3 19.4 0.2 0.3 0.5 0.4 0.0 15.2 0.2 0.1 0.1 0.4 0.2 88.5 29.7 0.0 3.9 55.1 0.0 39.9 1.3 87.4 32.0 0.8 20.0 20.2 29.0 32.5 10.0 8.8 27.8 40.0 4.1 19.5 5.4 1.0 72.8 18.1 23.6 28.2 27.9 31.6 24.4 24.4 29.0 24.7 29.7 27.8 25.7 41.5 1.7 0.0 1.1 1.6 3.2 1.9 0.6 0.5 1.2 10.9 0.3 1.0 8.4 2.8 0.2 0.0 2.1 0.9 8.9 0.0 0.0 0.0 1.2 0.4 0.8 2.0 0.0 6.6 4.0 0.2 1.3 4.5 0.0 0.8 22.9 2.9 2.5 0.1 1.9 5.0 3.2 0.4 2.0 0.3 12.0 1.2 1.8 6.3 12.4 1.9 2.5 1.6 22.6 4.5 23.5 0.8 0.0 0.4 3.3 0.4 0.0 0.2 0.3 9.3 0.0 0.0 2.2 0.1 1.2 0.2 1.1 1.4 12.9 0.2 0.3 0.6 RAB9B RAB9L ENSG00000123570 "RAB9B, member RAS oncogene family" Q9NP90 X 103822327-103832257 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 21.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 21.3;Cardiomyocytes: 79.0;Excitatory neurons: 28.4;Inhibitory neurons: 18.7;Muller glia cells: 32.2;Oligodendrocyte precursor cells: 37.7;Peritubular cells: 30.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 4.5;MOLT-4: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061932 Approved "Intracellular and membrane" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA061932: AB_2684640" "unprognostic (1.69e-2)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (7.28e-5)" "unprognostic (5.81e-2)" "unprognostic (3.89e-2)" "unprognostic (8.40e-2)" "unprognostic (1.42e-2)" "unprognostic (8.34e-2)" "unprognostic (8.29e-2)" "unprognostic (3.52e-4)" "unprognostic (1.10e-1)" "unprognostic (9.21e-4)" "unprognostic (1.37e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (2.04e-1)" 1.8 2.8 6.4 0.9 6.6 0.1 1.3 8.1 7.2 3.0 0.0 6.5 1.0 5.0 2.4 8.3 6.8 2.4 21.5 6.2 8.8 0.4 0.1 0.7 0.6 4.0 3.6 7.2 1.0 3.9 5.1 0.2 6.8 7.1 2.2 5.2 1.1 9.5 9.4 0.5 1.7 9.8 3.7 0.5 2.2 1.8 8.8 1.5 1.4 5.6 0.4 7.0 1.6 4.7 0.0 0.0 2.9 1.5 0.8 0.1 0.1 0.7 1.8 1.8 1.7 0.2 0.0 0.1 1.7 1.5 1.1 0.0 0.5 0.1 1.6 0.1 1.9 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.8 0.0 1.8 0.1 4.5 0.0 1.1 0.1 1.3 3.7 0.0 0.5 0.0 0.5 3.2 3.3 0.1 1.0 0.3 3.0 2.1 0.2 0.1 0.6 0.5 0.3 0.2 0.1 0.1 0.5 1.0 0.6 0.1 0.0 0.2 1.6 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 6.4 6.6 8.1 7.2 6.2 8.8 4.0 3.6 6.8 3.7 8.8 4.7 1.0 0.0 2.4 8.5 0.7 0.4 0.7 0.1 0.6 21.3 1.6 1.9 79.0 0.0 0.7 0.0 0.0 0.4 0.2 0.5 0.0 0.5 0.0 0.3 0.7 2.4 7.7 1.3 28.4 1.0 0.3 4.1 0.0 0.2 4.5 2.8 0.7 0.0 0.3 0.0 18.7 0.7 0.0 0.0 0.4 0.9 6.5 0.2 0.0 1.9 0.0 32.2 2.1 37.7 6.2 1.0 2.5 30.1 0.1 0.2 0.1 0.2 0.8 3.6 6.6 2.3 5.0 0.8 0.9 0.5 0.3 0.0 0.2 4.7 0.6 0.2 RABGAP1L "FLJ38519, HHL, KIAA0471, TBC1D18" ENSG00000152061 "RAB GTPase activating protein 1 like" "B7ZAP0, Q5R372" 1 174159410-174995308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 121.0" "Cell type enhanced" "Detected in all" "Excitatory neurons: 551.4;Inhibitory neurons: 444.0;Microglial cells: 267.0;Oligodendrocyte precursor cells: 362.4;Oligodendrocytes: 342.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 136.9;Karpas-707: 87.6;U-698: 85.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054695 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA054695: AB_2682577" "unprognostic (2.57e-2)" "unprognostic (7.77e-2)" "unprognostic (6.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.54e-2)" "unprognostic (6.96e-3)" "unprognostic (8.55e-2)" "prognostic favorable (1.16e-4)" "unprognostic (2.66e-2)" "unprognostic (3.51e-2)" "unprognostic (2.66e-2)" "unprognostic (1.98e-1)" "unprognostic (9.14e-3)" "unprognostic (6.69e-2)" "unprognostic (2.14e-1)" "unprognostic (5.03e-2)" "unprognostic (2.46e-1)" 12.1 8.6 16.1 22.8 19.1 31.1 15.7 46.1 20.6 15.0 51.2 20.4 22.0 13.1 16.3 18.6 19.0 22.1 121.0 19.4 17.2 16.8 16.3 26.4 41.9 9.6 13.2 28.8 19.9 10.5 20.5 18.3 11.2 10.4 21.2 16.2 23.6 10.5 6.5 16.5 24.3 13.4 10.0 26.3 22.6 31.1 15.9 20.1 10.0 7.4 50.1 19.9 10.3 19.5 15.6 8.0 6.0 6.2 16.4 23.9 13.3 18.1 16.0 7.9 10.6 7.5 56.0 136.9 12.5 14.0 9.3 19.6 5.2 12.1 11.0 37.7 8.5 34.2 11.0 11.5 10.1 15.1 13.2 18.9 8.2 5.7 8.5 13.3 17.7 12.6 20.2 87.6 12.8 5.3 11.9 14.4 37.2 20.9 4.8 41.0 12.0 45.7 15.5 70.9 17.5 10.4 17.2 28.8 12.1 18.4 14.0 18.1 24.5 9.9 8.9 11.0 10.7 75.6 26.3 85.7 10.9 10.1 7.5 16.7 50.0 110.2 25.7 86.5 22.7 34.7 31.5 31.5 40.3 26.4 15.2 23.5 89.6 80.3 180.8 53.6 42.3 32.9 16.1 19.1 46.1 20.6 19.4 17.2 9.6 13.2 11.2 10.0 15.9 19.5 23.1 73.7 106.1 143.7 63.8 12.4 11.4 19.9 39.3 38.7 20.7 13.2 263.0 47.1 38.6 33.1 31.3 39.1 101.2 43.3 13.7 28.8 117.2 59.0 18.6 17.6 49.1 33.8 551.4 36.9 9.5 35.3 46.9 46.8 24.6 8.9 23.9 16.3 38.5 21.9 444.0 37.8 18.3 57.0 16.2 121.3 15.5 63.1 16.0 267.0 100.4 17.3 68.0 362.4 342.8 24.5 36.0 18.8 81.8 11.5 39.8 13.3 100.3 23.8 6.6 15.0 25.1 91.8 18.5 36.9 13.1 28.2 74.6 26.1 27.0 27.5 RD3L "TDRD9-AS1, TDRD9AS1" ENSG00000227729 "Retinal degeneration 3 like" P0DJH9 14 103940426-103942561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 26 "heart muscle: 23.3;retina: 13.3" "Group enriched" "Detected in some" 9 "Bipolar cells: 78.5;Cardiomyocytes: 40.8;Cone photoreceptor cells: 29.2;Horizontal cells: 26.9;Rod photoreceptor cells: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "olfactory bulb: 10.4" "Low region specificity" "Detected in all" HPA067971 Enhanced Approved "Cell Junctions" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 56: Bipolar cells - Visual perception" "Cell Junctions" "HPA067971: AB_2685935" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.5 0.0 0.0 40.8 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF207 "C1orf188, FLJ32096, FLJ46380" ENSG00000158286 "Ring finger protein 207" Q6ZRF8 1 6205475-6221299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 34.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 31.8;Basal respiratory cells: 31.7;Club cells: 28.3;Urothelial cells: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.2;HaCaT: 7.6;HeLa: 7.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA028378, HPA042535" Uncertain Approved Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "HPA028378: AB_10601157, HPA042535: AB_2678042" "unprognostic (5.53e-3)" "unprognostic (1.23e-1)" "unprognostic (1.62e-2)" "unprognostic (4.46e-2)" "unprognostic (4.84e-2)" "unprognostic (5.91e-3)" "unprognostic (9.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.74e-2)" "unprognostic (9.93e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.76e-2)" "unprognostic (2.93e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" 3.3 3.3 3.2 1.3 3.2 0.0 3.1 4.0 4.2 9.5 5.9 5.8 2.0 4.3 1.5 5.9 7.9 0.9 34.7 3.2 3.1 9.8 7.6 1.7 0.9 3.7 2.9 2.5 6.9 1.2 5.5 1.2 3.7 11.8 1.4 2.1 6.7 3.8 1.7 1.2 4.4 1.2 2.6 1.4 4.1 1.2 3.2 0.5 6.7 4.2 1.3 6.3 5.4 3.0 2.6 4.5 0.4 2.9 0.2 0.3 3.1 1.3 1.0 0.2 0.3 2.2 17.2 0.2 1.3 1.1 0.0 7.6 0.4 1.0 0.1 2.8 1.7 0.1 7.0 2.2 1.3 1.7 0.1 1.1 0.2 0.0 0.0 3.8 0.1 0.3 0.7 3.6 0.1 1.8 0.2 0.3 0.2 0.3 3.8 0.0 0.7 2.9 2.2 3.9 0.4 1.1 2.8 1.5 1.1 0.7 2.7 0.1 0.5 0.0 0.8 0.4 0.0 3.9 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.2 3.2 4.0 4.2 3.2 3.1 3.7 2.9 3.7 2.6 3.2 3.0 2.9 9.6 3.9 2.0 1.7 0.3 31.8 31.7 6.2 4.0 4.4 4.3 19.5 14.3 28.3 18.4 2.1 15.6 0.4 8.5 0.0 15.4 0.7 2.3 6.8 2.9 3.6 0.4 13.2 9.8 6.3 4.6 17.3 2.7 0.0 1.7 1.1 3.9 1.1 3.3 13.2 15.6 10.2 0.0 0.7 0.2 0.0 1.6 0.0 0.0 2.2 7.5 0.0 3.5 1.7 19.0 3.5 1.2 1.5 21.3 9.5 3.5 10.1 16.3 6.6 1.5 5.0 0.1 2.8 3.8 0.4 5.6 1.9 2.0 6.4 37.1 RPS6KA2 "HU-2, RSK3" ENSG00000071242 "Ribosomal protein S6 kinase A2" Q15349 6 166409364-166906451 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 399.6;Excitatory neurons: 204.1;Horizontal cells: 287.7;Inhibitory neurons: 552.3;Oligodendrocyte precursor cells: 244.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 26.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "eosinophil: 22.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 22.4" "Cell line enhanced" "Detected in many" "ASC diff: 214.5;ASC TERT1: 156.1;HHSteC: 158.5;HSkMC: 141.4;hTERT-HME1: 173.0;hTERT-RPE1: 316.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026243, HPA045061, HPA054237, CAB069428" Approved Supported Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425" "unprognostic (8.71e-2)" "unprognostic (3.14e-3)" "unprognostic (7.29e-2)" "unprognostic (1.72e-1)" "unprognostic (3.80e-1)" "unprognostic (2.45e-1)" "unprognostic (6.44e-3)" "unprognostic (8.63e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (8.63e-5)" "unprognostic (8.68e-2)" "unprognostic (4.11e-2)" "prognostic favorable (2.86e-5)" "unprognostic (3.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.56e-2)" "unprognostic (2.01e-1)" 34.2 9.0 40.3 8.0 41.0 10.5 27.8 35.0 35.2 18.1 8.6 16.6 6.1 26.0 7.1 20.1 18.7 18.2 61.8 37.8 42.1 13.6 6.6 45.1 7.5 48.3 41.7 29.2 19.4 49.6 27.2 17.9 42.0 14.9 10.3 28.9 14.7 14.2 24.1 16.4 16.5 22.7 35.3 26.0 21.4 7.7 47.3 5.9 36.3 30.5 7.3 24.5 14.9 49.3 9.1 0.0 17.9 26.0 214.5 156.1 0.4 19.3 37.4 10.6 14.6 0.0 5.8 1.1 6.2 68.2 8.4 8.2 9.4 41.8 9.4 4.2 2.3 0.1 40.2 0.4 158.5 0.6 7.2 141.4 29.4 56.6 173.0 316.2 58.0 19.2 0.2 0.2 43.6 1.9 0.8 2.1 4.5 9.1 10.5 3.0 9.2 27.3 11.1 10.1 9.8 68.8 6.7 17.9 24.8 4.4 0.5 14.3 21.7 37.3 3.7 103.8 5.6 5.2 8.4 2.6 24.8 1.2 36.0 0.2 0.6 22.4 0.6 0.8 0.3 0.3 0.6 0.3 0.8 0.5 0.7 0.3 0.5 4.4 2.2 4.7 0.5 0.4 40.3 41.0 35.0 35.2 37.8 42.1 48.3 41.7 42.0 35.3 47.3 49.3 60.9 22.4 46.2 399.6 2.7 4.7 5.4 4.6 3.4 37.1 7.1 5.0 60.0 15.7 11.6 36.8 8.4 0.2 8.0 1.9 11.7 15.2 14.8 20.6 4.6 58.2 5.4 0.0 204.1 24.0 0.3 16.3 16.8 20.3 2.5 10.5 45.3 11.9 7.2 287.7 552.3 5.3 2.0 6.0 6.7 69.3 5.3 8.0 19.6 144.3 3.5 10.1 1.0 244.8 97.7 26.8 1.7 4.5 2.4 9.9 0.3 7.0 9.4 17.1 13.1 10.0 14.5 3.5 2.3 1.2 3.4 0.3 2.0 9.5 1.4 6.6 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042184-237833988 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 132.0" "Group enriched" "Detected in many" 10 "Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 0.7 0.7 9.1 0.8 15.9 0.0 0.6 8.7 24.0 1.5 0.0 2.0 0.2 0.7 0.4 2.9 0.7 1.9 132.0 10.5 0.0 0.1 0.1 1.8 0.1 0.0 0.0 2.9 8.4 0.0 1.8 1.2 0.0 2.9 0.5 6.5 0.5 1.7 0.1 0.3 0.5 0.7 0.0 1.3 1.5 1.1 0.0 0.1 4.4 0.3 0.0 1.2 0.4 13.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.9 0.3 0.0 0.0 7.7 8.5 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.0 0.0 0.0 2.7 3.1 0.6 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 9.1 15.9 8.7 24.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.2 0.0 0.5 17.0 0.0 0.4 0.0 0.0 0.0 74.2 0.3 0.1 2180.6 0.0 1.3 1.8 10.4 0.1 0.1 0.0 0.0 0.0 21.1 0.2 3.4 10.6 3.5 0.0 1320.5 2.9 0.1 53.6 0.0 0.5 0.0 0.5 1.1 0.0 0.1 1.7 790.6 0.0 0.0 0.0 0.2 15.3 1.2 1.3 8.8 48.7 0.0 1.3 0.0 29.7 140.6 0.4 0.0 0.0 0.1 0.0 1.0 0.2 0.7 5.3 0.0 0.5 21.6 5.8 2.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649687 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "heart muscle: 42.8" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 77.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 27.6;RH-30: 22.8" "Group enriched" "Detected in many" 5 "amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0" "Region enhanced" "Detected in many" "basal ganglia: 5.4" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.2 0.1 1.9 0.1 1.2 0.2 0.2 0.0 0.7 1.7 0.0 0.2 0.2 0.7 0.0 0.1 0.3 0.1 42.8 0.2 1.5 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.0 0.0 0.4 0.2 0.0 0.3 0.1 2.0 0.2 0.5 1.6 0.1 0.2 0.3 0.2 0.1 0.1 0.3 2.6 0.0 0.2 1.0 0.0 0.4 0.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.4 0.1 0.0 0.2 3.6 0.0 0.0 0.0 1.0 0.5 2.7 0.0 0.4 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.4 0.0 2.1 2.8 0.4 0.0 0.0 27.6 1.4 0.0 0.0 2.6 0.0 0.0 0.0 22.8 0.0 0.0 3.2 0.4 3.1 0.0 0.0 0.0 0.8 0.0 0.0 5.7 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.7 0.2 1.5 0.0 0.7 0.0 0.2 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 2.7 0.0 0.3 77.1 0.0 0.1 0.0 14.6 0.2 0.0 0.0 0.0 0.1 1.2 0.1 3.2 2.8 0.0 0.0 0.5 0.0 0.3 3.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 6.3 0.3 0.6 0.2 0.0 3.7 0.0 0.6 0.0 1.5 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.9 0.0 7.3 3.1 0.2 1.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4279266-4290722 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 10.0;heart muscle: 17.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 137.5;Hepatocytes: 57.3;Intestinal goblet cells: 54.6;Paneth cells: 78.8;Proximal enterocytes: 43.1;Undifferentiated cells: 49.4" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 178 "plasmacytoid DC: 17.8" "Lineage enriched" "Detected in single" 178 "dendritic cells: 17.8" "Group enriched" "Detected in some" 45 "RH-30: 58.4;SH-SY5Y: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.0 0.1 4.2 0.6 3.6 0.7 0.0 7.0 8.6 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.1 17.8 2.4 9.6 0.0 1.5 0.0 0.6 7.4 6.4 0.0 0.0 0.1 0.2 0.0 5.6 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 4.6 0.1 0.0 0.1 10.0 0.1 0.0 1.7 0.3 0.1 0.0 6.0 0.0 0.0 0.7 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 58.4 0.1 0.0 0.0 0.5 193.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 4.2 3.6 7.0 8.6 2.4 9.6 7.4 6.4 5.6 4.6 10.0 6.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.8 21.7 137.5 1.9 0.0 0.1 0.1 0.0 0.2 13.2 5.3 2.8 0.0 0.6 0.4 0.0 0.1 8.9 0.0 0.7 57.3 0.4 10.1 4.2 54.6 0.0 0.6 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.9 0.0 9.0 0.3 0.0 78.8 0.0 0.0 0.0 43.1 0.0 0.0 0.4 0.0 2.5 0.1 0.0 2.9 0.0 0.0 4.4 0.8 0.0 49.4 0.0 SIPA1L2 "KIAA1389, SPAR2" ENSG00000116991 "Signal induced proliferation associated 1 like 2" Q9P2F8 1 232397965-232630571 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024181, HPA027224" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus" No NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear membrane, Nuclear bodies" "Golgi apparatus" "HPA024181: AB_1856886, HPA027224: AB_2672165" "unprognostic (2.34e-2)" "unprognostic (9.67e-2)" "unprognostic (8.02e-2)" "unprognostic (1.71e-3)" "unprognostic (2.98e-1)" "unprognostic (5.68e-2)" "unprognostic (5.57e-3)" "unprognostic (7.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.80e-2)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.36e-2)" "unprognostic (2.75e-1)" "unprognostic (5.84e-3)" "unprognostic (3.45e-3)" 12.1 3.3 8.5 6.4 7.2 5.4 9.2 9.6 11.7 10.0 0.5 19.4 3.9 4.4 2.8 20.3 4.5 8.5 31.3 9.6 16.0 7.7 6.4 16.2 3.0 44.0 21.7 11.9 3.6 4.4 8.1 18.3 44.6 8.1 18.9 14.7 8.7 4.7 7.1 9.0 9.2 7.4 14.4 9.6 5.7 7.2 18.7 2.4 8.0 9.5 3.3 12.5 14.9 9.0 0.0 7.5 69.7 0.2 0.6 0.0 29.3 1.2 2.5 3.1 2.2 2.9 0.1 5.9 13.3 26.4 2.9 1.7 13.8 2.3 2.9 0.0 12.8 0.0 7.0 0.0 5.9 1.0 7.2 3.8 9.1 0.6 6.2 0.0 15.7 25.4 0.0 0.1 1.6 3.5 7.4 0.7 53.9 0.2 10.2 0.0 0.0 3.4 8.1 11.5 3.5 11.9 23.8 0.8 9.5 15.8 1.4 0.6 5.6 8.1 0.0 17.8 2.9 6.5 0.0 0.0 10.0 6.2 46.1 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.6 0.3 0.3 0.0 0.1 8.5 7.2 9.6 11.7 9.6 16.0 44.0 21.7 44.6 14.4 18.7 9.0 53.7 6.4 1.8 22.9 0.8 8.8 9.8 8.7 15.4 23.5 10.7 8.6 62.6 12.8 10.4 3.7 52.1 4.9 4.4 29.9 0.0 7.1 11.7 19.0 21.4 22.7 7.2 0.4 80.2 0.5 7.1 15.2 5.1 47.5 1.3 16.0 1.8 3.8 10.0 5.0 95.9 29.5 14.2 16.6 7.2 9.8 0.9 19.5 14.2 183.6 6.3 12.7 1.0 104.0 21.0 1.4 39.9 1.9 0.5 13.2 9.1 0.4 7.7 35.7 0.0 21.8 23.9 6.9 24.0 45.8 7.4 14.8 2.0 11.9 23.4 23.0 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596029-59789855 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 22.2" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 6.8 1.2 3.9 1.2 4.7 4.1 5.7 3.9 2.8 3.7 2.0 1.6 3.0 1.5 6.3 2.2 5.4 34.4 1.3 0.3 11.6 3.9 4.5 4.9 2.9 0.4 2.7 9.8 1.0 1.5 1.6 2.9 1.6 2.5 1.8 2.9 1.6 1.8 7.9 2.5 3.5 0.5 6.3 10.0 2.2 1.3 4.5 1.6 3.6 4.2 4.0 3.0 4.2 0.2 3.6 0.8 0.5 10.9 18.1 0.2 8.8 8.1 4.0 3.4 0.3 6.3 5.8 2.5 16.8 3.8 0.8 1.0 1.7 6.0 2.4 0.5 10.7 12.6 0.5 5.9 14.3 0.1 8.5 3.9 1.4 10.3 7.5 1.6 7.2 0.2 13.0 6.5 3.4 5.5 3.2 0.8 1.2 3.3 0.5 0.1 2.7 9.5 16.0 3.0 1.0 0.1 0.4 6.2 0.7 0.5 2.4 0.0 8.6 3.3 15.6 0.5 11.3 0.2 10.0 10.2 0.1 1.6 0.2 1.5 0.0 4.2 3.2 5.6 1.8 3.3 3.6 1.5 4.1 3.5 5.8 0.1 3.0 8.4 2.1 3.8 2.3 1.2 1.2 5.7 3.9 1.3 0.3 2.9 0.4 2.9 0.5 1.3 4.2 15.3 28.9 21.4 13.7 28.4 10.1 7.8 9.9 16.5 24.5 1.5 3.9 135.4 90.1 16.5 46.0 10.4 0.3 29.7 0.8 23.5 53.3 117.3 2.1 25.0 22.0 0.0 2.5 150.5 67.1 0.3 36.2 7.1 9.1 10.1 4.7 9.3 14.5 3.6 8.4 128.2 27.2 6.1 32.7 6.1 135.5 6.8 24.8 3.6 14.0 14.9 1.3 37.0 63.8 82.8 28.0 1.2 10.1 26.3 8.1 1.0 0.7 14.4 6.0 6.6 14.0 18.9 4.2 4.5 61.5 12.6 0.7 35.8 80.1 1.5 3.4 SLC4A3 "AE3, SLC2C" ENSG00000114923 "Solute carrier family 4 member 3" P48751 2 219627394-219641980 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 283.1;ovary: 124.1" "Group enriched" "Detected in many" 9 "Cardiomyocytes: 207.1;Horizontal cells: 558.6" "Cancer enhanced" "Detected in all" "glioma: 13.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "myeloid DC: 1.4;plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 54 "dendritic cells: 5.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063498 Approved Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA063498: AB_2685025" "unprognostic (9.49e-2)" "unprognostic (5.72e-3)" "unprognostic (8.92e-4)" "unprognostic (1.77e-2)" "unprognostic (6.61e-3)" "unprognostic (1.47e-1)" "unprognostic (2.60e-1)" "unprognostic (2.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-1)" "unprognostic (8.15e-3)" "unprognostic (1.97e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.12e-4)" 6.3 16.7 36.1 1.0 36.6 0.4 3.9 21.2 32.1 11.4 6.3 2.9 0.7 15.3 2.7 3.2 9.3 2.3 283.1 31.7 34.5 9.3 0.3 1.6 0.9 44.1 20.7 124.1 3.9 7.7 41.4 2.7 43.1 10.4 0.2 13.0 3.8 5.3 0.9 2.0 1.1 3.7 10.6 3.3 2.7 14.2 32.7 1.0 2.5 0.6 0.6 2.6 4.7 18.0 6.9 0.2 2.3 6.8 0.4 0.4 4.9 4.1 4.2 5.4 3.8 4.8 3.8 0.0 1.6 1.5 9.3 3.8 1.2 7.3 1.6 0.0 1.0 0.0 0.1 0.1 1.1 0.1 0.3 3.1 7.0 0.0 2.1 13.4 0.0 0.0 0.3 0.0 1.6 2.3 0.0 0.0 3.8 0.2 5.5 0.0 0.0 0.0 3.7 1.5 1.3 6.7 2.7 6.9 3.7 7.2 0.7 1.7 0.0 3.4 6.0 0.0 3.3 0.0 0.0 0.0 2.7 0.0 9.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 36.1 36.6 21.2 32.1 31.7 34.5 44.1 20.7 43.1 10.6 32.7 18.0 0.3 0.0 0.0 19.2 0.2 0.3 0.7 1.5 0.0 14.4 2.2 4.8 207.1 0.0 0.8 1.8 0.0 11.4 13.5 0.0 1.9 3.0 2.3 0.9 3.5 1.8 0.0 0.0 11.5 1.7 3.0 10.4 0.0 1.4 0.0 38.3 0.0 0.0 1.8 558.6 32.7 0.0 0.0 0.3 5.6 25.6 15.2 1.1 0.0 3.7 1.3 7.6 0.0 3.5 0.6 1.1 0.0 22.6 0.0 0.4 0.0 0.3 0.2 7.5 6.6 3.9 3.5 0.6 1.2 0.0 0.9 13.8 0.1 8.7 0.0 0.1 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 117.5" "Group enriched" "Detected in many" 8 "Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 44.2" "Group enriched" "Detected in many" 6 "granulocytes: 44.2;monocytes: 11.5" "Cell line enhanced" "Detected in many" "BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: AB_2686227" "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 6.1 4.0 25.7 7.2 25.8 2.0 1.6 0.0 28.0 4.7 0.0 9.6 5.0 19.7 5.6 5.9 5.6 6.5 117.5 30.6 11.0 17.5 3.1 5.8 3.3 1.5 19.8 2.5 1.8 0.7 0.8 11.2 0.7 18.8 4.8 5.9 1.0 27.1 0.3 1.5 5.5 23.4 2.7 7.3 3.5 0.7 19.5 2.0 0.8 0.9 1.5 8.9 2.5 24.1 3.0 2.2 2.1 0.2 3.1 6.4 0.0 28.9 11.1 9.4 6.1 0.0 4.7 0.1 2.2 70.4 10.1 1.1 0.5 4.8 9.5 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.5 3.7 0.0 10.8 19.8 4.3 0.7 0.0 0.0 0.4 12.1 0.0 0.9 0.1 1.4 0.3 4.0 7.8 14.8 0.0 3.3 0.4 3.2 0.6 0.0 0.0 0.0 9.7 0.1 0.6 9.8 8.8 0.3 0.0 3.1 1.6 0.0 0.0 1.4 1.7 1.4 0.0 8.3 0.0 0.0 9.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 44.2 0.0 11.5 0.3 0.0 1.1 25.7 25.8 0.0 28.0 30.6 11.0 1.5 19.8 0.7 2.7 19.5 24.1 10.3 3.2 2.8 39.5 3.6 1.3 0.0 0.2 1.2 79.1 0.5 5.8 743.1 2.8 0.6 35.0 4.2 0.5 0.3 0.0 0.0 0.0 1.1 2.3 52.8 15.1 0.0 3.0 1267.5 0.0 1.6 26.6 1.5 3.0 0.0 0.2 12.1 0.3 29.3 0.0 631.3 2.5 0.0 78.0 26.7 1.4 0.0 88.8 1.8 574.3 42.7 32.0 1.0 753.0 20.5 0.1 3.8 8.2 0.7 0.2 24.7 0.5 0.0 7.2 13.1 1.4 46.6 0.2 1.2 0.5 3.1 1.1 1.2 0.7 2.5 0.1 SNU13 "15.5K, FA-1, NHP2L1, SNRNP15-5, SPAG12, SSFA1" ENSG00000100138 "Small nuclear ribonucleoprotein 13" P55769 22 41673933-41690504 "Predicted intracellular proteins, Ribosomal proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 1057.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA029199 Uncertain NA NA 28000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 59: Non-specific - Transcription" "HPA029199: AB_10601041" "unprognostic (3.02e-1)" "unprognostic (4.82e-2)" "unprognostic (8.58e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-1)" "unprognostic (4.54e-2)" "unprognostic (1.94e-3)" "unprognostic (2.43e-1)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (3.03e-1)" "unprognostic (3.46e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (6.78e-2)" "unprognostic (1.43e-1)" 64.9 125.6 156.5 74.5 157.7 135.7 80.7 146.4 159.5 81.8 134.4 77.8 64.9 64.6 99.0 65.5 91.2 55.7 145.1 159.1 191.3 75.7 65.2 61.9 97.4 159.5 159.4 96.7 74.8 113.6 52.7 67.5 173.3 65.8 73.5 85.5 74.8 70.9 187.1 73.3 56.1 71.4 150.1 71.2 66.3 94.9 173.3 98.2 90.1 178.0 108.4 88.7 34.0 151.9 222.8 100.2 151.8 203.7 192.7 173.5 160.1 212.6 181.4 303.0 259.6 215.1 195.0 148.6 165.5 183.6 91.6 160.3 183.6 239.0 205.5 178.1 428.0 163.0 191.1 313.1 249.5 345.3 217.9 157.7 247.0 226.6 330.2 142.1 175.2 161.2 227.3 244.8 200.6 262.7 238.0 369.7 215.6 852.4 240.8 252.7 126.7 505.5 279.6 128.9 135.9 125.0 102.4 249.4 333.7 160.6 116.8 218.1 125.1 152.6 175.3 191.0 166.8 273.7 366.5 353.6 206.9 195.5 218.1 205.5 224.8 210.8 210.5 233.3 225.3 357.4 252.0 226.6 240.3 311.2 266.1 247.4 67.5 205.3 208.5 288.2 346.2 339.9 156.5 157.7 146.4 159.5 159.1 191.3 159.5 159.4 173.3 150.1 173.3 151.9 217.9 80.1 121.9 0.0 265.1 0.0 390.5 0.0 196.9 160.1 224.4 272.3 0.0 190.1 65.0 185.8 25.0 367.3 205.8 42.1 655.4 310.0 1057.6 223.4 169.0 198.0 70.4 144.7 0.0 302.3 438.5 172.4 125.4 251.9 77.0 162.3 181.3 205.0 293.1 109.4 0.0 118.9 0.0 140.1 0.0 318.4 211.9 162.9 0.0 0.0 186.3 181.8 151.4 0.0 0.0 340.9 127.7 174.2 261.9 630.5 202.2 462.5 68.5 128.4 138.1 169.0 143.0 505.9 279.5 219.8 0.0 460.5 208.0 193.8 139.5 505.0 SORBS1 "CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12" ENSG00000095637 "Sorbin and SH3 domain containing 1" Q9BX66 10 95311771-95561414 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 800.2;Cardiomyocytes: 612.3;Excitatory neurons: 401.1;Inhibitory neurons: 295.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 6.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 6.1" "Cell line enhanced" "Detected in many" "CACO-2: 28.0;Hep G2: 19.5;HMC-1: 48.3;SK-MEL-30: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027559, CAB032850, HPA043084" Enhanced Supported "Plasma membrane,Focal adhesion sites,Centrosome" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Focal adhesion sites" "Plasma membrane, Centrosome" "CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307" "prognostic favorable (2.84e-4)" "unprognostic (3.53e-1)" "unprognostic (1.89e-1)" "unprognostic (7.85e-2)" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (2.98e-2)" "unprognostic (5.30e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-2)" "unprognostic (3.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.40e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.55e-2)" "unprognostic (5.01e-3)" 370.8 21.6 128.5 53.3 153.3 4.7 78.3 101.7 144.1 46.0 42.6 312.8 25.6 169.4 32.1 155.5 99.2 81.3 351.6 127.0 165.4 17.6 49.3 34.4 3.1 164.0 161.5 19.0 22.0 26.4 11.5 30.3 126.7 140.6 67.0 39.0 24.5 217.4 190.5 24.5 62.7 151.0 138.9 8.1 143.1 14.4 127.0 3.7 14.8 155.9 1.5 235.3 47.1 139.9 1.6 1.2 12.4 3.1 4.2 0.2 2.4 0.4 0.1 0.4 0.1 28.0 10.9 0.0 2.2 0.2 4.2 0.6 2.4 0.6 0.4 3.2 4.5 7.2 0.4 19.5 1.5 0.0 48.3 0.9 0.4 0.5 0.3 0.2 4.9 1.9 11.7 2.3 1.3 0.8 0.1 0.8 5.7 6.2 2.6 1.0 4.0 0.4 15.1 18.3 4.9 3.7 1.8 0.6 45.2 8.9 2.1 0.4 0.3 0.1 4.0 0.1 2.4 1.8 0.5 0.2 4.8 0.5 11.7 6.1 0.1 1.2 0.4 0.6 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.3 0.1 128.5 153.3 101.7 144.1 127.0 165.4 164.0 161.5 126.7 138.9 127.0 139.9 42.2 22.4 20.9 800.2 0.8 11.6 8.7 0.0 5.2 7.5 6.5 19.3 612.3 12.8 1.3 1.8 2.1 20.2 1.0 4.0 3.9 7.2 70.4 1.4 15.8 25.7 6.0 16.0 401.1 3.1 2.4 21.4 8.6 1.6 16.4 8.2 30.4 50.5 3.1 6.7 295.1 10.9 0.0 3.8 12.0 48.6 7.5 1.1 14.2 163.9 0.7 22.1 1.0 155.3 22.6 2.3 2.8 76.8 1.1 4.7 1.2 6.1 0.1 5.5 0.0 11.8 51.6 3.4 3.7 1.9 12.5 29.6 1.6 0.1 5.1 5.9 SORBS2 "ARGBP2, KIAA0777" ENSG00000154556 "Sorbin and SH3 domain containing 2" O94875 4 185585444-185956652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 575.3;thyroid gland: 277.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 557.8;Cone photoreceptor cells: 771.5;Excitatory neurons: 397.4;Rod photoreceptor cells: 815.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 241.1;TIME: 133.1;WM-115: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (3.30e-2)" "unprognostic (5.09e-2)" "unprognostic (1.20e-1)" "prognostic favorable (6.07e-5)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "prognostic favorable (1.47e-5)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" "unprognostic (8.30e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.10e-6)" "unprognostic (1.26e-1)" "unprognostic (2.42e-1)" "unprognostic (2.79e-3)" "unprognostic (2.51e-2)" 27.4 166.6 32.3 11.5 62.5 0.1 38.9 0.0 40.3 31.8 14.1 85.9 10.5 17.6 34.3 36.5 37.0 29.0 575.3 38.0 2.1 32.4 126.5 19.2 5.3 16.1 0.9 17.6 117.3 100.5 29.1 69.0 18.2 56.1 25.9 156.1 74.4 62.3 6.9 8.1 16.1 31.6 1.9 26.2 40.5 3.0 2.8 31.1 277.6 12.8 11.3 50.1 16.3 26.7 0.4 0.5 241.1 0.2 33.6 59.4 12.0 0.5 0.2 0.0 0.6 6.8 19.4 0.0 25.8 2.2 1.6 0.0 0.0 9.1 0.2 0.1 3.6 3.8 18.4 16.0 0.0 0.0 0.2 22.0 2.7 37.1 2.9 31.7 44.8 6.7 0.1 0.2 2.7 0.0 0.0 0.7 23.4 0.0 0.0 23.9 0.0 0.2 32.8 5.9 30.2 9.0 0.0 0.1 14.9 23.3 7.3 0.0 133.1 18.2 2.4 0.3 9.4 0.3 0.4 0.3 39.3 0.0 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.3 62.5 0.0 40.3 38.0 2.1 16.1 0.9 18.2 1.9 2.8 26.7 71.1 22.4 41.4 18.9 2.4 6.5 18.5 44.1 21.6 99.7 81.4 45.6 557.8 228.8 85.5 64.4 771.5 12.8 1.9 8.5 5.9 166.1 3.2 80.8 4.0 69.6 41.9 5.3 397.4 110.1 2.6 30.7 30.1 75.3 2.5 102.4 26.7 206.6 1.6 5.0 247.3 14.0 61.1 4.1 8.0 6.9 5.6 2.5 19.6 150.9 3.1 265.7 12.3 204.1 7.2 57.7 27.1 3.8 5.3 25.8 15.8 25.8 149.3 815.8 118.3 4.4 297.8 0.3 1.4 12.4 5.5 10.9 1.8 13.2 26.8 19.3 SSTR5 ENSG00000162009 "Somatostatin receptor 5" P35346 16 1078781-1080142 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 6.9;kidney: 2.9;pituitary gland: 7.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "hypothalamus: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "Hep G2: 15.4;PC-3: 54.7" "Group enriched" "Detected in some" 5 "basal ganglia: 4.1;hypothalamus: 2.3" "Low region specificity" "Detected in many" HPA066503 Supported "Plasma membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane" "HPA066503: AB_2685679" "unprognostic (2.16e-2)" "unprognostic (7.31e-2)" "unprognostic (3.69e-2)" "unprognostic (2.39e-2)" "unprognostic (2.14e-1)" "unprognostic (9.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.72e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (4.09e-2)" 0.0 2.5 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 6.9 0.3 1.5 2.9 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.0 7.3 0.0 0.1 0.7 0.0 0.2 1.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.4 0.0 0.2 0.2 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 54.7 0.0 2.1 0.6 0.0 2.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.3 1.5 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393881-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.4;heart muscle: 3.9" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.0 0.3 0.6 0.0 0.6 0.0 0.4 0.6 2.2 0.8 0.0 0.1 0.0 0.4 0.8 0.0 0.0 0.2 3.9 1.5 1.2 0.1 0.0 0.0 0.0 8.4 1.9 0.0 0.0 0.0 0.2 0.0 8.2 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.4 1.8 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.2 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.0 4.1 0.0 0.0 0.0 11.7 8.9 0.0 0.0 0.6 5.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.2 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 2.2 1.5 1.2 8.4 1.9 8.2 0.1 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SYNDIG1 "C20orf39, DSPC2, FLJ14220, IFITMD5, TMEM90B" ENSG00000101463 "Synapse differentiation inducing 1" Q9H7V2 20 24469629-24666616 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;heart muscle: 26.9" "Group enriched" "Detected in some" 4 "Excitatory neurons: 157.4;Microglial cells: 472.2;Oligodendrocytes: 214.3" "Cancer enhanced" "Detected in many" "glioma: 10.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 15.4;RH-30: 43.4;RPMI-8226: 43.6;SCLC-21H: 10.0;U-87 MG: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044271, HPA059267" Enhanced Vesicles NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "HPA044271: AB_2732515, HPA059267: AB_2683961" "unprognostic (9.33e-2)" "unprognostic (1.83e-2)" "unprognostic (2.17e-1)" "unprognostic (9.56e-2)" "unprognostic (5.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (4.69e-2)" "unprognostic (4.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.94e-2)" "unprognostic (7.75e-3)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.16e-6)" "unprognostic (1.40e-3)" 1.8 0.9 23.7 1.5 23.2 0.0 0.5 27.6 26.8 3.2 8.6 0.8 1.2 3.2 0.7 0.2 4.2 8.8 26.9 21.1 21.0 4.9 0.0 0.7 2.0 28.4 23.0 0.9 0.7 0.2 0.7 0.2 28.4 3.3 0.9 1.8 0.3 12.3 0.1 0.2 2.1 2.2 27.8 0.7 1.6 0.8 25.3 1.6 4.8 0.1 2.4 1.7 2.0 36.4 0.0 0.3 2.6 0.0 0.8 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 15.4 0.0 0.8 0.0 0.0 2.6 0.0 0.0 0.0 43.4 43.6 0.0 0.0 10.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 23.2 27.6 26.8 21.1 21.0 28.4 23.0 28.4 27.8 25.3 36.4 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.2 0.7 0.6 1.2 0.0 0.0 157.4 0.0 0.0 2.0 0.0 0.8 0.0 21.9 0.0 0.0 0.1 3.3 69.7 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.0 472.2 0.0 1.9 0.0 41.7 214.3 1.5 0.0 7.2 0.0 0.0 0.0 5.9 0.0 0.5 0.0 0.5 1.4 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TAF9B "DN-7, DN7, TAF9L, TAFII31L, TFIID-31" ENSG00000187325 "TATA-box binding protein associated factor 9b" Q9HBM6 X 78129748-78139650 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045275, HPA058961" Approved Approved Nucleoplasm NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "HPA045275: AB_10962831, HPA058961: AB_2683863" "unprognostic (3.62e-3)" "prognostic favorable (5.40e-5)" "unprognostic (1.91e-1)" "unprognostic (1.78e-1)" "unprognostic (4.20e-2)" "unprognostic (6.43e-2)" "unprognostic (1.02e-1)" "unprognostic (5.67e-2)" "unprognostic (3.46e-2)" "unprognostic (2.37e-3)" "unprognostic (5.68e-2)" "unprognostic (9.56e-2)" "unprognostic (8.42e-3)" "unprognostic (8.71e-2)" "unprognostic (9.34e-3)" "unprognostic (9.47e-2)" "unprognostic (2.62e-1)" 15.7 11.4 12.8 10.4 14.0 12.0 15.6 13.7 17.5 15.5 12.9 14.5 6.5 23.1 14.2 18.2 16.1 13.5 23.1 13.7 15.1 18.2 14.0 11.0 11.5 13.5 12.4 14.4 9.7 22.9 12.0 13.1 13.4 19.8 10.0 33.6 10.1 17.2 15.4 12.3 8.1 30.7 14.5 10.7 11.0 10.4 12.8 17.0 18.9 14.0 10.7 16.5 10.3 18.0 25.6 21.8 52.7 23.3 20.2 20.5 7.9 22.5 20.7 35.6 19.8 30.7 43.3 29.2 31.2 24.5 29.0 19.8 79.5 18.5 36.9 45.7 27.6 16.0 28.7 28.2 20.1 25.4 17.0 26.3 9.8 39.1 26.7 22.5 21.8 28.7 33.4 61.1 32.0 39.1 40.3 19.8 61.9 33.4 40.4 34.3 68.6 26.9 24.6 51.2 33.3 33.1 62.3 26.7 24.7 27.2 43.3 18.2 23.3 27.4 41.6 30.2 27.4 26.2 56.8 21.3 47.6 50.5 39.3 0.8 4.1 1.2 6.6 4.4 12.5 5.6 15.1 11.5 5.2 5.2 15.1 11.3 1.9 14.2 3.3 6.5 17.7 8.7 12.8 14.0 13.7 17.5 13.7 15.1 13.5 12.4 13.4 14.5 12.8 18.0 14.9 9.6 7.8 2.9 6.6 15.6 26.7 6.1 56.3 16.1 12.2 8.8 26.6 10.0 6.2 20.2 8.4 18.1 4.5 1.4 7.9 6.8 1.0 4.7 8.2 16.4 12.6 14.1 4.0 8.6 16.4 12.9 4.1 5.0 2.5 3.0 13.2 5.6 6.9 8.4 4.0 5.4 12.2 3.5 7.9 1.7 10.5 4.9 23.2 3.7 7.6 22.9 2.1 4.5 8.9 3.9 5.0 13.9 14.1 11.7 1.0 17.6 4.1 13.6 19.7 9.3 20.4 5.9 33.5 23.0 8.8 8.5 9.9 3.0 4.4 13.2 TANGO2 "C22orf25, DKFZp761P1121" ENSG00000183597 "Transport and golgi organization 2 homolog" Q6ICL3 22 20017014-20067164 "Disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 78.9" "Cell type enhanced" "Detected in all" "Erythroid cells: 111.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003080 Approved NA NA 200000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "HPA003080: AB_1078350" "unprognostic (4.05e-1)" "unprognostic (1.90e-3)" "unprognostic (2.16e-1)" "unprognostic (1.06e-1)" "unprognostic (3.48e-1)" "unprognostic (1.37e-1)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (6.13e-2)" "unprognostic (6.76e-2)" "prognostic favorable (3.01e-4)" "unprognostic (2.21e-1)" "unprognostic (1.83e-3)" "unprognostic (3.95e-2)" "unprognostic (5.49e-2)" "unprognostic (2.60e-1)" "unprognostic (2.62e-2)" 17.0 26.7 20.9 13.8 19.2 50.5 13.4 19.1 23.8 10.9 15.9 14.9 9.8 13.0 9.2 11.5 10.9 10.9 78.9 21.8 22.4 21.3 20.0 19.2 17.7 24.7 26.6 7.9 15.4 27.7 19.7 11.6 30.2 17.1 11.3 6.4 12.2 12.2 27.7 12.8 16.2 12.0 20.6 34.0 21.2 7.5 25.7 12.4 24.3 29.0 11.7 15.1 9.7 20.5 15.6 14.2 4.8 9.6 33.6 10.9 8.7 15.7 20.8 14.5 12.8 10.0 12.1 6.2 11.1 42.4 20.2 18.9 11.2 17.5 9.2 36.8 11.4 16.9 11.9 12.0 24.6 15.7 29.1 15.6 12.9 21.0 11.6 14.5 21.6 10.4 44.0 13.1 20.8 17.7 10.3 10.7 2.3 37.7 9.5 9.5 12.9 4.0 11.7 19.9 8.4 4.7 16.1 27.7 35.3 10.3 7.0 14.3 14.7 19.0 14.4 25.2 11.0 6.7 4.1 6.4 25.9 12.9 13.6 76.3 44.1 77.8 14.9 53.4 16.2 20.5 15.9 19.2 41.6 15.7 10.0 13.1 55.8 31.3 70.1 14.3 28.7 39.6 20.9 19.2 19.1 23.8 21.8 22.4 24.7 26.6 30.2 20.6 25.7 20.5 5.8 16.0 5.8 10.7 11.9 3.8 3.9 4.2 2.2 4.9 3.9 3.4 17.1 10.0 4.6 7.3 4.2 10.6 10.2 11.5 19.6 11.5 5.5 2.7 3.4 5.7 6.6 111.4 20.6 9.7 17.4 5.9 9.2 4.9 15.2 4.5 6.4 6.4 39.4 10.1 13.3 7.0 8.2 21.6 7.1 15.9 5.0 24.0 19.6 15.9 24.8 7.6 19.6 3.0 30.9 11.6 9.2 4.9 7.2 4.8 13.8 7.7 6.1 2.9 19.7 3.0 6.6 4.8 3.1 5.3 4.5 11.5 9.7 13.0 6.3 3.5 TBX20 ENSG00000164532 "T-box transcription factor 20" Q9UMR3 7 35202430-35254100 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "heart muscle: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "medulla oblongata: 1.2;pons: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.2;HEL: 3.2;HHSteC: 3.4;HMC-1: 3.9;RH-30: 3.8;SH-SY5Y: 7.4;WM-115: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA007840 Approved "Nucleoli fibrillar center" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoli fibrillar center" "HPA007840: " "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.87e-2)" "unprognostic (8.47e-2)" "unprognostic (3.95e-2)" "unprognostic (2.75e-1)" "unprognostic (1.74e-1)" "unprognostic (9.75e-2)" 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 35.9 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.5 3.7 3.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.7 2.3 0.0 0.4 0.0 0.1 0.2 3.2 0.0 0.0 1.7 2.5 3.2 0.9 0.0 3.4 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 3.8 0.0 0.0 0.0 0.2 7.4 0.3 0.0 0.0 1.9 0.0 2.9 0.0 0.0 0.1 2.7 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 TBX5 HOS ENSG00000089225 "T-box transcription factor 5" Q99593 12 114353911-114408442 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial fibrillation, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 88.1;lung: 20.8;placenta: 28.7" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 104.7" "Cancer enhanced" "Detected in some" "lung cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 18.9;BJ hTERT+: 41.5;BJ hTERT+ SV40 Large T+: 9.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HAP1: 16.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008786, HPA064683" Uncertain Approved Nucleoplasm NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA008786: AB_10601720, HPA064683: AB_2685320" "unprognostic (3.09e-2)" "unprognostic (1.53e-1)" "unprognostic (3.79e-2)" "unprognostic (2.75e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-7)" "unprognostic (2.29e-2)" "unprognostic (1.68e-2)" "unprognostic (7.34e-2)" "unprognostic (4.38e-3)" 3.4 0.0 0.1 0.0 0.0 0.0 4.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 88.1 0.9 0.0 0.0 0.0 20.8 0.6 0.3 0.1 0.0 0.0 1.3 0.0 28.7 0.3 3.4 0.0 0.3 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 5.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 18.9 41.5 9.2 12.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 16.3 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.9 0.0 0.3 0.1 0.3 0.0 0.0 0.2 2.9 0.0 0.6 1.6 0.0 0.1 0.0 0.0 0.0 4.5 0.1 0.1 104.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.1 0.0 0.0 0.0 2.1 0.3 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 TECRL "DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL" ENSG00000205678 "Trans-2,3-enoyl-CoA reductase like" Q5HYJ1 4 64275257-64409468 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "heart muscle: 554.3" "Cell type enriched" "Detected in some" 35 "Cardiomyocytes: 1775.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" 0.0 0.3 0.1 0.1 0.3 1.0 0.6 0.8 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.1 554.3 0.1 0.5 0.0 0.0 0.2 0.4 0.3 0.1 0.1 0.5 0.1 0.0 0.1 0.4 1.7 0.0 0.5 0.3 0.0 56.2 1.0 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.6 1.9 0.0 0.3 0.0 0.9 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.3 0.1 0.5 0.3 0.1 0.4 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1775.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.2 0.0 0.0 50.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TENM2 "KIAA1127, ODZ2, Ten-M2, TEN2" ENSG00000145934 "Teneurin transmembrane protein 2" Q9NT68 5 167284799-168264157 "Predicted membrane proteins, Transporters" "Cell adhesion, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 9.8;heart muscle: 35.1" "Group enriched" "Detected in many" 5 "Astrocytes: 512.9;Excitatory neurons: 706.2;Inhibitory neurons: 965.9" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 15.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 66.1;HBEC3-KT: 43.0;HDLM-2: 43.3;U-138 MG: 74.6;U-2 OS: 64.0;U-251 MG: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038018, HPA038420, HPA068691" Uncertain Approved Nucleoli No No 11000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli "HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019" "unprognostic (6.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.94e-2)" "unprognostic (9.16e-3)" "unprognostic (3.88e-3)" "unprognostic (3.81e-3)" "unprognostic (5.81e-2)" "unprognostic (2.41e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (3.68e-3)" "unprognostic (4.34e-2)" "unprognostic (4.69e-5)" "unprognostic (3.47e-2)" "unprognostic (1.03e-1)" "unprognostic (5.16e-4)" "prognostic unfavorable (7.52e-4)" 0.1 0.5 2.9 0.0 4.7 0.0 1.9 0.0 9.8 1.3 0.0 0.2 0.4 0.0 0.5 1.9 0.1 0.4 35.1 6.0 1.2 0.8 1.3 0.2 0.0 0.6 0.1 0.7 0.1 0.0 0.7 0.0 1.6 2.2 0.1 4.1 0.5 1.0 0.0 3.2 0.2 0.0 0.0 0.0 0.1 1.3 4.3 2.2 0.4 0.5 1.0 0.1 2.0 0.0 0.1 0.0 13.4 0.0 0.0 0.4 0.0 1.9 0.0 0.7 1.8 0.0 0.0 0.0 0.0 66.1 1.7 0.0 0.0 43.0 0.8 43.3 0.0 0.0 0.2 0.0 2.0 0.0 0.0 3.0 7.4 0.3 5.3 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.3 9.8 0.2 0.0 0.0 6.6 0.0 0.1 0.0 0.1 2.4 3.8 0.1 0.0 74.6 64.0 0.1 50.0 0.0 0.0 0.0 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 4.7 0.0 9.8 6.0 1.2 0.6 0.1 1.6 0.0 4.3 0.0 0.5 0.0 0.0 512.9 0.0 14.8 1.1 20.3 33.6 15.5 0.3 13.0 144.0 0.0 1.4 0.0 18.8 0.0 0.0 1.0 0.0 3.4 23.5 0.1 0.3 1.7 0.0 0.0 706.2 0.2 0.0 2.2 0.0 0.2 1.3 1.6 0.4 5.1 0.1 121.1 965.9 0.7 0.0 0.0 1.2 18.2 4.4 0.2 1.8 36.5 0.0 2.3 0.0 21.6 12.8 0.0 0.0 61.7 0.0 1.4 0.3 0.0 0.6 1.8 0.0 0.4 1.5 1.2 1.1 1.4 1.7 0.0 0.1 0.0 0.4 0.1 TLL2 ENSG00000095587 "Tolloid like 2" Q9Y6L7 10 96364608-96513926 "Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.7;heart muscle: 3.6;tongue: 1.9" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 82.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "RPTEC TERT1: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.28e-2)" "unprognostic (7.54e-4)" "unprognostic (1.50e-1)" "unprognostic (3.31e-3)" "unprognostic (2.67e-1)" "unprognostic (2.14e-3)" "unprognostic (1.31e-2)" "unprognostic (3.52e-4)" "unprognostic (7.08e-2)" "unprognostic (2.50e-1)" "unprognostic (6.71e-2)" "unprognostic (3.37e-2)" "unprognostic (4.98e-4)" "unprognostic (2.90e-1)" "unprognostic (8.41e-2)" "unprognostic (1.95e-4)" "unprognostic (2.30e-1)" 0.0 0.1 1.3 0.1 1.5 0.2 0.0 0.6 1.7 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.3 3.6 1.2 1.3 0.0 0.0 0.0 0.1 2.6 1.0 0.1 0.2 0.0 0.4 0.1 2.9 0.1 0.1 0.2 0.2 0.0 0.9 0.0 0.3 0.1 2.2 0.1 0.3 0.1 4.7 0.0 0.1 1.9 0.0 0.0 0.0 2.0 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.1 0.2 0.1 0.2 0.1 0.0 2.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.6 0.1 0.1 0.4 0.0 20.1 0.0 0.7 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.6 1.7 1.2 1.3 2.6 1.0 2.9 2.2 4.7 2.0 0.4 0.0 1.1 0.3 0.7 0.1 0.5 1.9 0.0 0.0 0.0 0.0 5.5 1.5 1.0 0.0 0.0 2.4 0.1 0.0 0.0 0.2 6.9 0.2 0.1 1.4 0.0 0.0 1.9 0.6 0.1 2.4 1.5 0.5 0.0 82.4 0.0 0.0 0.3 0.0 5.6 1.7 2.0 0.3 1.4 5.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 18.6 0.7 0.0 0.0 1.4 0.8 1.0 0.2 0.2 0.0 0.0 0.7 0.4 0.2 2.6 0.0 0.4 3.4 0.3 0.1 0.2 0.6 TMEM88 "FLJ20025, MGC71744" ENSG00000167874 "Transmembrane protein 88" Q6PEY1 17 7855066-7856099 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 98.5" "Group enriched" "Detected in many" 7 "Adipocytes: 177.3;Endothelial cells: 142.1;Hepatic stellate cells: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Group enriched" "Detected in many" 6 "AN3-CA: 65.2;HHSteC: 42.3;HUVEC TERT2: 51.4;NTERA-2: 26.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052991 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA052991: AB_2682006" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (3.44e-2)" "unprognostic (3.03e-1)" "unprognostic (6.49e-2)" "prognostic favorable (4.43e-6)" "unprognostic (1.98e-1)" "unprognostic (2.64e-2)" "unprognostic (2.18e-1)" "unprognostic (5.68e-3)" "unprognostic (9.04e-2)" "unprognostic (1.09e-2)" "unprognostic (2.68e-3)" "unprognostic (1.71e-1)" "unprognostic (7.56e-2)" "unprognostic (2.72e-1)" 63.2 22.3 11.2 7.9 11.0 6.9 29.5 12.4 24.4 20.0 14.3 18.1 5.7 24.1 3.6 6.4 26.4 12.7 98.5 11.3 11.6 37.7 5.9 14.1 3.6 12.6 11.6 8.5 10.8 7.4 21.4 23.7 12.0 19.3 2.7 2.4 9.3 6.3 35.4 3.8 15.4 10.1 11.0 15.9 18.2 4.9 12.9 2.5 39.6 36.8 0.8 19.1 14.0 10.9 0.2 0.8 8.1 65.2 0.0 0.3 3.9 0.4 0.2 0.1 0.2 1.9 0.3 0.4 0.3 0.7 0.4 0.5 0.6 0.4 0.1 0.0 0.1 0.5 1.2 1.1 42.3 0.6 2.6 1.0 1.8 1.2 0.3 0.6 51.4 0.9 1.2 0.1 0.8 5.0 0.5 1.2 26.5 0.3 0.0 0.3 0.2 0.1 0.6 1.6 0.7 3.7 0.5 0.8 2.0 2.2 1.4 0.2 5.2 0.4 1.6 2.2 0.5 0.2 0.1 0.4 0.2 0.4 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 11.2 11.0 12.4 24.4 11.3 11.6 12.6 11.6 12.0 11.0 12.9 10.9 177.3 6.4 2.2 2.0 6.2 4.1 4.0 1.4 2.2 4.7 7.9 5.2 5.9 0.0 2.4 1.8 4.2 3.1 3.1 2.0 0.0 2.2 3.0 3.1 2.0 142.1 6.6 0.0 0.6 2.2 1.0 19.2 4.6 6.7 4.5 1.8 109.9 2.4 2.6 3.3 0.9 2.5 0.0 7.3 9.3 8.6 0.9 9.9 0.0 5.6 0.2 0.6 0.0 0.0 0.1 4.0 5.7 0.0 1.0 6.5 2.4 0.6 1.5 1.4 0.0 11.3 6.5 1.7 1.8 2.7 3.1 5.2 2.5 0.8 1.5 3.2 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 622 "heart muscle: 10813.5" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 12618.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6" "Region enhanced" "Detected in many" "olfactory bulb: 10.9" "Low region specificity" "Detected in many" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol NA NA 2400000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol Vesicles "CAB009349: AB_793465, HPA046428: AB_2679661" "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 1.1 3.0 0.3 0.0 0.5 0.0 17.3 0.2 0.4 0.7 0.7 0.7 0.0 0.3 0.1 0.8 6.2 0.9 10813.5 0.6 0.2 1.0 1.1 7.3 1.6 0.5 2.8 1.4 2.3 0.2 0.6 1.0 1.3 2.4 0.0 0.2 1.3 0.0 6.5 1.2 0.6 0.0 0.6 0.4 0.7 3.7 0.3 0.1 1.5 2.4 0.0 0.4 0.6 0.3 1.2 0.6 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 0.0 0.3 1.8 6.3 0.0 1.1 1.1 1.2 0.3 0.0 0.0 13.0 3.0 0.0 1.9 0.5 0.0 20.3 0.0 0.6 0.1 0.3 0.1 0.1 0.8 39.1 0.8 0.0 0.6 0.2 0.0 0.7 54.6 0.5 1.9 0.4 0.1 1.8 0.0 0.1 2.2 0.0 0.0 0.2 0.0 2.8 9.5 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.6 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.4 0.6 0.2 0.5 2.8 1.3 0.6 0.3 0.3 0.1 0.0 0.0 0.0 0.2 6.9 0.0 0.8 13.6 0.0 1.0 0.9 12618.4 8.6 1.8 5.5 0.0 1.4 0.1 0.4 0.0 0.7 56.2 3.5 0.1 131.3 1.8 0.0 0.0 0.2 0.5 202.7 0.0 1.3 0.0 996.2 0.0 0.0 2.2 1.7 0.2 0.4 2.0 0.3 0.7 222.9 0.3 4.6 1.8 1.9 0.0 4.2 0.0 0.0 0.1 1.0 0.0 1.9 0.0 0.0 0.0 0.1 11.2 0.5 0.0 0.4 123.6 6.4 16.1 0.7 2.8 2.5 0.6 1.2 1.0 0.1 TNNI3K CARK ENSG00000116783 "TNNI3 interacting kinase" Q59H18 1 74235387-74544428 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "heart muscle: 58.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 27.0;Early spermatids: 32.0;Late spermatids: 6.6;Proximal tubular cells: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.0" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (1.04e-2)" "unprognostic (1.34e-2)" "unprognostic (3.83e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-1)" "unprognostic (3.40e-2)" "unprognostic (3.05e-1)" "unprognostic (2.48e-3)" "unprognostic (2.00e-1)" "unprognostic (9.66e-2)" "unprognostic (5.04e-2)" "unprognostic (1.80e-1)" "unprognostic (3.59e-3)" "unprognostic (4.88e-3)" "unprognostic (1.20e-1)" "unprognostic (8.80e-2)" "unprognostic (8.77e-2)" 1.8 1.4 3.6 0.3 3.6 0.1 1.4 4.9 7.2 1.0 2.0 2.0 0.4 1.3 2.5 0.6 1.5 0.4 58.7 3.7 3.9 3.4 0.4 0.9 0.4 3.3 3.2 1.5 0.4 0.7 2.3 0.0 3.6 1.1 0.5 5.2 0.8 0.4 1.5 1.6 0.8 0.9 3.5 1.4 1.1 4.0 3.5 0.4 1.0 0.6 0.5 1.4 0.9 4.8 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.2 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.6 3.6 4.9 7.2 3.7 3.9 3.3 3.2 3.6 3.5 3.5 4.8 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 1.2 0.2 0.3 27.0 0.0 0.1 1.8 0.0 0.0 0.0 0.1 1.9 0.1 32.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 6.6 0.9 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 8.0 0.1 0.5 0.0 0.6 0.8 0.5 1.4 0.0 0.3 0.1 0.1 0.0 0.0 0.2 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377764 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 205 "heart muscle: 10670.6" "Cell type enriched" "Detected in many" 32 "Cardiomyocytes: 12561.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 1077.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.8" "CAB015371, HPA015774, HPA017888" Enhanced Approved "Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules" No No 57000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Nucleoli" "Focal adhesion sites, Microtubules" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 2.2 4.9 12.4 0.6 13.9 0.1 11.9 11.7 20.4 2.3 11.7 1.3 0.3 3.2 0.8 7.8 1.9 3.8 10670.6 16.8 11.6 51.9 2.3 22.0 2.7 11.6 11.6 1.3 5.0 0.0 4.5 10.3 11.6 6.1 0.1 0.4 3.6 0.7 16.5 21.7 1.6 0.1 11.6 0.7 2.0 1.7 11.6 2.1 2.0 9.4 0.5 19.3 5.0 15.8 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.5 0.0 0.0 6.7 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.0 44.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 1.1 0.0 0.0 2.2 3.3 0.0 0.0 1077.7 0.0 0.7 0.4 1.1 0.8 0.1 2.0 0.0 61.2 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 13.9 11.7 20.4 16.8 11.6 11.6 11.6 11.6 11.6 11.6 15.8 0.6 3.2 3.0 0.3 0.0 3.4 1.4 1.7 1.8 3.9 0.9 1.7 12561.8 0.0 1.1 1.8 0.0 3.5 0.0 2.3 0.0 0.4 11.6 1.2 0.2 93.3 0.0 0.0 9.4 0.4 1.2 385.3 1.1 2.4 0.0 0.0 0.0 0.0 3.1 0.0 0.5 1.7 0.0 0.0 0.8 19.3 0.6 0.3 0.0 1.9 2.6 0.0 0.0 0.5 0.7 1.2 1.4 1.2 0.0 2.1 0.8 0.9 0.7 0.6 0.0 8.7 145.8 0.5 0.2 2.5 7.2 4.2 0.1 0.8 3.2 1.5 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451500 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 157.8;Erythroid cells: 181.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: AB_2684702" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favorable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 24.1 20.3 53.2 16.4 63.7 52.2 14.8 61.2 60.9 16.1 55.6 22.4 13.4 14.3 13.0 16.7 13.9 18.7 70.9 47.3 54.0 23.7 14.1 20.7 17.3 92.9 67.6 9.7 15.4 26.6 12.4 23.7 86.8 12.8 22.8 20.1 26.4 15.2 14.8 8.1 16.1 20.4 99.9 18.1 12.2 7.8 69.7 12.4 34.9 26.8 13.6 15.7 9.0 102.2 11.6 15.5 9.4 34.3 61.6 87.4 10.6 39.2 32.8 27.4 31.9 24.4 9.8 7.1 16.3 50.6 26.4 11.2 20.0 12.9 43.5 21.4 13.0 15.5 25.6 15.9 33.8 12.3 18.4 48.4 10.8 28.8 22.2 27.5 40.4 11.0 12.4 26.9 55.8 16.6 9.6 6.9 10.6 11.3 32.7 12.1 24.9 10.6 21.9 15.6 18.6 24.0 21.0 15.5 63.6 13.6 12.4 12.4 50.2 44.2 16.6 31.0 25.7 16.2 30.2 8.3 37.2 18.2 24.4 2.6 5.5 6.2 7.8 7.0 7.3 9.3 10.1 6.7 4.3 14.2 6.9 7.3 3.4 11.1 6.5 2.3 12.6 6.0 53.2 63.7 61.2 60.9 47.3 54.0 92.9 67.6 86.8 99.9 69.7 102.2 34.0 16.0 29.8 37.5 17.8 8.3 3.4 6.3 11.4 45.4 14.4 8.8 157.8 22.8 13.4 9.2 73.0 10.3 9.3 27.9 7.9 13.9 1.9 12.7 20.9 21.0 29.5 181.0 92.3 14.7 4.8 16.9 10.7 25.7 19.6 10.3 15.0 14.3 10.6 77.4 75.6 20.6 10.2 12.9 7.7 3.8 8.1 13.2 26.6 22.5 14.2 5.1 12.3 47.7 57.0 10.7 14.5 12.8 16.8 5.7 21.7 8.9 14.9 22.1 13.1 23.2 23.3 9.4 12.8 16.2 4.1 5.6 16.6 18.7 24.5 7.2 VPS45 "h-vps45, H1, VPS45A, VPS45B" ENSG00000136631 "Vacuolar protein sorting 45 homolog" Q9NRW7 1 150067279-150145329 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 202.8;Late spermatids: 267.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027425, HPA027441" Uncertain Approved Microtubules NA NA "Cluster 44: Non-specific - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" Microtubules "HPA027425: AB_10599415, HPA027441: AB_10602284" "unprognostic (1.57e-1)" "unprognostic (2.75e-1)" "unprognostic (2.03e-1)" "unprognostic (5.51e-2)" "unprognostic (1.56e-2)" "unprognostic (8.36e-3)" "prognostic unfavorable (6.57e-6)" "unprognostic (4.76e-2)" "unprognostic (2.94e-2)" "unprognostic (2.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.49e-2)" "unprognostic (1.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-2)" 19.1 26.8 32.3 12.0 34.6 6.6 17.8 40.2 43.0 20.1 27.7 22.0 12.6 18.7 22.5 16.7 16.1 13.7 38.6 34.0 33.2 21.1 12.5 15.4 13.5 30.6 31.4 14.0 11.1 26.4 19.1 17.3 31.5 18.8 17.2 29.2 14.3 20.1 19.3 16.5 15.3 25.2 31.5 16.2 17.4 11.0 32.9 17.0 19.8 16.6 15.3 18.5 15.9 32.8 31.5 24.3 40.9 27.0 37.1 29.4 19.0 44.7 23.7 45.3 37.4 17.7 26.1 19.3 26.5 37.0 19.9 26.0 42.4 27.0 49.0 38.7 31.1 24.6 33.5 16.8 24.7 17.6 30.2 25.8 24.8 43.5 22.8 29.7 37.1 38.6 34.4 28.3 40.0 53.5 34.7 17.5 28.4 28.7 38.4 23.7 41.9 27.4 31.2 30.0 28.5 59.7 34.9 29.8 46.9 46.2 48.9 45.6 32.6 20.8 25.1 18.7 31.3 21.3 49.4 18.9 30.9 24.4 30.2 23.6 26.6 4.7 16.0 28.0 15.0 15.6 13.6 15.1 25.9 12.8 13.2 13.9 2.5 14.1 19.9 14.6 16.8 18.4 32.3 34.6 40.2 43.0 34.0 33.2 30.6 31.4 31.5 31.5 32.9 32.8 9.4 12.8 14.0 85.8 11.9 7.4 8.2 12.7 13.1 20.9 11.0 10.2 44.0 8.6 11.0 16.5 18.8 20.9 12.5 8.3 7.9 12.3 202.8 9.7 14.2 10.4 7.8 4.6 79.4 7.2 9.5 14.7 12.8 10.1 6.3 24.6 12.1 7.2 19.0 30.3 90.2 8.1 14.2 18.0 8.6 267.9 21.5 13.6 10.6 45.9 19.7 17.9 6.2 92.5 59.5 11.4 11.6 14.7 8.4 6.4 13.6 9.2 11.5 23.8 32.9 7.3 17.1 18.1 15.1 11.6 7.7 14.8 11.2 21.2 9.7 7.9 VSTM2L "C20orf102, dJ1118M15.2" ENSG00000132821 "V-set and transmembrane domain containing 2 like" Q96N03 20 37903111-37945350 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0;heart muscle: 81.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 25.2;Cholangiocytes: 61.5;Club cells: 28.7;Inhibitory neurons: 44.0;Respiratory ciliated cells: 83.0" "Group enriched" "Detected in all" 5 "lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 67.2;HDLM-2: 98.8;hTCEpi: 23.4;SH-SY5Y: 22.5;SK-BR-3: 81.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043832 Uncertain "Secreted - unknown location" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA043832: AB_10968449" "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.63e-5)" "unprognostic (4.96e-3)" "unprognostic (1.56e-1)" "unprognostic (1.83e-2)" "unprognostic (1.39e-1)" "unprognostic (1.52e-1)" "unprognostic (2.34e-3)" "unprognostic (9.86e-2)" "unprognostic (2.00e-1)" "unprognostic (1.85e-3)" "unprognostic (1.29e-3)" "unprognostic (1.68e-1)" "unprognostic (9.66e-2)" "prognostic unfavorable (8.14e-4)" 0.7 6.1 33.9 0.8 33.8 0.0 0.5 1.3 76.9 12.5 0.0 3.2 1.2 1.7 9.7 1.0 15.5 17.5 81.8 87.0 38.7 1.4 3.0 11.5 0.4 19.1 36.5 0.3 2.6 0.0 17.3 0.8 10.6 9.2 0.4 3.0 7.3 16.2 1.1 1.0 1.2 0.8 41.8 29.6 7.9 4.9 45.9 3.0 1.7 0.0 1.0 0.7 0.6 20.0 0.0 0.8 7.7 0.3 0.3 0.4 0.2 0.9 0.0 0.0 0.0 0.3 67.2 0.0 0.4 0.6 0.3 0.2 0.1 3.2 0.0 98.8 1.9 0.1 0.1 0.0 3.6 0.1 2.5 3.2 23.4 0.1 0.7 2.4 0.0 0.1 0.0 0.0 8.4 0.0 0.1 0.1 0.2 2.3 20.1 0.0 0.0 0.3 0.1 0.0 2.6 22.5 2.7 81.0 0.8 0.0 0.4 0.0 4.6 0.0 0.6 0.2 1.5 0.2 0.1 0.0 0.5 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 33.8 1.3 76.9 87.0 38.7 19.1 36.5 10.6 41.8 45.9 20.0 0.1 6.4 1.8 2.0 0.1 0.4 1.2 10.7 1.8 8.5 1.0 0.0 25.2 61.5 28.7 0.0 8.4 0.6 1.3 0.2 0.0 3.7 0.4 0.1 0.5 0.3 18.6 0.0 17.8 0.2 0.2 1.8 4.1 0.0 0.0 1.5 2.9 1.3 0.0 13.5 44.0 1.2 10.2 0.8 1.5 0.9 5.3 0.9 0.0 1.9 0.0 0.9 0.0 3.0 3.2 7.9 2.6 16.1 0.1 5.3 0.1 1.0 83.0 4.6 0.0 0.0 2.9 0.2 0.8 0.1 0.6 0.1 1.2 3.5 0.2 0.7 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133509 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 25.3 25.9 19.9 22.1 20.7 37.5 24.0 23.4 24.8 24.7 18.3 28.9 25.2 22.5 19.2 20.2 19.7 18.0 58.6 19.9 19.9 22.9 15.5 26.0 28.8 21.1 21.2 26.7 17.7 23.3 21.5 22.9 21.1 20.6 28.9 19.9 21.9 20.0 22.3 25.7 28.9 21.2 18.6 26.6 21.5 12.5 22.6 24.2 23.3 15.6 26.9 23.8 22.1 23.9 26.1 12.5 21.1 24.3 83.2 46.0 16.9 29.8 64.0 43.7 46.6 28.8 37.8 22.5 18.1 44.8 41.3 28.0 31.2 25.3 43.2 22.2 22.0 15.9 25.6 29.7 58.6 28.0 27.2 47.8 31.2 47.6 30.5 46.2 33.1 19.2 26.6 22.2 53.9 19.1 15.5 48.0 17.1 16.7 58.4 23.1 30.1 13.7 30.5 29.3 7.3 22.4 27.8 25.9 40.9 30.9 31.6 19.2 49.4 22.0 18.5 62.7 25.0 23.4 48.3 19.1 48.9 51.4 9.0 1.0 9.1 9.9 9.1 11.6 10.1 5.1 8.0 8.8 7.3 4.9 7.7 6.0 4.1 8.2 6.9 4.6 9.2 7.9 19.9 20.7 23.4 24.8 19.9 19.9 21.1 21.2 21.1 18.6 22.6 23.9 16.2 38.5 28.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 10.6 11.0 0.0 0.0 22.9 14.7 0.0 7.4 10.0 0.0 0.0 16.7 0.0 45.7 19.9 7.9 0.0 0.0 0.0 15.6 6.9 8.9 0.0 20.3 15.2 13.5 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.6 0.0 0.0 11.7 41.5 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 7.7 7.8 9.4 0.0 0.0 ZFP57 "bA145L22, bA145L22.2, C6orf40, ZNF698" ENSG00000204644 "ZFP57 zinc finger protein" Q9NU63 6 29672483-29681155 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "heart muscle: 8.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.8;Erythroid cells: 4.6;Extravillous trophoblasts: 4.4;Ionocytes: 8.2;Late spermatids: 5.9;Pancreatic endocrine cells: 4.0;Spermatogonia: 3.6" "Cancer enriched" "Detected in many" 10 "testis cancer: 18.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 5 "basophil: 11.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.1" "Group enriched" "Detected in some" 13 "BEWO: 40.3;SuSa: 12.8" "Low region specificity" "Detected in all" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.35e-1)" "unprognostic (1.74e-1)" "unprognostic (5.02e-2)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.72e-3)" "unprognostic (4.65e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-4)" "prognostic favorable (1.95e-4)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (2.29e-2)" "unprognostic (8.56e-2)" "unprognostic (7.45e-2)" "unprognostic (6.11e-2)" 0.3 0.3 0.2 0.0 0.3 1.8 1.6 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.4 0.2 8.9 0.0 0.0 0.2 0.0 0.6 0.9 0.5 0.2 0.0 0.0 0.0 0.1 1.4 0.3 0.5 0.2 0.0 0.7 2.1 0.0 0.8 0.4 0.2 0.2 1.0 0.0 0.7 0.2 0.3 0.1 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 11.1 1.4 0.0 1.7 0.9 0.7 0.8 1.0 1.1 2.1 0.2 0.3 1.0 0.0 1.3 0.3 0.1 1.5 1.2 0.2 0.3 0.2 0.3 0.0 0.0 0.5 0.2 0.3 0.2 0.2 0.8 1.1 0.0 0.6 0.0 0.7 0.3 0.2 0.4 2.8 0.0 0.6 1.8 4.8 0.0 0.2 0.0 0.0 0.2 0.7 0.0 0.0 0.9 2.1 0.0 0.0 0.1 0.0 4.6 0.0 1.1 4.4 0.6 1.1 0.0 2.5 2.0 0.0 0.0 1.2 0.0 0.1 0.0 8.2 0.0 1.3 5.9 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 2.1 4.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 3.6 0.3 0.1 0.3 1.7 0.2 0.1 0.1